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Abstract:
Glioblastoma is the most common and aggressive adult brain malignancy 
against which conventional surgery and chemoradiation provide limited 
benefit. Even when a good treatment response is obtained, recurrence 
inevitably occurs either locally (c.80%) or distally (c.20%), driven by 
cancer clones that are often genomically distinct from those in the 
primary tumour. Glioblastoma cells display a characteristic infiltrative 
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phenotype, invading the surrounding tissue and often spreading across 
the whole brain. Cancer cells responsible for relapse can reside in two 
compartments of residual disease that are left behind after treatment: 
the infiltrated normal brain parenchyma, and the sub-ventricular zone 
(SVZ). However, these two sources of residual disease in glioblastoma 
are understudied because of the difficulty in sampling these regions 
during surgery. Here we present the results of whole-exome sequencing 
of 69 multi-region samples collected using fluorescence-guided resection 
from 11 patients, including the infiltrating tumour margin (M) and the 
SVZ for each patient, as well as matched blood. We used a phylogenomic 
approach to dissect the spatio-temporal evolution of each tumour and 
unveil the relation between residual disease and the main tumour mass. 
We also analysed two patients with paired primary-recurrence samples 
with matched residual disease. Our results suggest that infiltrative 
subclones can arise early during tumour growth in a subset of patients. 
After treatment, the infiltrative subclones may seed the growth of a 
recurrent tumour, thus representing the ‘missing link’ between the 
primary tumour and recurrent disease. These results are consistent with 
recognised clinical phenotypic behaviour and suggest that more specific 
therapeutic targeting of cells in the infiltrated brain parenchyma may 
improve patient’s outcome.
 
Page 1 of 185 Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
1
Evolutionary dynamics of residual disease in 
human glioblastoma
I. Spiteri1,*, G. Caravagna1,*, G. D. Cresswell1, A. Vatsiou1, D. Nichol1, A. Acar1, L. Ermini1, K. 
Chkhaidze1, B. Werner1, R. Mair2, E. Brognaro3, R. G. W. Verhaak4, G. Sanguinetti5, S. G. M. 
Piccirillo6,§, C. Watts7,§, A. Sottoriva1,§.
1. Evolutionary Genomics & Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. 
2. Department of clinical Neurosciences, University of Cambridge, Cambridge, UK.
3. Department of Neurosurgery, S. Maria della Misericordia Hospital, Rovigo, Italy.
4. Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
5. School of Informatics, University of Edinburgh, Edinburgh, UK.
6. Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, USA.
7. Birmingham Brain Cancer Program, Institute of Cancer Genome Sciences, University of Birmingham, Birmingham, UK.
* These authors contributed equally to this work
§ Correspondence should be addressed to:
Dr. Andrea Sottoriva 
The Institute of Cancer Research
Molecular Pathology
15 Cotswold road
Sutton
London
Surrey
SM2 5NG
United Kingdom of Great Britain and Northern Ireland
Phone: +(44) 2087224072
andrea.sottoriva@icr.ac.uk
Abstract
Glioblastoma is the most common and aggressive adult brain malignancy against which 
conventional surgery and chemoradiation provide limited benefit. Even when a good 
treatment response is obtained, recurrence inevitably occurs either locally (c.80%) or distally 
(c.20%), driven by cancer clones that are often genomically distinct from those in the primary 
tumour. Glioblastoma cells display a characteristic infiltrative phenotype, invading the 
surrounding tissue and often spreading across the whole brain. Cancer cells responsible for 
relapse can reside in two compartments of residual disease that are left behind after 
treatment: the infiltrated normal brain parenchyma, and the sub-ventricular zone (SVZ). 
However, these two sources of residual disease in glioblastoma are understudied because of 
the difficulty in sampling these regions during surgery. Here we present the results of whole-
exome sequencing of 69 multi-region samples collected using fluorescence-guided resection 
from 11 patients, including the infiltrating tumour margin (M) and the SVZ for each patient, as 
well as matched blood. We used a phylogenomic approach to dissect the spatio-temporal 
evolution of each tumour and unveil the relation between residual disease and the main 
tumour mass. We also analysed two patients with paired primary-recurrence samples with 
matched residual disease. Our results suggest that infiltrative subclones can arise early 
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during tumour growth in a subset of patients. After treatment, the infiltrative subclones may 
seed the growth of a recurrent tumour, thus representing the ‘missing link’ between the 
primary tumour and recurrent disease. These results are consistent with recognised clinical 
phenotypic behaviour and suggest that more specific therapeutic targeting of cells in the 
infiltrated brain parenchyma may improve patient’s outcome.
Key words: glioblastoma, tumour margin, subventricular zone, cancer evolution, phylogenetics
Key message: In this study we investigate the evolution of residual disease in glioblastoma 
that is left behind after surgery, in particular cancer cells in the infiltrative tumour margin and 
in the subventricular zone. We found that residual disease samples contained early precursor 
cancer clones that were involved in the development of the disease and may contribute to 
recurrence.
Introduction
Glioblastoma (GB) is a lethal brain cancer against which effective therapeutic options are 
lacking [1]. The disease is characterised by variegated clinical phenotypes[2-4] and intra-
tumour heterogeneity (ITH) [5-7]. The disease aetiology and clinical course have distinct 
features compared to other cancers. Unlike other solid tumours, glioblastoma rarely 
metastasises outside the brain, but it invariably recurs, limiting the median survival to 
approximately 14 months [1]. In approximately 80% of aggressively treated patients, disease 
progression/recurrence occurs within 2cm of the resection margin. In the remaining patients, 
even when complete surgical removal of the primary lesion was possible, the tumour recurs 
distally [6-8] and even drastic hemispherectomy procedures fail to eradicate the disease [9]. 
Cancer cells from these distal recurrent lesions, despite sharing a common ancestor with the 
primary tumour, are often genomically distinct [6-8]. Moreover, at diagnosis glioblastoma 
already displays a characteristic infiltrative phenotype, invading the surrounding brain tissue 
and often diffusely infiltrating the whole brain [10]. We have previously shown that malignant 
clones present in the sub-ventricular zone (SVZ), a known neural stem cell germinal niche, 
often contain tumour precursor cells [11], a finding that has been recently corroborated [12]. 
Indeed, infiltration is ubiquitous in glioblastoma, with cells migrating through diverse regions of 
the brain microenvironment including white matter tracts [13] and blood vessels [14]. In 
addition, up to 10% of glioblastoma cases present as multifocal disease at diagnosis [15], a 
rare occurrence in other solid tumours. 
The accumulating clinical and genomic evidence suggests that infiltration may be a very early 
event in glioblastoma development, so that no matter how early a cancer is detected, it has 
already spread to distal regions of the brain, including the normal brain parenchyma and the 
SVZ (Figure 1A). After treatment (Figure 1B), infiltrative cells in the brain parenchyma and in 
the SVZ can drive relapse. Thus, even in the case of optimal surgery and when the tumour 
mass has been macroscopically resected, residual disease will trigger new growth, giving rise 
to recurrence, either locally or distally (Figure 1C). We argue that the recent seminal studies 
performed on primary-recurrent matched glioblastoma samples [6-8] point at the infiltrative 
population as the “missing link”, connecting the primary and the recurrent malignant clone in 
the evolution of the disease. 
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Methods 
Patient cohort and samples
Sixty-nine tissue samples were collected from neurosurgical fluorescence-guided resections 
performed on ten IDH1 wildtype glioblastoma patients and one IDH1 mutant anaplastic 
astrocytoma patient (see Table S1 for clinical information). Between 5 and 9 multiple samples 
from the tumour mass (T, at least 1cm apart), sub-ventricular zone (SVZ) and infiltrative 
margin (M) areas were collected from each patient (Figure 2). Tumour mass samples were 
numbered as the surgery progressed and hence T4 samples tend to be deeper into the 
resection cavity than T1 samples. SVZ samples are taken after T4. In the case of the two 
primary/recurrence cases, 3 samples (T, SVZ, M) were taken during the primary and 
secondary surgical resections for a total of 6 specimens per patient. Thirty 10-um 
cryosections were taken from each frozen tissue for DNA extraction using the DNeasy Blood 
& Tissue kit (Qiagen). Patient informed consent was obtained and tissue collection/storage 
protocols were compliant with the UK Human Tissue Act 2004 and approved by the Local 
Regional Ethics Committee (LREC ref 04/Q0108/60). No difference in 5-ALA labelling 
capacity was observed between patients. 
Whole-exome and targeted sequencing
Between 100-300ng of DNA from each of the 69 tumour specimens and 11 blood samples 
were used for whole exome sequencing using the Agilent SureSelectXT Human All Exon V5 
Kit. Median coverage was 157X (min. 108X, max. 187X). A custom targeted sequencing 
panel for 891 SNVs (covered by a total of 5,090 amplicons) identified from the exome 
sequencing data was designed using Agilent’s Haloplex technology (TES1). In addition, we 
designed a separate Agilent SureSelect XT2 capture panel to specifically validate 1,054 
SNVs found in the M and SVZ samples across all patients (TES2). Both amplicon (TES1) and 
targeted capture (TES2) libraries were sequenced on an Illumina HiSeq2500 obtaining a 
median coverage of 4,050X and 1,128X respectively in reported variants (Figure 3A and S1). 
Copy number alterations per sample are reported in Figure 3B. See Supplementary Material 
and Methods for details about bioinformatics analysis.
Results
Intra-tumour heterogeneity in the tumour mass and residual disease
We performed fluorescence-guided multi-region sampling of different regions from primary 
tumours (T1, T2, T3, …; Figure 2A) and also collected samples from the infiltrative margin M 
(n=11; Figure 2B) and the SVZ (n=15; Figure 2C). The margin is defined by non-fluorescent 
tissue beyond the fluorescent tumour mass. We previously reported that this area appears 
histologically as normal brain and is composed by only 5-10% of tumour cells [16]. The 
tumour mass and SVZ samples displayed high tumour content (median 58.5% and 22.1% 
respectively). The SVZ samples are fluorescent and we demonstrated contain cancer clones 
[11]. Clinical and follow-up information, as well as imaging was available (Table S1). Samples 
from the tumour mass and SVZ from 7/11 patients were common to our previous studies, for 
which we had performed microarray copy number profiling and gene expression alone [5, 11]. 
The margin samples are presented here for the first time. 
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In the present study, multi-region whole-exome sequencing (see Material and Methods) 
identified extensive intra-tumour heterogeneity at the level of single nucleotide variants 
(SNVs). Heterogeneity at the level of SNV putative drivers (from ref [4]) was evident in 5/11 
patients, especially in EGFR, PIK3R1 and TP53 (Figure 3A and S1). Copy number profiles 
inferred from the whole-exome sequencing confirmed the heterogeneity levels reported in 
previous studies (Figure 3B and S2). Copy number events were highly recurrent, especially 
EGFR amplification (SP42, SP54, SP55, A23 and A34), chromosome 10 loss containing 
PTEN (all patients), and CDKN2A homozygous deletion (SP42, SP52, SP55, SP56, SP57 
and A44), corroborating the findings from large scale studies [2]. Our custom Targeted panel 
TES1 (see Material and Methods) confirmed the results from exome sequencing (Figures 3A 
and S1). See Table S2 for purity estimations, Table S3 for copy number states and 
Supplementary Data for VCF files with SNV calls.
Because the infiltrative margin (M) samples consist of scattered cancer cells in the 
surrounding normal brain, the purity of those samples was expectedly low (5-10%). Purity is a 
confounding factor for calling mutations, leading to possible false negatives that may impact 
the phylogenetic analysis [17]. To tackle this problem, we designed a second targeted 
sequencing panel (TES2) specifically to validate whether mutations that were present in all 
the other tumour samples were really absent from the infiltrative areas (indicating the margin 
or SVZ as an ancestral subclone). This panel confirmed that several mutations that appeared 
truncal to the tumour mass (putative truncal) were not present in the margin sample (Figure 
3A and S1, TES2 panel). In addition, to further support our results, we developed a statistical 
method to test whether genomic variants in targeted sequencing that are not found in the 
margin are likely to be truly absent, rather than being false negatives (i.e. in the second case, 
if there is no power to determine with reasonable certainty that the mutation is not present). 
Our test scans mutations that were identified as “putatively truncal” from the tumour mass 
samples (T1, T2, …). These mutations have high cancer cell fraction (CCF) in all T samples 
(Figure 4A, representative example of patient SP52). We reasoned that if the cancer 
subclones in the margin were just infiltrative cells deriving from the tumour mass – rather than 
an early ancestor – then “putative truncal” mutations should also be found in the margin (“truly 
truncal”). However, a failure to identify these mutations in the margin, despite the very high 
depth of sequencing of targeted panels, may occur as a false negative owing to low purity. 
Similar to previous approaches [18], our statistical method accounts for the confounding 
factor of purity, and tests the null hypothesis that “putative truncal” mutations are present in 
the margin, but miss to be detected in the margin. Rejecting the null indicates that these 
mutations are unlikely to be present in M. 
We first fit a beta-binomial distribution to the set of putative truncal mutations, separated by 
copy number state (Figure 4B, see Supplementary Material and Methods for details). This 
provides the expected variant allele frequency of a mutation in a high purity sample, such as 
T1-4. This model allows calculation of the expected frequency of a mutant given any purity 
value, for example the 5% purity of the margin sample. We then examine the whole-exome 
and targeted sequencing data (TES1 and TES2) from margin samples and consider those 
putative truncal SNVs that were not detected by any assay (Figure 4C). Given the coverage 
achieved at the locus of the missing mutation, and the beta-binomial model trained on 
putative truncal SNVs, we can calculate the likelihood of the data assuming the null is true 
(i.e., the mutation is truly truncal but 0 mutant reads are found at the locus, for a given purity). 
Application of our method to our dataset revealed that a considerable proportion of testable 
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mutations (see Supplementary Material and Methods for details) were unlikely to be present 
in the margin ( , using Bonferroni correction), even when we assumed the margin 𝑝 <  0.05
purity to be as low as 1% (Figure 4D). These results indicate that these SNVs are likely to be 
absent in M, and hence cannot be truncal. The method is potentially applicable to any 
genomic dataset to test true negatives (see Supplementary Material and Methods and Figure 
S3). The results of the test for all patients are reported in Figure 3A and S1, left hand side of 
each heatmap. This allowed us to perform a more reliable phylogenetic analysis for each 
patient that included residual disease in the SVZ and the infiltrative margin M.
Evolutionary trajectories suggest early ancestor clones within residual disease
Residual disease samples diverged early from the rest of the tumour mass in the majority of 
patients for which M samples were available, with particular evidence for SP49, SP52, SP57, 
A44, SP28 for which we could apply our test (Figure 5, testable mutations that did not pass 
our test were excluded from the phylogeny). Importantly, residual disease was also found at 
recurrence, demonstrating the presence of a reservoir of cancer cells in the infiltrative margin 
at relapse (patients A23 and SP28). In case A23, the primary tumour mass appeared to have 
originated from earlier cancer cell lineages located in the margin M and SVZ collected at 
primary resection. However, at the time of relapse, whereas both T and SVZ appear to have 
acquired additional new mutations (long branch), the ‘M recurrence’ lineage has remained 
similar to the primary tumour. A comparable pattern is observed in SP28 where ‘M 
recurrence’ also shows as an early residual clone present at relapse. Hence, early ancestral 
clones are present both at primary and recurrence and are not generally resected. We do 
acknowledge that the bulk tumour mass at relapse can also be driven by incomplete resection 
of the primary tumour due to the neoplastic tissue extending to vital parts of the brain that 
cannot be removed. We note that A23 and SP28 were local recurrences and more residual 
disease samples from distal recurrent tumours will need to be collected in the future.
As a whole, this analysis indicates that subclones present in M may arise early during tumour 
growth. Moreover, in 6/11 patients, the SVZ appeared also as an early ancestor, as we 
previously reported [11] and as recently confirmed [12]. See Figure S4 for bootstrapping 
values. We do acknowledge however that in those branches some mutations may be missing 
due to limits of detectability. To validate further these results, we also performed single-allele 
methylation molecular clock analysis [19] on the same samples for a subset of patients, in 
particularly those where we had primary-recurrence pairs (Figure S5). Methylation molecular 
clock haplotyping is a single-molecule approach that allows reading the status of single CpGs 
in CpG island from the same DNA molecule. We have shown that some of these CpG island 
loci can be used for phylogenetic reconstruction, both colorectal cancer and glioblastoma [11, 
19]. Importantly, because this assay is ‘single-molecule’, alleles that come from non-
proliferative normal cells (e.g. normal contamination from neurons in the margin samples) can 
be discarded because of their low methylation status. Therefore, this analysis does not suffer 
from the problems of tumour purity of the exome analysis (see Material and Methods). 
Eliminating the methylation haplotypes coming from non-cancer cells allows reconstructing 
the tumour phylogeny orthogonally with respect to the exome trees. The results strikingly 
confirmed the structure of the phylogenetic trees inferred from exome sequencing, thus 
corroborating the results in Figure 5.
Interestingly, histopathology reports (pre WHO 2016 revision) are congruent with these 
phylogenetic data in multiple cases, for example SP49 GBM with low-grade areas, SP52 & 
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SP28 GBM with oligodendroglial component. Together these data indicate a less aggressively 
proliferative phenotype at early stages of the evolution of the malignancy. After the primary 
tumour has been treated with radio- and chemotherapy the quiescent residual subclones may 
trigger new growth and further clonal evolution, producing the divergence that has been 
observed by us and others between primary and recurrent samples in GB. This interpretation 
of the data is consistent with an early onset of tumour cell infiltration. Residual ancestral 
disease present in the SVZ and in the infiltrative margin is the source of the inevitable relapse 
that occurs in GB patients. This model is also consistent with the high incidence of multifocal 
lesions and the accumulating evidence of evolutionary divergence that is emerging from 
genomic data [6, 7]. 
Discussion
A key to understanding cancer is not just exposing intra-tumour heterogeneity, the natural 
process that underlines clonal evolution, but also to understand such heterogeneity in a way 
that is clinically relevant and therapeutically tractable. An important aspect of genomic ITH is 
that it embeds the evolutionary history of the tumour, a fundamental biological element that 
cannot be directly measured in humans. Nevertheless, inferring and understanding that 
history may be critical in developing a rationale for combinatorial therapeutics [20].
Specifically, in this study we leveraged the spatio-temporal decomposition of the clonal 
architecture of the tumour to understand the link between subclones in the main tumour mass 
and in residual disease left behind in the su rounding brain parenchyma and sub-ventricular 
zone following surgery. This residual disease is a key factor contributing to GB treatment 
failure because of resistance to radiation and alkylating chemotherapy coupled with an 
inherent ability to seed re-growth. Therefore, the main message of this study is that residual 
disease and not just the main tumour mass [5-8, 21, 22] must be investigated in depth from 
the point of view of tumour evolution if we are to understand how treatment-resistant disease 
develops. We acknowledge that to study the mechanisms that link residual disease to tumour 
relapse, additional analysis is needed, especially of primary-recurrence pairs from distal 
relapses where also SVZ and M would be collected. However, this remains a technical and 
ethical challenge.
This observation presents a challenge to the GB research community to develop the tools and 
strategies needed to collect and robustly analyse difficult samples from residual disease 
areas in prospective cohorts. Due to the limited number of patients in this study, additional 
analyses on larger cohorts are necessary to validate these findings. We acknowledge that 
analysing sparse cancer cells in the margin remains challenging, even with the most 
advanced sequencing and bioinformatics approaches currently available. Further work is also 
needed to improve purification of margin samples, which is not currently possible due to lack 
of reliable markers to sort GB cells. Therefore, new efforts of collecting infiltrative cells that lay 
distant from the main tumour mass will be needed to study residual disease with more 
accuracy. To do this, post-mortem efforts such as the PEACE study (Postohumous 
Evaluation of Advanced Cancer Environment) are likely to play a key role in revealing the 
biology of infiltrative disease in glioblastoma. 
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9
Figure Legends
Figure 1. Residual disease in glioblastoma. (A) At surgery, the primary tumour mass (red) 
only is removed (in dark grey the resection cavity). (B) However, infiltrative cells in the normal 
brain parenchyma (green) and SVZ (blue) are left behind. (C) Residual glioblastoma cells 
infiltrated throughout the brain can give rise to relapse, both locally and distally. 
Figure 2. Study design: multi-region tumour and residual disease sampling. (A) The 
large majority of patients present at diagnosis with a large tumour mass that is positive for 5-
ALA fluorescence. In this study, we collected multiple spatially separated regions of the 
tumour mass (4-6 regions per tumour in 9 patients), as well as matched primary-relapse 
samples in 2 patients. (B) Extensive infiltration is also present in the surrounding normal brain 
but cancer cells are so sparse beyond the resection margin that do not appear fluorescent. 
Samples from the non-fluorescent infiltrative margin were collected from 9/11 patients. From 
paired primary-recurrent patients, we collected matched margin from the primary tumour and 
another margin sample from the relapsed neoplasm. (C) In a subset of patients, disease is 
also found in the sub-ventricular zone (SVZ), which appears fluorescent and contains 
malignant clones. We collected 1-3 samples of the SVZ from all patients, including matched 
SVZ in primary and relapsed tumours. Through surgery and chemo-radiation, it is possible to 
extensively remove the primary tumour but treatment is unlikely to completely remove the 
infiltrative disease, nor cancer cells in the SVZ. Those represent the majority of residual 
disease in glioblastoma.
Figure 3. Multi-region genomic profiles of glioblastoma residual disease. (A) For four 
representative patients we report the cancer cell fractions (>80%) for the tumour mass 
samples and presence/absence of mutation in all the residual disease samples (see Figure 
S1 for all cases, Table S2 for purity and Supplementary Data for SNV calls). Putative SNV 
driver events are annotated. WES=whole exome sequencing; TES1=targeted amplicon 
sequencing panel 1; TES2=targeted exome capture sequencing panel 2. T1…4=tumour mass 
sample; SVZ=sub ventricular zone; M=margin. (B) Digital copy number alterations are 
reported for each sample (see Figure S2 and Table S3 for details).
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Figure 4. Testing the absence of putative truncal mutations in the infiltrative margin 
(representative case SP52). (A) We detected SNVs using joint-sample variant calling from 
WES. We selected SNVs that had cancer cell fraction  in all tumour mass samples CCF ≥ 0.8
(T1, T2, …) and the same CNA status across all T samples. We call these “putative truncal” 
SNVs. If cancer cells in M developed from T, then these mutations are “truly truncal” and 
should be detected also in M. However, calling these mutations in the margin might be 
confounded by the low purity of margin samples. (B) From read counts of selected SNVs, we 
train for every sample a Beta-Binomial model of expected Variant Allele Frequency (VAF), 
accounting for tumour purity and copy number status. This model describes,  for each such 
SNV, the expected number of reads with the variant allele as a function of sample purity (i.e. 
we can predict how many mutant reads we expect to find in a sample like M, at purity 5%). 
(C) We use deep-sequencing data from targeted panels TES1 and TES2 to identify which 
putative truncal SNVs were not detected in the margin sample by any assay (missing SNVs). 
Based on the Beta-Binomial trained model, we created a statistical test for the null hypothesis 
that these mutations are truly truncal in the tumour (and hence present also in M), but remain 
undetected in M due to low purity. (D) Based on the expectation and the depth of coverage 
achieved for each tested mutation, we can calculate a p-value under the null. Rejecting the 
null means that we have evidence for the fact that these SNVs are not truly truncal, and that 
they are missing in the margin. This provides further evidence that the margin is ancestral to 
the tumour mass. The power of the test increases with higher coverage; we used a 
conservative setting of worst-case purity with  (1% tumour, 99% normal) for the test, 𝜋 = 0.01
and corrected it for multiple testing via Bonferroni.
Figure 5. Phylogenetic reconstruction indicates residual disease subclones may arise 
early. Phylogenetic trees built with WES data and excluding mutations that do not pass our 
test show the infiltrative margin sample at the top of the phylogeny, suggesting it contains 
cancer clones that occur early during tumour growth. In 6/11 samples the SVZ appears as an 
early subclone as well. Often the phylogeny recapitulates the spatial structure of the tumour, 
where T1, T2, … T4 samples are taken in this order as the tumour resection extends deeper 
into the brain. Matched samples from M and SVZ in paired primary-relapse cases A23 and 
SP28 show the role of residual disease in the development of glioblastoma recurrence.
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Supplementary Material and Methods
Bioinformatics Analysis
Purity estimation: Purity estimates were gathered from a potential clonal diploid 
mutation (PCDM) present in the tumour mass samples and estimation by ASCAT[1] 
derived from the copy number solution.
Copy number analysis: Sequenza was used to identify heterozygous single nucleotide 
polymorphisms (SNPs) in the WES (0.4-0.6 allele frequency in the matched normal 
sample) and normalise depth ratios for GC content[2]. Loci were filtered for a minimum 
of 25 reads in the matched normal sample. Log2 ratios (LRR) were derived from the 
depth ratios by calculating the log (base 2) of the depth ratio and subtracting by the 
global median. LRR outliers were smoothed using CGHcall[3]. The mirrored allele 
frequencies of the heterozygous loci were segmented using piece-wise constant fitting 
(PCF)[4]. If BAF values in segments are considered not to be drawn from a normal 
distribution expected in allele balance (BAF = 0.5, Kolmogorov-Smirnov test, p < 0.05), 
a two-component Gaussian mixture model was fitted to the B-allele frequency (BAF) 
values of the segment utilising mixtools version 1.0.4[5], in order to estimate BAFs 
representative of the major allele (code available as an R package at, 
www.github.com/georgecresswell/MiMMAl). Major allele BAF and the LRR of the 
genome segments were used as input for ASCAT to estimate tumour purity and ploidy, 
limiting the minimum purity of the solution to the lower 95% binomial confidence limit 
(Wilson method) of a PCDM purity estimate adjusted for a tetraploid solution. Ploidy 
parameter space was restricted in tumours manually determined to have high ploidy 
states, additionally purity and ploidy was preset if a solution was not determined. The 
purity and ploidy of the ASCAT solution was used to assess the clonality of each 
segment using the Battenberg methodology[6]. If a segment was considered subclonal, 
the copy number state with the highest prevalence was taken.
Identification and validation of somatic variants: adapter trimming was performed with 
Skewer v0.1.126[7] specifying criteria on the length and quality of the reads (minimum 
of 35 after trimming and mean of 10 before trimming accordingly). Then, Burrows-
Wheeler Aligner (BWA) v0.7.12[8] was used to map the reads to human reference 
genome hg19, and PCR duplicates were flagged using Picard tools. Mutation calling 
was performed in two ways: 1) with Mutect2[9] on single tumour-normal pairs 2) with 
Platypus v0.8.1[10], carrying out joint mutation calling among all samples from the same 
patient. All mutations derived from step (1) with Mutect2 were accessioned as biased 
prior (‘source’) option in Platypus run, to benefit from both mutational calling methods 
and explore a wider range of true positive calls. Somatic variants in WES samples were 
filtered as follows: i) variants in segmental duplicated regions and centromeric regions 
were removed ii) only specific Platypus FILTER field was considered (PASS, alleleBias, 
Q20, QD, SC and HapScore), iii) a minimum value of 10 was accepted for coverage and 
genotype quality, iv) minimum of 3 reads coverage on the alternative variant in at least 
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one of the tumour samples per patient to allow for variants in low allele frequencies to 
be identified, v) None of the reads covering the alternative variant should be present in 
the germline sample, and vi) genotype in the germline sample should be homozygous to 
the reference (0/0) . Mutations with a Variant Allele Frequency (VAF) <=5% were 
excluded. Somatic variants were annotated both with CAVA[11] and VEP[12]. SNV 
calling on the targeted capture samples was performed using Platypus in genotyping 
mode. Somatic SNVs were filtered based on i) genotype quality, minimum of 10 ii) total 
coverage, minimum of 300 and iii) coverage on the alternative variant, minimum of 10. 
Somatic mutations that failed to be validated in all samples per patient were excluded 
from the analysis. In any other case, VAF is indicated as NA in the failed sample. All 
somatic mutation calls from TES and WES panels are available in VCF files as 
Supplementary Data. 
Driver genes: the complete set of SNVs was compared to a list of known putative driver 
genes in glioblastoma from ref[13]. 
Cancer cell fraction estimation: Cancer cell fraction of each variant is calculated using 
the VAF, estimated purity of the sample and total copy number state of the segment in 
which the variant belongs[14]. The estimated purity calculated by ASCAT was used 
unless the estimation was 1, then the PCDM purity estimate was used. To avoid 
overcalling subclonality, the number of mutated alleles was assumed to be 1.
Phylogenetic reconstruction: for each patient, SNVs identified from the whole exome 
sequencing panel were used to construct sample phylogenies using PAUP* (version 
4.0a) with the maximum-parsimony criterion[15]. CCF values for the SNVs were first 
dicotomised to produce tables indicating the pr sence/absence of each mutation in 
each sample by defining a mutation as present where CCF≥0.2. For patient 54, the SVZ 
sample was included in the phylogenetic analysis with mutations identified by the TES2 
panel and dicotomised as above. For all patients, we considered only mutations for 
which the presence/absence in each sample was determined. Where a mutation was 
absent from a margin sample (M) for a patient, but not identified as a true negative with 
high probability, this mutation was omitted from the phylogenetic reconstruction. The 
maximum-parsimony trees were identified via a heuristic search with default settings. 
For each phylogenetic tree, 1000 replicates of bootstrap analysis were carried out to 
assess the support (Figure 5). Trees were rendered with the R package phytools[16] (R 
version 3.3.2, phytools version 0.6-44).
Molecular Clock Analysis
Molecular clock phylogenetic reconstruction: FASTQ files were trimmed to remove 
adaptor sequences using Skewer v0.1.126 [7]. Paired reads were then aligned to hg19 
using Bismark v0.18.2 [17]. Bismark methylation extractor was then used to extract 
methylation states of possible CpG sites from the original top and bottom strands. For 
each molecular clock loci called CpGs are identified. CpGs are used for analysis if they 
have a total number of calls for a position (methylated plus unmethylated) greater than 
or equal to the value at which the cumulative density function equals 0.05 for a Poisson 
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distribution where  is equal to the maximum CpG count in the clock region. Reads with 
a call missing for a genomic position that passes this coverage filter are removed to 
leave only complete reads with a methylation call on all locations. In each tumour 
sample reads are required to have at least 2 methylated CpG sites and reads can only 
have a maximum of 80% methylation, to remove reads that are likely produced by cells 
that have a low turnover (normal cells) and clocks that have reached saturation and are 
therefore non-informative, respectively. Remaining haplotypes (reads) with an overall 
abundance of 1% or less are removed due to their rarity. For each tumour sample 100 
random haplotypes are selected with replacement and an additional set of 100 
‘synthetic’ unmethylated haplotypes are created as a reference for each case. 
A similarity measurement is then performed pairwise between tumour samples and the 
unmethylated reference as used previously[18]. In brief, the Hamming distance of each 
haplotype combination between the two samples is measured and the shortest distance 
of all these combinations is recorded and the haplotype pair is removed from 
consideration. This is perf rmed iteratively until all haplotype pairs have been removed 
and the Hamming distances of the chosen pairs is summed. This similarity 
measurement between all tumour samples and the unmethylated reference is used to 
create a Neighbour Joining tree using phangorn v2.2.0 [19]. Trees are then rendered 
using the same method as the somatic mutation trees.
Method for statistical testing for mutations in the margin
Training a statistical model from read-counts: For each patient, we used its CCFs and 
CNA values to identify putative clonal SNVs in exomic regions. From Platypus VCF 
files, we selected only entries with:
1. A single-nucleotide mutation;
2. CCF >0.8 in all primary samples;
3. the same CNA status across all primary samples.
Mutations that do not fulfil these conditions are likely subclonal, or are not SNVs, and 
neglected by this analysis. Read counts for clonal SNVs are extracted from VCF files 
reporting Number of Variants (NV, number of reads with the alternative allele) and 
Reads (NR, i.e., coverage). 
We corrected read counts for CNA status and tumour purity, before using them to train 
a statistical model for the test. Correction is carried out to estimate how many of the 
observed reads  come from the actual tumour. The correction is a standard r
procedure[6] which uses tumour purity  (here estimated from WES data) and tumour π
copy number status c as follows
r = c * πc * π + 2 * (1 -  π) * r
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Factor two in the correction is the diploid copy number status of normal cells. After 
correction,  is the number of reads, out of r, that are estimated coming from tumour r < r
cells. To be conservative, we assume the mutation multiplicity (number of allele copies 
that bear the mutation) is always 1.
With the corrected coverage value, we can fit a Beta-Binomial with number of trials , r
and successes NV. A success in this experiment is the detection of a read with the 
mutant allele; the overall Binomial sampling consists in the repetition of this experiment 
with  reads (i.e., the number of reads at a locus). The contribution of the Beta r
distribution is to capture uncertainty over the success probability of the experiment. 
Hence, this statistical model describes the probability of observing  mutated at v
coverage  as a function of the Beta distribution r B(α,β)
BetaBin(𝑣|𝑟;𝛼,𝛽) = B(𝑣 + 𝛼,𝑟 ― 𝑣 + 𝛽)(𝑟𝑣)B(𝛼,𝛽)
This quantity is related to the so-called Variant Allele Frequency (VAF), which is defined 
to be . This compound model extends Binomial sampling with over-dispersion effects v/r
that better account for non-uniform coverage in sequencing assays [20]. Technically, it 
is a Binomial distribution whose parameter follows a Beta distribution with hyper-
parameters  and , greater than 0. α β
Multiple Beta-Binomial models were trained for each copy number status for the input 
SNVs, and each WES sample of the primary tumour. By separating read counts by copy 
number status, we can adjust data for every non-diploid SNV in a more precise and 
consistent way. To train a model at minimum acceptable quality for the next test, we 
discarded all combination of parameters for which we do not have, at least, 10 available 
SNVs. When that is the case, we removed from downstream analysis this configuration 
of copy number status and input sample. 
To learn the model parameters  and from data, we used the Maximum Likelihood α β 
fitting procedure vglm for vector generalized linear models that is implemented in the R 
package VGAM (version 1.0-5).
Testing: We identified testable SNVs from two deep-sequencing targeted panels. 
Because panels have ~3000x coverage, we require each SNV to have at least  k = 10
reads with the variant allele (NV ).  When that is not the case, the SNV is  ≥ 10
considered missing from the panel, and it qualifies as suitable for our test. We 
particularly care about the ones that are missing in the margin sample (M): if the margin 
was ancestral to the primary tumour, we expect it to lack some SNVs that are clonal in 
the primary WES samples. 
If a patient has more than one margin sample (e.g. Patient A23), we require the 
mutation to be absent across all margin samples. SNVs selected in this way appear 
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indeed clonal in the primary tumour but are missing in the margin biopsy from the 
targeted panels. Some patients have no testable mutations (e.g. Patient 42). The SNVs 
that we detected from both targeted panels are pooled together, and their number of 
reads (NR) from the VCF files is stored; if an SNV is detected from both panels, we sum 
the NR values from both panels.
Read counts from the margins are corrected as with the training set. Copy number 
status for mutations in the margin is the same for the training set, by design choice. 
Purity correction instead requires some considerations. Estimation of purity  for margin π
samples is hard because of the apparent high contamination of normal cells. To be 
conservative, we have used a fixed, worst-case low purity estimate of  (1% π = 0.01
tumour, 99% normal). This value is much lower than the margin’s likely true purity and 
renders the test harder since the power to reject the null decreases with coverage. 
Thus, a conservative purity estimate leads us to rescale observed coverage to lower 
values (i.e., we ``throw away’’ coverage from the targeted panels). 
The set of SNVs to test is divided according to the copy number status and matched to 
the trained models. Each group is tested independent against all models trained from 
the different primary regions. The null hypothesis  for testing a group of SNVs is the H0
probability of detecting NV (with ) mutated reads at the corrected coverage, < k k = 10
given the parameters  of the matched Beta-Binomial modelμ,ρ
𝐻0: 𝑘∑
𝑤 = 1BetaBin(𝑣 = 𝑤|𝑟;𝜇,𝜌)
The p-value is hence the probability of finding less than k reads with the variant allele at 
the designed locus with coverage , given the fact that we expect for a clonal SNV the r
number of reads to follow a Beta-Binomial model with parameters  (fit from WES). α,β
Thus, rejecting  means rejecting the hypothesis that the SNV is present and clonal in H0
the margin but just at lower frequency due to purity. Combined with phylogenetic 
analysis, this provides strong evidence of the ancestral relation between the margin and 
the primary, and that these missing SNVs are real true negatives in M. The tests are 
executed at confidence level , and corrected for multiple testing with the α = 0.05
stringent correction possible (Family-wise Error Rate, via Bonferroni).
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Supplementary Figure and Table Legends
Figure S1. Multi-region SNV profiling of all patients. For each patient we report the 
cancer cell fractions (>80%) for the tumour mass samples and presence/absence of 
mutation in all the residual disease samples for a set of representative cases (see Table 
S2 for purity and Supplementary Data for SNV calls). Putative SNV driver events are 
annotated. WES=whole exome sequencing; TES1=targeted amplicon sequencing panel 
1; TES2=targeted exome capture sequencing panel 2. T1…4=tumour mass sample; 
SVZ=sub ventricular zone; M=margin.
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Figure S2. Log-R-ratio and B-allele-frequency profiles per sample. For each patient 
and sample we report the raw LRR and BAF plots based on which the digital copy 
number states were estimated.
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Figure S3. Margin variant testing method. (A) We analyzed read counts to estimate 
CCF values from WES panels of primary tumours, margins and SVZ. We group SNVs 
by CN status and consider clonal those with the same CN across all samples, a CCF > 
0.8. (B) We train a Beta-Binomial model for the frequency of the mutant allele at each 
SNV. The training is independent for each sample (primary tumour region), and CN 
status. (C) From deep sequencing of targeted panels, we can observe that some SNVs 
which are clonal in the primary tumours, are missing from margin samples. We consider 
them missing when they have less than k=10 reads with the variant allele: this is 
reasonable for a deep sequencing panel. (D) Phylogenetic analysis of this tumour 
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suggest that the margin could contain cells that are ancestral to the primary tumour. (E) 
We devised a test based on the Beta-Binomial models fit to the data for the null 
hypothesis that the missing SNVs in the margin – those that support early divergence – 
were not detected due to purity. With that we can compute exact p-values (adjusted for 
multiple comparison via Bonferroni) and isolate those where we can reject the null: 
those SNVs are unlikely clonal. The power of the test depends on the coverage at the 
analyzed SNVs. The higher the coverage, the less likely is that we have (by chance) 
observed k<10 mutant reads for a clonal SNV. We implement the test in very stringent 
condition: we assume purity of the sample 1% (very contaminated) and correct the 
observed coverage accordingly.
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Figure S4. Phylogenetic trees bootstrapping values. Phylogenetic bootstrapping 
values for WES trees (p=primary, r=relapse – e.g. Mr, SVZ p).
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Figure S5. Phylogenetic trees using methylation clocks. Phylogenetic trees 
reconstructed using single-allele methylation molecular clocks from a subset of 
analysed patients
Sample ID Surviv
al after 
surger
y 
(days)
Location Histology MI
B
IDH
1
Post op 
radiology
F/U
SP42 190 Lt parieto-
occipital
GBM 
(Grade IV)
52
%
wt Residual 
enhancem
ent
radiotherapy
SP49 288 Lt temporal 
lobe and 
thalamus
GBM 
(Grade IV)
40
%
wt Partial 
resection
radiotherapy
SP52 27 Rt 
Frontoparie
tal
GBM 
(Grade IV)
 wt Partial 
resection
radiotherapy
SP54 321 Lt frontal 
lobe
GBM 
(Grade IV)
30
%
wt Mild 
enhancem
ent post op
TMZ + 
radiotherapy
SP55 298 Left 
temporal
GBM 
(Grade IV)
 wt Residual 
tumour
 
SP56 86 Rt Frontal GBM 
(Grade IV)
 wt  NCCU for 
clotting issues
SP57 354 Rt frontal GBM 
(Grade IV)
 wt Good 
resection
Concomitant 
and adjuvant 
TMZ + 
radiotherapy
A34 alive Lt frontal Anaplastic 
astrocytom
a 
20
%
mut  Prior TMZ and 
radiotherapy (in 
2006), re-treat 
with TMZ
A44 104 Rt parietal GBM 
(Grade IV) 
25
%
wt Minimal 
residual 
disease
Concomitant 
and adjuvant 
TMZ + 
radiotherapy
A23
(primary)
1059 Lt temporal GBM 
(Grade IV)
25
%
wt Debulking Concomitant 
and adjuvant 
TMZ + 
radiotherapy
A23 
(recurrenc
e)
142 Lt temporo-
parietal
GBM 
(Grade IV)
31
%
wt Debulking Rre-challenge 
with TMZ
SP28 
(primary)
588 Lt parietal GBM 
(Grade IV)
 wt   Gliadel, 
adjuvant TMZ + 
radiotherapy
SP28 
(recurren
ce)
200  GBM 
(Grade IV)
 wt  For 
consideration of 
PCV 
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chemotherapy
Table S1. Clinical and follow-up information.
Table S2. Purity and ploidy estimates per sample.
Table S3. Copy number estimates per sample.
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Sample ID Survival 
after surgery 
(days)
Location Histology MI
B
IDH1 Post op 
radiology
F/U
SP42 190 Lt parieto-
occipital
GBM (Grade IV) 52
%
wt Residual 
enhancement
radiotherapy
SP49 288 Lt temporal 
lobe and 
thalamus
GBM (Grade IV) 40
%
wt Partial 
resection
radiotherapy
SP52 27 Rt 
Frontoparietal
GBM (Grade IV)  wt Partial 
resection
radiotherapy
SP54 321 Lt frontal lobe GBM (Grade IV) 30
%
wt Mild 
enhancement 
post op
TMZ + radiotherapy
SP55 298 Left temporal GBM (Grade IV)  wt Residual 
tumour
 
SP56 86 Rt Frontal GBM (Grade IV)  wt  NCCU for clotting issues
SP57 354 Rt frontal GBM (Grade IV)  wt Good 
resection
Concomitant and adjuvant 
TMZ + radiotherapy
A34 alive Lt frontal Anaplastic 
astrocytoma 
20
%
mut  Prior TMZ and radiotherapy 
(in 2006), re-treat with TMZ
A44 104 Rt parietal GBM (Grade IV) 25
%
wt Minimal 
residual 
disease
Concomitant and adjuvant 
TMZ + radiotherapy
A23
(primary)
1059 Lt temporal GBM (Grade IV) 25
%
wt Debulking Concomitant and adjuvant 
TMZ + radiotherapy
A23 
(recurrence)
142 Lt temporo-
parietal
GBM (Grade IV) 31
%
wt Debulking Rre-challenge with TMZ
SP28 
(primary)
588 Lt parietal GBM (Grade IV)  wt   Gliadel, adjuvant TMZ + 
radiotherapy
SP28 
(recurrence)
200  GBM (Grade IV)  wt  For consideration of PCV 
chemotherapy
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SamplePCDM.Gene PCDM.Mutation PCDM.lower.tetraploid PCDM.lower
PCDM.purity PCDM.upper ASCAT.purityASCAT.ploidy min.ASCAT.purity
max.ASCAT.purity min.ASCAT.ploidy max.ASCAT.ploidy
SP42M PITX1 5_134364968 0,003417294 0,004533464 0,025641026 0,13821714
1 2 0,003417294 1 1,5 5,5
SP42S PITX1 5_134364968 0,438622444 0,609952062 0,764705882 0,932386808 0,62
3,45 0,438622444 1 2,5 4,5
SP42T1 PITX1 5_134364968 0,778064268 0,875001086 1,015706806 1,155793182
0,92 3,25 0,778064268 1 2,5 4,5
SP42T2 PITX1 5_134364968 0,499826906 0,66676475 0,837606838 1,018773638
0,83 3,5 0,499826906 1 2,5 4,5
SP42T3 PITX1 5_134364968 0,447929505 0,618907944 0,773722628 0,940880768
0,69 3,5 0,447929505 1 2,5 4,5
SP42T4 PITX1 5_134364968 0,257866457 0,409607576 0,554621849 0,727491568
0,41 3,55 0,257866457 1 2,5 4,5
SP49M ZNF469 16_88498626 0,005518529 0,008941017 0,032520325
0,114700873 1 2 0,005518529 1 1,5 5,5
SP49SVZ ZNF469 16_88498626 0,23779339 0,383820973 0,514285714
0,670693622 0,57 3,45 0,23779339 1 1,5 5,5
SP49T1 ZNF469 16_88498626 0,335161492 0,501872872 0,655737705
0,830620563 0,59 3,4 0,335161492 1 1,5 5,5
SP49T2 ZNF469 16_88498626 0,123690219 0,220494522 0,366197183
0,576963445 0,39 3,4 0,123690219 1 1,5 5,5
SP49T3 ZNF469 16_88498626 0,13748596 0,241933984 0,343949045
0,477301706 0,35 3,4 0,13748596 1 1,5 5,5
SP49T4 ZNF469 16_88498626 0,157935828 0,272782744 0,413043478
0,600356278 0,74 3,45 0,157935828 1 1,5 5,5
SP52M FSIP2 2_186660349 0,001272673 0 0 0,022876621 1 2
0,001272673 1 1,5 5,5
SP52SVZ FSIP2 2_186660349 0,094858661 0,173897814 0,23943662 0,325275996
0,3 1,95 0,094858661 1 1,5 5,5
SP52T1 FSIP2 2_186660349 0,285195417 0,443466404 0,542750929 0,654911089
0,58 2,05 0,285195417 1 1,5 5,5
SP52T2 FSIP2 2_186660349 0,434408432 0,605858065 0,705167173 0,811281853
0,73 2 0,434408432 1 1,5 5,5
SP52T3 FSIP2 2_186660349 0,517995827 0,682727527 0,784431138 0,891037042
0,77 2 0,517995827 1 1,5 5,5
SP52T4 FSIP2 2_186660349 0,49736365 0,664570037 0,764705882 0,870099224
0,76 2 0,49736365 1 1,5 5,5
SP54M1 OR5H1 3_97851850 0,027256086 0,05276419 0,103225806
0,197063014 1 2 0,027256086 1 1,5 5,5
SP54T1 OR5H1 3_97851850 0,235748743 0,38114927 0,515151515
0,676575808 0,63 2,25 0,235748743 1 1,5 5,5
SP54T2 OR5H1 3_97851850 0,38481754 0,555776617 0,69005848
0,837959853 0,66 2,2 0,38481754 1 1,5 5,5
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SP54T3 OR5H1 3_97851850 0,162065544 0,278883719 0,403361345
0,565154757 0,69 2,35 0,162065544 1 1,5 5,5
SP54T4 OR5H1 3_97851850 0,501423113 0,668182999 0,812121212
0,964608613 0,85 2,2 0,501423113 1 1,5 5,5
SP54T5 OR5H1 3_97851850 0,378082357 0,548693517 0,694444444
0,856074261 0,88 2,15 0,378082357 1 1,5 5,5
SP54T6 OR5H1 3_97851850 0,424142147 0,595780835 0,736196319
0,888759755 0,72 2,2 0,424142147 1 1,5 5,5
SP55S CA2 8_86388035 0,309355847 0,472254668 0,572463768 0,684410678 0,62
2,05 0,309355847 1 1,5 5,5
SP55T1 CA2 8_86388035 0,226695342 0,369216999 0,460431655 0,56635479
0,55 2,1 0,226695342 1 1,5 5,5
SP55T2 CA2 8_86388035 0,68676232 0,814273309 0,94017094 1,068001211
0,87 2,1 0,68676232 1 1,5 5,5
SP55T3 CA2 8_86388035 0,174006049 0,296290299 0,386554622 0,496307126
0,35 2,15 0,174006049 1 1,5 5,5
SP55T4 CA2 8_86388035 0,499320154 0,666313847 0,787878788 0,916383345
0,67 2,1 0,499320154 1 1,5 5,5
SP56M PIK3R1 5_67589138 0,281843965 0,43938943 0,541832669
0,658088661 0,4 3,75 0,281843965 1 3 5
SP56S PIK3R1 5_67589138 0,110783562 0,199947437 0,2734375 0,368410355
0,17 3,95 0,110783562 1 3 5
SP56T1 PIK3R1 5_67589138 0,327077256 0,492716613 0,606334842
0,733404757 0,47 4,05 0,327077256 1 3 5
SP56T2 PIK3R1 5_67589138 0,033132842 0,064119837 0,108786611
0,181649225 0,1 4 0,1 0,1 4 4
SP56T3 PIK3R1 5_67589138 0,144688654 0,252922815 0,337552743
0,443314944 0,31 4,05 0,144688654 1 3 5
SP56T4 PIK3R1 5_67589138 0,188205583 0,316551989 0,436619718
0,58636628 0,61 3,9 0,188205583 1 3 5
SP57M TRAK2 2_202262283 0,001272673 0 0 0,049617962 1
2 0,001272673 1 1,5 5,5
SP57S TRAK2 2_202262283 0,01028518 0,018819203 0,048192771 0,12062212
1 2 0,01028518 1 1,5 5,5
SP57T1 TRAK2 2_202262283 0,061216814 0,116011825 0,188679245
0,299625066 0,24 2,15 0,061216814 1 1,5 5,5
SP57T2 TRAK2 2_202262283 0,21528677 0,353938859 0,481751825
0,637835288 0,5 2 0,21528677 1 1,5 5,5
SP57T3 TRAK2 2_202262283 0,240067824 0,38678302 0,52991453
0,702933365 0,47 1,95 0,240067824 1 1,5 5,5
SP57T4 TRAK2 2_202262283 0,096266275 0,176232913 0,276422764
0,420440433 0,44 2,05 0,096266275 1 1,5 5,5
A23_recurrent_M ATP10B 5_160097490 0,002302304 0,00218098 0,012345679
0,068265323 1 2 0,002302304 1 1,5 5,5
A23_recurrent_S ATP10B 5_160097490 0,009763359 0,017745715 0,045454545
0,113942038 1 2 0,009763359 1 1,5 5,5
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A23_recurrent_T ATP10B 5_160097490 0,216092032 0,355026225 0,466666667
0,600595639 0,28 3,8 0,216092032 1 1,5 5,5
A34S1 GANAB 11_62397228 0,096892376 0,177269474 0,271428571 0,404502418
1 2,05 0,096892376 1 1,5 3
A34S2 GANAB 11_62397228 0,046629049 0,089517744 0,162601626 0,286407588
1 2 0,046629049 1 1,5 3
A34S3 GANAB 11_62397228 0,002943439 0,003534864 0,02 0,108972392 1
2,05 0,002943439 1 1,5 3
A34T1 GANAB 11_62397228 0,410114508 0,581770217 0,752293578 0,939682266
0,99 2 0,410114508 1 1,5 3
A34T2 GANAB 11_62397228 0,010722001 0,019716366 0,057692308 0,162800802
1 2,05 0,010722001 1 1,5 3
A34T3 GANAB 11_62397228 0,074098529 0,138671152 0,25 0,430056042 1
2,1 0,074098529 1 1,5 3
A34T4 GANAB 11_62397228 0,170348563 0,290994897 0,427184466 0,604564923
1 2,05 0,170348563 1 1,5 3
A34T5 GANAB 11_62397228 0,304662979 0,466744519 0,620689655 0,798952003
1 2 0,304662979 1 1,5 3
A34T6 GANAB 11_62397228 0,532003914 0,694769977 0,872727273 1,059273934
0,76 2,05 0,532003914 1 1,5 3
A44M ZBED9 6_28539945 0,005532187 0,008969558 0,026315789 0,075928621
1 2,05 0,005532187 1 1,5 5,5
A44S ZBED9 6_28539945 0,001923597 0,001379764 0,0078125 0,043581951
1 2,05 0,001923597 1 1,5 5,5
A44T1 ZBED9 6_28539945 0,270669965 0,425645732 0,534562212 0,659670943
0,6 2,1 0,270669965 1 1,5 5,5
A44T2 ZBED9 6_28539945 0,176394421 0,299731151 0,394495413 0,510229794
0,34 2,1 0,176394421 1 1,5 5,5
A44T3 ZBED9 6_28539945 0,137116782 0,241367031 0,337078652 0,460799122
0,23 2,3 0,137116782 1 1,5 5,5
A44T5 ZBED9 6_28539945 0,030915124 0,059856825 0,106280193 0,185270096
1 2 0,030915124 1 1,5 5,5
SP28_recurrent_M ZNF219 14_21561310 0,006775275 0,011561406 0,033898305
0,097279331 1 2 0,006775275 1 1,5 5,5
SP28_recurrent_S ZNF219 14_21561310 0,347119584 0,515216743 0,644067797
0,78804037 0,53 1,85 0,347119584 1 1,5 5,5
SP28_recurrent_T ZNF219 14_21561310 0,172229419 0,293722021 0,408163265
0,55274896 0,49 1,95 0,172229419 1 1,5 5,5
A23_primary_M ATP10B 5_160097490 0,112886836 0,203329283 0,301369863
0,435231756 0,18 3,75 0,112886836 1 3 5
A23_primary_S ATP10B 5_160097490 0,348816349 0,517091071 0,637254902
0,770827707 0,5 3,9 0,348816349 1 3 5
A23_primary_T ATP10B 5_160097490 0,376029461 0,546520696 0,682926829
0,83384694 0,52 4 0,376029461 1 3 5
SP28_primary_M ZNF219 14_21561310 0,00260813 0,00282719 0,016
0,087849505 1 2 0,00260813 1 1,5 5,5
Page 34 of 185Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
SP28_primary_S ZNF219 14_21561310 0,002363042 0,002309377 0,013071895
0,072179331 1 2 0,002363042 1 1,5 5,5
SP28_primary_T ZNF219 14_21561310 0,685567714 0,813435611 0,991452991
1,170013778 0,89 1,95 0,685567714 1 1,5 5,5
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patient sample merged_name chr startpos endpos BAF LogR nMajornMinor
clonal
SP42 M SP42M 1 762273 248813749 0,5 0,02445006 1
1 TRUE
SP42 M SP42M 2 41720 242839614 0,5 0,019696926 1 1
TRUE
SP42 M SP42M 3 386247 197717569 0,5 0,039682578 1
1 TRUE
SP42 M SP42M 4 60400 189065435 0,5 0,04718493 1 1
TRUE
SP42 M SP42M 5 163205 180670414 0,502 0,016111579 1
1 TRUE
SP42 M SP42M 6 335251 170892848 0,505 0,020996747 1
1 TRUE
SP42 M SP42M 7 286402 159025180 0,5 0,039302399 1
1 TRUE
SP42 M SP42M 8 280241 145750138 0,5 0,020481356 1
1 TRUE
SP42 M SP42M 9 286593 141008876 0,5 -0,004549274 1
1 TRUE
SP42 M SP42M 10 323283 135381766 0,5 -0,00080535 1
1 TRUE
SP42 M SP42M 11 193096 134856661 0,505 0,001777874 1
1 TRUE
SP42 M SP42M 12 250239 8090839 0,5 -0,007644283 1
1 TRUE
SP42 M SP42M 12 8386857 8386878 0,7815 -0,912025702 1
0 FALSE
SP42 M SP42M 12 8509668 133732624 0,505 0,026052284 1
1 TRUE
SP42 M SP42M 13 19042919 19529067 0,759 -0,077714185 1
0 FALSE
SP42 M SP42M 13 19532448 115091073 0,5065 0,010377902 1
1 TRUE
SP42 M SP42M 14 19118237 107283160 0,5 -0,014475786 1
1 TRUE
SP42 M SP42M 15 20170150 102359203 0,5 0,011899145 1
1 TRUE
SP42 M SP42M 16 109665 90161852 0,5 -0,05835287 1
1 TRUE
SP42 M SP42M 17 6188 81083419 0,5 -0,027431135 1 1
TRUE
SP42 M SP42M 18 334994 77728221 0,5 0,012542862 1
1 TRUE
SP42 M SP42M 19 311708 59074653 0,5 -0,07694256 1
1 TRUE
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SP42 M SP42M 20 76962 62904542 0,5 0,005745028 1 1
TRUE
SP42 M SP42M 21 9825966 48078611 0,5 -0,004742163 1
1 TRUE
SP42 M SP42M 22 16157827 51207915 0,5 -0,031923097 1
1 TRUE
SP42 S SP42S 1 762273 11879468 0,625 -0,133396477 2 1
TRUE
SP42 S SP42S 1 11879685 248813749 0,503 0,180150254 2 2
TRUE
SP42 S SP42S 2 41720 242839614 0,504 0,162175639 2 2 TRUE
SP42 S SP42S 3 386247 197717569 0,5 0,169707278 2 2
TRUE
SP42 S SP42S 4 60400 189065435 0,5 0,169889722 2 2 TRUE
SP42 S SP42S 5 163205 180670414 0,5 0,14644615 2 2
TRUE
SP42 S SP42S 6 335251 58776982 0,5 0,18468169 2 2
TRUE
SP42 S SP42S 6 58777039 58778649 0,5 -2,924857267 0 0
TRUE
SP42 S SP42S 6 58778809 65655883 0,523 -0,546074429 1 1
TRUE
SP42 S SP42S 6 65767393 70071173 0,79 -0,387438336 2 0
TRUE
SP42 S SP42S 6 70589630 71011831 0,508 0,382622725 2 2
TRUE
SP42 S SP42S 6 71137992 167424293 0,807 -0,545079507 2 0
TRUE
SP42 S SP42S 6 167440128 167791524 0,645 -0,518014485 2 1
TRUE
SP42 S SP42S 6 168298875 170892848 0,8085 -0,33137124 2 0
TRUE
SP42 S SP42S 7 286402 54621692 0,627 0,556662093 4 2
FALSE
SP42 S SP42S 7 54724286 55214443 0,987 5,149326692 163 2
TRUE
SP42 S SP42S 7 55706275 57233554 0,504 0,015252487 2 2
TRUE
SP42 S SP42S 7 57528997 62694495 0,984 3,410269801 48 0
TRUE
SP42 S SP42S 7 62941320 65228128 0,503 0,124917995 2 2
TRUE
SP42 S SP42S 7 65439189 159025180 0,627 0,54709236 4 2
FALSE
SP42 S SP42S 8 280241 145750138 0,5 0,101303979 2 2
TRUE
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SP42 S SP42S 9 286593 20916828 0,807177232 -0,533482579 2
0 TRUE
SP42 S SP42S 9 20923618 141008876 0,619 -0,168157045 2 1
TRUE
SP42 S SP42S 10 323283 46221393 0,807028291 -0,534596522 2
0 TRUE
SP42 S SP42S 10 46960084 47416860 0,505 -0,334723744 1 1
TRUE
SP42 S SP42S 10 47605468 51586514 0,809 -0,3725256 2 0
TRUE
SP42 S SP42S 10 51620278 51631972 0,54 -0,29373087 1 1
TRUE
SP42 S SP42S 10 51785694 135381766 0,8255 -0,393975075 2 0
FALSE
SP42 S SP42S 11 193096 50381417 0,5 0,232506447 2 2
TRUE
SP42 S SP42S 11 51411914 134856661 0,812 -0,494700811 2 0
TRUE
SP42 S SP42S 12 250239 133732624 0,5 0,086013177 2 2
TRUE
SP42 S SP42S 13 19042919 115091073 0,622 -0,152322569 2 1
TRUE
SP42 S SP42S 14 19118237 20148052 0,698 -0,751716534 1 0
TRUE
SP42 S SP42S 14 20216334 107283160 0,807397015 -0,531837231 2
0 TRUE
SP42 S SP42S 15 20170150 20173275 0,698 -0,212729083 2 1
TRUE
SP42 S SP42S 15 20279438 48752278 0,504 0,179590808 2 2
TRUE
SP42 S SP42S 15 48755168 48813107 0,81 -0,168138455 2 0
TRUE
SP42 S SP42S 15 48903126 102359203 0,5 0,137492066 2 2
TRUE
SP42 S SP42S 16 109665 90161852 0,574 -0,216179362 2 1
FALSE
SP42 S SP42S 17 6188 47118995 0,617 -0,200558114 2 1 TRUE
SP42 S SP42S 17 47121551 81083419 0,5 0,116704473 2 2
TRUE
SP42 S SP42S 18 334994 77728221 0,503 0,114596776 2 2
TRUE
SP42 S SP42S 19 311708 24014850 0,64 -0,015953325 2 1
FALSE
SP42 S SP42S 19 28296408 59074653 0,509 -0,399230715 1 1
TRUE
SP42 S SP42S 20 76962 62904542 0,507 0,150332437 2 2 TRUE
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SP42 S SP42S 21 9825966 48078611 0,5 0,13088944 2 2
TRUE
SP42 S SP42S 22 16157827 51207915 0,571 -0,13818939 2 1
FALSE
SP42 T1 SP42T1 1 762273 15441029 0,64 -0,50164975 2
1 FALSE
SP42 T1 SP42T1 1 15490865 121129557 0,585 0,137303102 2
1 FALSE
SP42 T1 SP42T1 1 142620901 144931392 0,517 0,149630129 2
2 FALSE
SP42 T1 SP42T1 1 144951880 248813749 0,591 0,117671811 2
1 FALSE
SP42 T1 SP42T1 2 41720 141130501 0,5 0,039036734 2 2
TRUE
SP42 T1 SP42T1 2 141457962 141625410 0,947853287 -0,88088444
2 0 TRUE
SP42 T1 SP42T1 2 142012027 242839614 0,5 0,044738573 2
2 TRUE
SP42 T1 SP42T1 3 386247 10359628 0,5 0,386444071 2
2 TRUE
SP42 T1 SP42T1 3 10382111 10452231 0,6865 0,988958755 4
2 FALSE
SP42 T1 SP42T1 3 11076400 197717569 0,5 0,341667196 2
2 TRUE
SP42 T1 SP42T1 4 60400 189065435 0,554 -0,156307098 1 1
FALSE
SP42 T1 SP42T1 5 163205 180670414 0,504 0,296288443 2
2 TRUE
SP42 T1 SP42T1 6 335251 65098768 0,505 0,227507947 2
2 TRUE
SP42 T1 SP42T1 6 65149185 65525121 0,952 -0,388952118 2
0 TRUE
SP42 T1 SP42T1 6 65622463 65655883 0,5 -3,926944202 0
0 TRUE
SP42 T1 SP42T1 6 65767393 70071173 0,945894516 -0,934082942
2 0 TRUE
SP42 T1 SP42T1 6 70589630 71011831 0,51 0,349733018 2
2 TRUE
SP42 T1 SP42T1 6 71137992 116600774 0,95541438 -0,654886609
2 0 TRUE
SP42 T1 SP42T1 6 116774264 116783330 0,517 -0,574300255 1
1 TRUE
SP42 T1 SP42T1 6 116836720 167440244 0,959 -0,684413895 2
0 TRUE
SP42 T1 SP42T1 6 167590541 167704944 0,568 -0,52039039 1
1 TRUE
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SP42 T1 SP42T1 6 167754661 167772755 0,951 -0,626843734 2
0 TRUE
SP42 T1 SP42T1 6 167786551 167791524 0,5 -0,613232941 1
1 TRUE
SP42 T1 SP42T1 6 168298875 170892848 0,957773469 -0,57645785
2 0 TRUE
SP42 T1 SP42T1 7 286402 54621692 0,621 0,638934588 3
2 FALSE
SP42 T1 SP42T1 7 54724286 55780176 0,954 3,454117017 36
2 TRUE
SP42 T1 SP42T1 7 55832454 159025180 0,62 0,603509355 3
2 FALSE
SP42 T1 SP42T1 8 280241 145750138 0,5 -0,503046869 1
1 TRUE
SP42 T1 SP42T1 9 286593 20946952 0,961 -0,553352428 2
0 TRUE
SP42 T1 SP42T1 9 20948311 21695893 0,5 -3,971614216 0
0 TRUE
SP42 T1 SP42T1 9 21816637 25678122 0,75 -3,135457898 1
0 TRUE
SP42 T1 SP42T1 9 27044587 43860959 0,69 -0,009452239 2
1 FALSE
SP42 T1 SP42T1 9 65973514 68409702 0,519 -0,100945976 2
2 TRUE
SP42 T1 SP42T1 9 68415386 141008876 0,692 -0,033529732 2
1 FALSE
SP42 T1 SP42T1 10 323283 30728101 0,958 -0,715755692 2
0 TRUE
SP42 T1 SP42T1 10 30915590 30978282 0,6135 -0,301450297 2
1 TRUE
SP42 T1 SP42T1 10 30978377 46221393 0,954061836 -0,698001309
2 0 TRUE
SP42 T1 SP42T1 10 46960084 47416860 0,5 -0,770610796 1
1 TRUE
SP42 T1 SP42T1 10 47605468 51586514 0,957 -0,704405567 2
0 TRUE
SP42 T1 SP42T1 10 51620278 51631972 0,522 -0,062667075 2
2 TRUE
SP42 T1 SP42T1 10 51785694 135381766 0,955211704 -0,661429889
2 0 TRUE
SP42 T1 SP42T1 11 193096 50381417 0,504 0,222107404 2
2 TRUE
SP42 T1 SP42T1 11 51411914 98436532 0,95528182 -0,659169607
2 0 TRUE
SP42 T1 SP42T1 11 99690286 100061865 0,513 -0,529270259 1
1 TRUE
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SP42 T1 SP42T1 11 100064417 105923564 0,951445625 -0,777909416
2 0 TRUE
SP42 T1 SP42T1 11 106408212 106849400 0,556 0,010086936 2
2 TRUE
SP42 T1 SP42T1 11 106849520 134856661 0,957 -0,65218679 2
0 TRUE
SP42 T1 SP42T1 12 250239 133732624 0,503 0,164035201 2
2 TRUE
SP42 T1 SP42T1 13 19042919 115091073 0,541 -0,371132036 1
1 FALSE
SP42 T1 SP42T1 14 19118237 19585390 0,636 -0,640604604 2
1 TRUE
SP42 T1 SP42T1 14 20085357 81499624 0,962 -0,579473545 2
0 TRUE
SP42 T1 SP42T1 14 81574844 81610583 0,5 -0,780521565 1
1 TRUE
SP42 T1 SP42T1 14 82382741 106993845 0,957483538 -0,586329679
2 0 TRUE
SP42 T1 SP42T1 14 107087259 107283160 0,899 -0,538062336 2
0 TRUE
SP42 T1 SP42T1 15 20170150 48752278 0,6045 -0,120254543 2
1 FALSE
SP42 T1 SP42T1 15 48755168 48813107 0,935201639 -1,194265443
1 0 TRUE
SP42 T1 SP42T1 15 48903126 102359203 0,614 -0,108649129 2
1 FALSE
SP42 T1 SP42T1 16 109665 33412844 0,618 -0,223415439 2
1 FALSE
SP42 T1 SP42T1 16 33413927 33424950 0,51 -0,157956576 1
1 TRUE
SP42 T1 SP42T1 16 46389677 90161852 0,609 -0,201544527 2
1 FALSE
SP42 T1 SP42T1 17 6188 21206440 0,699 -0,329221791 2 1
FALSE
SP42 T1 SP42T1 17 21207844 22253231 0,551 -0,123381594 1
1 FALSE
SP42 T1 SP42T1 17 25628820 47243622 0,698 -0,272424939 2
1 FALSE
SP42 T1 SP42T1 17 47579417 81083419 0,5 0,299105202 2
2 TRUE
SP42 T1 SP42T1 18 334994 77728221 0,595 -0,316358703 2
1 FALSE
SP42 T1 SP42T1 19 311708 20857775 0,543 0,057891592 2
2 FALSE
SP42 T1 SP42T1 19 20874651 24014850 0,7165 0,949243222 5
2 TRUE
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SP42 T1 SP42T1 19 28296408 59074653 0,506 0,06225464 2
2 TRUE
SP42 T1 SP42T1 20 76962 62904542 0,5 0,138122639 2 2
TRUE
SP42 T1 SP42T1 21 9825966 11058349 0,6185 0,103366264 2
1 TRUE
SP42 T1 SP42T1 21 14418486 48078611 0,508 0,108736909 2
2 TRUE
SP42 T1 SP42T1 22 16157827 50169157 0,5 0,144145591 2
2 TRUE
SP42 T1 SP42T1 22 50277835 50499967 0,687 0,719138386 4
2 FALSE
SP42 T1 SP42T1 22 50512617 51207915 0,5 0,182456866 2
2 TRUE
SP42 T2 SP42T2 1 762273 14507057 0,638 -0,177090696 2
1 TRUE
SP42 T2 SP42T2 1 15441029 237993724 0,5 0,187471124 2
2 TRUE
SP42 T2 SP42T2 1 239216186 240307048 0,7845 -0,11397225 3
1 TRUE
SP42 T2 SP42T2 1 240307380 248813749 0,5 0,104526931 2
2 TRUE
SP42 T2 SP42T2 2 41720 141130501 0,566 0,14888084 2 1
FALSE
SP42 T2 SP42T2 2 141457962 141625410 0,859 -0,692766964 2
0 FALSE
SP42 T2 SP42T2 2 142012027 242839614 0,561 0,196397188 3
2 FALSE
SP42 T2 SP42T2 3 386247 197717569 0,5 0,201124979 2
2 TRUE
SP42 T2 SP42T2 4 60400 189065435 0,5 0,182364671 2 2
TRUE
SP42 T2 SP42T2 5 163205 180670414 0,5 0,181462649 2
2 TRUE
SP42 T2 SP42T2 6 335251 57841273 0,5 0,170976985 2
2 TRUE
SP42 T2 SP42T2 6 58776982 58778809 0,648914925 -2,675732443
0 0 FALSE
SP42 T2 SP42T2 6 62442604 65149185 0,533 0,278671661 2
2 TRUE
SP42 T2 SP42T2 6 65300516 68643897 0,856 -1,108004893 1
0 TRUE
SP42 T2 SP42T2 6 69728452 70071173 0,916173344 -0,609392758
2 0 TRUE
SP42 T2 SP42T2 6 70589630 71011831 0,512 0,586251923 3
3 TRUE
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SP42 T2 SP42T2 6 71137992 116600774 0,911082954 -0,694443696
2 0 TRUE
SP42 T2 SP42T2 6 116774264 116783330 0,5 -0,307574977 1
1 TRUE
SP42 T2 SP42T2 6 116836720 167440128 0,909915951 -0,713255361
2 0 TRUE
SP42 T2 SP42T2 6 167440244 167591954 0,508 -0,651923542 1
1 TRUE
SP42 T2 SP42T2 6 167704944 167772755 0,916882594 -0,597134315
2 0 TRUE
SP42 T2 SP42T2 6 167786551 167791524 0,556 -0,576482605 1
1 TRUE
SP42 T2 SP42T2 6 168298875 170892848 0,9155 -0,558105969 2
0 TRUE
SP42 T2 SP42T2 7 286402 54621692 0,592 0,487965549 3
2 TRUE
SP42 T2 SP42T2 7 54724286 55780176 0,9205 2,996332778 28
2 TRUE
SP42 T2 SP42T2 7 55832454 65228128 0,638 -0,1596465 2
1 TRUE
SP42 T2 SP42T2 7 65439189 159025180 0,595 0,460289369 3
2 TRUE
SP42 T2 SP42T2 8 280241 145750138 0,64 -0,179220927 2
1 TRUE
SP42 T2 SP42T2 9 286593 20946952 0,909710937 -0,716534916
2 0 TRUE
SP42 T2 SP42T2 9 20948311 21816758 0,5 -2,902551585 0
0 TRUE
SP42 T2 SP42T2 9 21838145 141008876 0,646 -0,179188572 2
1 TRUE
SP42 T2 SP42T2 10 323283 46221393 0,927431761 -0,401321944
2 0 FALSE
SP42 T2 SP42T2 10 46960084 47416860 0,505 -0,239817708 1
1 TRUE
SP42 T2 SP42T2 10 47605468 51586514 0,930874436 -0,331203026
3 0 TRUE
SP42 T2 SP42T2 10 51620278 51631972 0,5 -0,002439484 2
2 TRUE
SP42 T2 SP42T2 10 51785694 135381766 0,931987727 -0,307778798
3 0 TRUE
SP42 T2 SP42T2 11 193096 50381417 0,5 0,208677957 2
2 TRUE
SP42 T2 SP42T2 11 51411914 134856661 0,911385629 -0,689524362
2 0 TRUE
SP42 T2 SP42T2 12 250239 133732624 0,647 -0,19438342 2
1 TRUE
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SP42 T2 SP42T2 13 19042919 115091073 0,645 -0,198549091 2
1 TRUE
SP42 T2 SP42T2 14 19118237 19585390 0,614 -0,897271488 1
1 FALSE
SP42 T2 SP42T2 14 20085357 106993845 0,911319349 -0,690603038
2 0 TRUE
SP42 T2 SP42T2 14 107087259 107283160 0,822 -0,601238211 2
0 TRUE
SP42 T2 SP42T2 15 20170150 20173275 0,685 -0,130193167 2
1 TRUE
SP42 T2 SP42T2 15 20279438 48752278 0,5 0,164716568 2
2 TRUE
SP42 T2 SP42T2 15 48755168 48813107 0,915483973 -0,621208623
2 0 TRUE
SP42 T2 SP42T2 15 48903126 102359203 0,5 0,158010417 2
2 TRUE
SP42 T2 SP42T2 16 109665 90161852 0,635 -0,266379039 2
1 FALSE
SP42 T2 SP42T2 17 6188 15811871 0,6465 -0,259619622 2 1
TRUE
SP42 T2 SP42T2 17 16004537 22253231 0,612 -0,158154461 2
1 FALSE
SP42 T2 SP42T2 17 25628820 47121551 0,645 -0,199587417 2
1 TRUE
SP42 T2 SP42T2 17 47122492 81083419 0,5 0,178925969 2
2 TRUE
SP42 T2 SP42T2 18 334994 77728221 0,502 0,105030788 2
2 TRUE
SP42 T2 SP42T2 19 311708 24014850 0,5 -0,022870138 2
2 TRUE
SP42 T2 SP42T2 19 28296408 59074653 0,575 -0,119974083 2
1 FALSE
SP42 T2 SP42T2 20 76962 26063560 0,508 0,184500007 2 2
TRUE
SP42 T2 SP42T2 20 29449501 29625724 0,722 0,264714655 3
1 TRUE
SP42 T2 SP42T2 20 29625788 62904542 0,5 0,156684522 2
2 TRUE
SP42 T2 SP42T2 21 9825966 11058349 0,6185 -0,090712069 2
1 FALSE
SP42 T2 SP42T2 21 14418486 48078611 0,5 0,136565577 2
2 TRUE
SP42 T2 SP42T2 22 16157827 49937236 0,631 -0,224195753 2
1 FALSE
SP42 T2 SP42T2 22 50169157 50354819 0,761 0,434530902 4
1 FALSE
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SP42 T2 SP42T2 22 50470516 51207915 0,625 -0,168823576 2
1 FALSE
SP42 T3 SP42T3 1 762273 12835868 0,625 -0,204744955 2
1 TRUE
SP42 T3 SP42T3 1 13182899 248813749 0,503 0,157547168 2
2 TRUE
SP42 T3 SP42T3 2 41720 141130501 0,5 0,102673436 2 2
TRUE
SP42 T3 SP42T3 2 141457962 141625410 0,7295 -0,130358669 3
1 FALSE
SP42 T3 SP42T3 2 142012027 242839614 0,5 0,167277901 2
2 TRUE
SP42 T3 SP42T3 3 386247 197717569 0,573 0,384719595 3
2 FALSE
SP42 T3 SP42T3 4 60400 189065435 0,5 0,164428641 2 2
TRUE
SP42 T3 SP42T3 5 163205 180670414 0,5 0,159032072 2
2 TRUE
SP42 T3 SP42T3 6 335251 32548214 0,5 0,091070492 2
2 TRUE
SP42 T3 SP42T3 6 32548470 32800224 0,621 0,264052196 3
2 FALSE
SP42 T3 SP42T3 6 32805307 58778809 0,5 0,139981917 2
2 TRUE
SP42 T3 SP42T3 6 62442604 65622662 0,598 -0,149352793 2
1 TRUE
SP42 T3 SP42T3 6 65655883 70071173 0,827 -0,56440545 2
0 TRUE
SP42 T3 SP42T3 6 70589630 71011831 0,586 0,528165161 3
2 TRUE
SP42 T3 SP42T3 6 71137992 116600774 0,844 -0,597516634 2
0 TRUE
SP42 T3 SP42T3 6 116774264 116783330 0,538 -0,208420729 1
1 TRUE
SP42 T3 SP42T3 6 116836720 170892848 0,848 -0,564997176 2
0 TRUE
SP42 T3 SP42T3 7 286402 54621692 0,6 0,447714215 3
2 FALSE
SP42 T3 SP42T3 7 54724286 55780176 0,969 4,008742547 68
2 TRUE
SP42 T3 SP42T3 7 55832454 159025180 0,599 0,38960563 3
2 FALSE
SP42 T3 SP42T3 8 280241 145750138 0,603 -0,130391226 2
1 FALSE
SP42 T3 SP42T3 9 286593 20923618 0,84 -0,578467646 2
0 TRUE
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SP42 T3 SP42T3 9 20946952 141008876 0,606 -0,125262761 2
1 FALSE
SP42 T3 SP42T3 10 323283 30728101 0,86939122 -0,322920745
3 0 FALSE
SP42 T3 SP42T3 10 30915590 30978377 0,625 0,023509247 2
1 TRUE
SP42 T3 SP42T3 10 30978433 46221393 0,87 -0,330698794 3
0 FALSE
SP42 T3 SP42T3 10 46960084 47416860 0,5 -0,269936302 1
1 TRUE
SP42 T3 SP42T3 10 47605468 51586514 0,876 -0,197425052 3
0 TRUE
SP42 T3 SP42T3 10 51620278 51631972 0,513 0,278536089 2
2 TRUE
SP42 T3 SP42T3 10 51785694 135381766 0,8805 -0,209907633 3
0 TRUE
SP42 T3 SP42T3 11 193096 50381417 0,5 0,189030065 2
2 TRUE
SP42 T3 SP42T3 11 51411914 134856661 0,843955582 -0,579625607
2 0 TRUE
SP42 T3 SP42T3 12 250239 133732624 0,597 -0,111571477 2
1 FALSE
SP42 T3 SP42T3 13 19042919 115091073 0,602 -0,136183393 2
1 FALSE
SP42 T3 SP42T3 14 19118237 20085357 0,6355 -0,830429792 1
0 FALSE
SP42 T3 SP42T3 14 20137084 107283160 0,84280016 -0,590268603
2 0 TRUE
SP42 T3 SP42T3 15 20170150 20173275 0,508 -0,332423819 1
1 TRUE
SP42 T3 SP42T3 15 20279438 48752278 0,5 0,136831504 2
2 TRUE
SP42 T3 SP42T3 15 48755168 48813107 0,846 -0,35797611 2
0 TRUE
SP42 T3 SP42T3 15 48903126 102359203 0,504 0,099861178 2
2 TRUE
SP42 T3 SP42T3 16 109665 90161852 0,576 -0,231654672 2
1 FALSE
SP42 T3 SP42T3 17 6188 47579417 0,627 -0,24148955 2 1
TRUE
SP42 T3 SP42T3 17 47696070 81083419 0,5 0,096178725 2
2 TRUE
SP42 T3 SP42T3 18 334994 77728221 0,506 0,058449045 2
2 TRUE
SP42 T3 SP42T3 19 311708 59074653 0,5 -0,140870367 2
2 TRUE
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SP42 T3 SP42T3 20 76962 26063560 0,508 0,160489323 2 2
TRUE
SP42 T3 SP42T3 20 29449501 62904542 0,502 0,101144692 2
2 TRUE
SP42 T3 SP42T3 21 9825966 15460891 0,626 -0,172918185 2
1 TRUE
SP42 T3 SP42T3 21 15481234 48078611 0,505 0,142456304 2
2 TRUE
SP42 T3 SP42T3 22 16157827 16953727 0,75 -0,911041512 1
0 TRUE
SP42 T3 SP42T3 22 17055458 50169157 0,597 -0,152150768 2
1 FALSE
SP42 T3 SP42T3 22 50277835 50499967 0,73 0,347312101 3
1 FALSE
SP42 T3 SP42T3 22 50512617 51207915 0,593 -0,069781243 2
1 FALSE
SP42 T4 SP42T4 1 762273 12318079 0,57 -0,114172061 2
1 FALSE
SP42 T4 SP42T4 1 12339619 248813749 0,5 0,107346803 2
2 TRUE
SP42 T4 SP42T4 2 41720 242839614 0,5 0,088636249 2 2
TRUE
SP42 T4 SP42T4 3 386247 197717569 0,5 0,112728386 2
2 TRUE
SP42 T4 SP42T4 4 60400 189065435 0,5 0,107341335 2 2
TRUE
SP42 T4 SP42T4 5 163205 180670414 0,5 0,09953025 2
2 TRUE
SP42 T4 SP42T4 6 335251 57467323 0,5 0,107917063 2
2 TRUE
SP42 T4 SP42T4 6 57841273 70071173 0,631 -0,523167606 1
0 TRUE
SP42 T4 SP42T4 6 70589630 71011831 0,5 0,332845264 3
3 TRUE
SP42 T4 SP42T4 6 71137992 170892848 0,703 -0,379567363 2
0 TRUE
SP42 T4 SP42T4 7 286402 54621692 0,583 0,355800646 3
2 FALSE
SP42 T4 SP42T4 7 54724286 55780176 0,7965 2,327357802 24
5 TRUE
SP42 T4 SP42T4 7 55832454 159025180 0,584 0,328851688 3
2 FALSE
SP42 T4 SP42T4 8 280241 145750138 0,508 -0,033530632 2
2 TRUE
SP42 T4 SP42T4 9 286593 20923618 0,7 -0,417940901 2
0 TRUE
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SP42 T4 SP42T4 9 20946952 141008876 0,566 -0,110946165 2
1 FALSE
SP42 T4 SP42T4 10 323283 46221393 0,728905051 -0,266169139
2 0 FALSE
SP42 T4 SP42T4 10 46960084 47673801 0,519 -0,249136452 1
1 TRUE
SP42 T4 SP42T4 10 47673858 51586514 0,7335 -0,217158052 3
0 FALSE
SP42 T4 SP42T4 10 51620278 51631972 0,514 0,086096259 2
2 TRUE
SP42 T4 SP42T4 10 51785694 135381766 0,737 -0,230034988 3
0 FALSE
SP42 T4 SP42T4 11 193096 51412353 0,5 0,123806117 2
2 TRUE
SP42 T4 SP42T4 11 51426207 134856661 0,703 -0,378964202 2
0 TRUE
SP42 T4 SP42T4 12 250239 133732624 0,505 -0,032130779 2
2 TRUE
SP42 T4 SP42T4 13 19042919 115091073 0,558 -0,13016898 2
1 FALSE
SP42 T4 SP42T4 14 19118237 107283160 0,706 -0,391132839 2
0 TRUE
SP42 T4 SP42T4 15 20170150 48752278 0,5 0,088403961 2
2 TRUE
SP42 T4 SP42T4 15 48755168 48779402 0,734507279 -0,236043211
3 0 TRUE
SP42 T4 SP42T4 15 48797124 102359203 0,5 0,100705068 2
2 TRUE
SP42 T4 SP42T4 16 109665 33424950 0,5 -0,167426105 1
1 TRUE
SP42 T4 SP42T4 16 46389677 46394622 0,5 -3,46776357 0
0 TRUE
SP42 T4 SP42T4 16 46405156 90161852 0,5 -0,129666001 1
1 TRUE
SP42 T4 SP42T4 17 6188 47579417 0,559 -0,129327629 2 1
FALSE
SP42 T4 SP42T4 17 47696070 81083419 0,5 0,078965485 2
2 TRUE
SP42 T4 SP42T4 18 334994 77728221 0,5 0,089117772 2
2 TRUE
SP42 T4 SP42T4 19 311708 59074653 0,503 -0,045819552 2
2 TRUE
SP42 T4 SP42T4 20 76962 62904542 0,5 0,081379355 2 2
TRUE
SP42 T4 SP42T4 21 9825966 9907416 0,7145 -0,207716499 2
0 TRUE
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SP42 T4 SP42T4 21 10971892 14916496 0,52 0,138804678 2
2 TRUE
SP42 T4 SP42T4 21 15281913 15281957 0,608519889 -0,796309919
1 0 TRUE
SP42 T4 SP42T4 21 15460877 48078611 0,5 0,086504932 2
2 TRUE
SP42 T4 SP42T4 22 16157827 17055458 0,705 -0,157673867 2
0 TRUE
SP42 T4 SP42T4 22 17060166 48942566 0,5 -0,110135953 2
2 TRUE
SP42 T4 SP42T4 22 49246450 50470516 0,659 0,157773254 3
1 TRUE
SP42 T4 SP42T4 22 50499967 51207915 0,5 -0,142552239 1
1 TRUE
SP49 M SP49M 1 865628 248814052 0,5 -0,012181383 1
1 TRUE
SP49 M SP49M 2 675831 242794191 0,5 0,002754186 1
1 TRUE
SP49 M SP49M 3 386247 197581147 0,504 0,005361827 1
1 TRUE
SP49 M SP49M 4 64892 189065441 0,5 0,030638571 1 1
TRUE
SP49 M SP49M 5 163205 179498595 0,5 -0,001003828 1
1 TRUE
SP49 M SP49M 5 179528999 179529004 0,762 -0,010722704 1
0 TRUE
SP49 M SP49M 5 179529124 180660723 0,5 0,008633197 1
1 TRUE
SP49 M SP49M 6 335251 29913344 0,5 -0,055885549 1
1 TRUE
SP49 M SP49M 6 29921064 29921242 0,783 -0,689987728 1
0 FALSE
SP49 M SP49M 6 29924996 32557483 0,503 -0,003317697 1
1 TRUE
SP49 M SP49M 6 32557506 32605451 0,731 -0,238361988 1
0 FALSE
SP49 M SP49M 6 32609015 170878886 0,5 -0,037639573 1
1 TRUE
SP49 M SP49M 7 331427 159024638 0,5 0,069692724 1
1 TRUE
SP49 M SP49M 8 182934 146171437 0,5 -0,011912723 1
1 TRUE
SP49 M SP49M 9 214706 141069978 0,5 -0,045466212 1
1 TRUE
SP49 M SP49M 10 93945 135272948 0,5 -0,077329084 1 1
TRUE
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SP49 M SP49M 11 193865 134238518 0,502 -0,0036868 1
1 TRUE
SP49 M SP49M 12 176139 57535266 0,5 -0,039782753 1
1 TRUE
SP49 M SP49M 12 57573329 62864417 0,7415 0,654348028 3
1 TRUE
SP49 M SP49M 12 62887608 133795960 0,5 -0,001533191 1
1 TRUE
SP49 M SP49M 13 19526019 115047700 0,5 0,006545451 1
1 TRUE
SP49 M SP49M 14 19188622 107283076 0,5 -0,03890771 1
1 TRUE
SP49 M SP49M 15 20170150 20467994 0,644 -0,000358767 1
1 FALSE
SP49 M SP49M 15 20588458 102313869 0,5 -0,057765485 1
1 TRUE
SP49 M SP49M 16 105325 90142087 0,5 0,002167003 1
1 TRUE
SP49 M SP49M 17 177359 81052407 0,505 -0,00482082 1
1 TRUE
SP49 M SP49M 18 48228 77918221 0,505 -0,00934461 1 1
TRUE
SP49 M SP49M 19 288062 59082605 0,5 -0,006407524 1
1 TRUE
SP49 M SP49M 20 76962 62904542 0,5 -0,004176817 1 1
TRUE
SP49 M SP49M 21 9891930 48083526 0,5 0,056330087 1
1 TRUE
SP49 M SP49M 22 16348231 51219006 0,5 -0,061134433 1
1 TRUE
SP49 SVZ SP49SVZ 1 865628 59465849 0,5 0,146460773 2
2 TRUE
SP49 SVZ SP49SVZ 1 59465881 59465926 0,75 -0,323671964 2
0 TRUE
SP49 SVZ SP49SVZ 1 60019782 248814052 0,503 0,143982336 2
2 TRUE
SP49 SVZ SP49SVZ 2 675831 136479641 0,509 0,13537146 2
2 TRUE
SP49 SVZ SP49SVZ 2 136561557 242794191 0,6 0,009491617 2
1 FALSE
SP49 SVZ SP49SVZ 3 386247 174814920 0,533 -0,44153805 1
1 FALSE
SP49 SVZ SP49SVZ 3 174974177 186358768 0,9395 2,442604524 25
1 TRUE
SP49 SVZ SP49SVZ 3 186360409 191107445 0,8765 1,447103906 12
1 TRUE
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SP49 SVZ SP49SVZ 3 192125768 197581147 0,506 -0,417208076 1
1 TRUE
SP49 SVZ SP49SVZ 4 64892 189065441 0,5 0,140694867 2 2
TRUE
SP49 SVZ SP49SVZ 5 163205 180660723 0,5 0,175484722 2
2 TRUE
SP49 SVZ SP49SVZ 6 335251 32261771 0,609 -0,13756386 2
1 TRUE
SP49 SVZ SP49SVZ 6 32268501 32609015 0,644 -0,083434449 2
1 FALSE
SP49 SVZ SP49SVZ 6 32609057 32634467 0,5 -0,265637373 1
1 TRUE
SP49 SVZ SP49SVZ 6 32634482 170878886 0,61 -0,149918271 2
1 TRUE
SP49 SVZ SP49SVZ 7 331427 75183403 0,635 0,590648057 4
2 TRUE
SP49 SVZ SP49SVZ 7 75185985 159024638 0,5795 0,379555951 3
2 TRUE
SP49 SVZ SP49SVZ 8 182934 6794114 0,775299027 -0,543687958
2 0 TRUE
SP49 SVZ SP49SVZ 8 7215484 7720995 0,579 -0,694236253 1
1 TRUE
SP49 SVZ SP49SVZ 8 8176221 146171437 0,782442718 -0,497076892
2 0 TRUE
SP49 SVZ SP49SVZ 9 214706 131586913 0,5 0,150464311 2
2 TRUE
SP49 SVZ SP49SVZ 9 131670457 141069978 0,582 0,432509352 3
2 TRUE
SP49 SVZ SP49SVZ 10 93945 30728250 0,778 -0,536470069 2 0
TRUE
SP49 SVZ SP49SVZ 10 30915590 30915906 0,512 -0,746660931 1
1 TRUE
SP49 SVZ SP49SVZ 10 30960568 114496687 0,783 -0,499947129 2
0 TRUE
SP49 SVZ SP49SVZ 10 115334124 135272948 0,853 0,095981242 4
0 FALSE
SP49 SVZ SP49SVZ 11 193865 134238518 0,61 -0,131245408 2
1 TRUE
SP49 SVZ SP49SVZ 12 176139 34175508 0,5 0,155692133 2
2 TRUE
SP49 SVZ SP49SVZ 12 37969194 48142418 0,774 -0,489450586 2
0 FALSE
SP49 SVZ SP49SVZ 12 48144243 57592909 0,78523443 -0,478444311
2 0 TRUE
SP49 SVZ SP49SVZ 12 57627717 62864417 0,9265 2,056447039 19
1 TRUE
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SP49 SVZ SP49SVZ 12 62887608 133795960 0,5 0,151740824 2
2 TRUE
SP49 SVZ SP49SVZ 13 19526019 115047700 0,612 -0,162015693 2
1 TRUE
SP49 SVZ SP49SVZ 14 19188622 107283076 0,607 -0,142336331 2
1 TRUE
SP49 SVZ SP49SVZ 15 20170150 102313869 0,611 -0,155421629 2
1 TRUE
SP49 SVZ SP49SVZ 16 105325 90142087 0,5 0,172848424 2
2 TRUE
SP49 SVZ SP49SVZ 17 177359 18284262 0,83 -0,131266134 3
0 TRUE
SP49 SVZ SP49SVZ 17 18301096 18314964 0,533 -0,215669905 1
1 TRUE
SP49 SVZ SP49SVZ 17 18417838 19959693 0,818 -0,094597562 3
0 FALSE
SP49 SVZ SP49SVZ 17 20000131 81052407 0,614 -0,119104594 2
1 TRUE
SP49 SVZ SP49SVZ 18 48228 77918221 0,5 0,11598802 2 2
TRUE
SP49 SVZ SP49SVZ 19 288062 59082605 0,5 0,151046541 2
2 TRUE
SP49 SVZ SP49SVZ 20 76962 62904542 0,611 -0,119728564 2 1
TRUE
SP49 SVZ SP49SVZ 21 9891930 48083526 0,633 0,546290714 4
2 TRUE
SP49 SVZ SP49SVZ 22 16348231 51219006 0,785 -0,480021719 2
0 TRUE
SP49 T1 SP49T1 1 865628 58996203 0,503 0,150654012 2
2 TRUE
SP49 T1 SP49T1 1 59096479 59096669 0,698 0,317559645 3
1 TRUE
SP49 T1 SP49T1 1 59096689 248605395 0,504 0,18609838 2
2 TRUE
SP49 T1 SP49T1 1 248722611 248814052 0,6 0,097506759 2
1 TRUE
SP49 T1 SP49T1 2 675831 242794191 0,502 0,137368468 2
2 TRUE
SP49 T1 SP49T1 3 386247 174814920 0,542 -0,346704311 1
1 FALSE
SP49 T1 SP49T1 3 174974177 186395572 0,948 2,587794508 27
1 TRUE
SP49 T1 SP49T1 3 186501502 191107445 0,899 1,795469361 14
1 TRUE
SP49 T1 SP49T1 3 192125768 197581147 0,552 -0,39520961 1
1 FALSE
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SP49 T1 SP49T1 4 64892 189065441 0,5 0,171172051 2 2
TRUE
SP49 T1 SP49T1 5 163205 108516629 0,5 0,190910856 2
2 TRUE
SP49 T1 SP49T1 5 109110537 180660723 0,571 0,395300428 3
2 TRUE
SP49 T1 SP49T1 6 335251 29911419 0,613 -0,128429402 2
1 TRUE
SP49 T1 SP49T1 6 29911538 29921242 0,692 -0,03886164 3
1 TRUE
SP49 T1 SP49T1 6 29924996 170878886 0,614 -0,131209513 2
1 TRUE
SP49 T1 SP49T1 7 331427 75145495 0,636 0,619267388 4
2 TRUE
SP49 T1 SP49T1 7 75168900 159024638 0,584 0,397416822 3
2 TRUE
SP49 T1 SP49T1 8 182934 146171437 0,791 -0,502055045 2
0 TRUE
SP49 T1 SP49T1 9 214706 130446493 0,507 0,19059556 2
2 TRUE
SP49 T1 SP49T1 9 130446836 141069978 0,593 0,437103148 3
2 FALSE
SP49 T1 SP49T1 10 93945 46148326 0,780426001 -0,577232009 2
0 FALSE
SP49 T1 SP49T1 10 46194651 47729407 0,7125 -0,137882313 2
0 FALSE
SP49 T1 SP49T1 10 48370595 135272948 0,792841755 -0,493258025
2 0 TRUE
SP49 T1 SP49T1 11 193865 134238518 0,615 -0,103586667 2
1 TRUE
SP49 T1 SP49T1 12 176139 34175508 0,5 0,158350577 2
2 TRUE
SP49 T1 SP49T1 12 37969194 57592909 0,791653666 -0,501508496
2 0 TRUE
SP49 T1 SP49T1 12 57627717 62864417 0,9385 2,2062155 20
1 TRUE
SP49 T1 SP49T1 12 62887608 133795960 0,5 0,155251062 2
2 TRUE
SP49 T1 SP49T1 13 19526019 115047700 0,618 -0,142142201 2
1 TRUE
SP49 T1 SP49T1 14 19188622 107283076 0,613 -0,129449795 2
1 TRUE
SP49 T1 SP49T1 15 20170150 102313869 0,613 -0,130379061 2
1 TRUE
SP49 T1 SP49T1 16 105325 90142087 0,5 0,16400587 2
2 TRUE
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SP49 T1 SP49T1 17 177359 18284262 0,838239607 -0,136383192
3 0 TRUE
SP49 T1 SP49T1 17 18301096 18314964 0,562 -0,036787358 2
1 FALSE
SP49 T1 SP49T1 17 18417838 19861458 0,835373911 -0,161717762
3 0 TRUE
SP49 T1 SP49T1 17 19959693 81052407 0,614 -0,13660086 2
1 TRUE
SP49 T1 SP49T1 18 48228 77918221 0,5025 0,151682967 2 2
TRUE
SP49 T1 SP49T1 19 288062 59082605 0,5 0,088560109 2
2 TRUE
SP49 T1 SP49T1 20 76962 62904542 0,614 -0,1136852 2 1
TRUE
SP49 T1 SP49T1 21 9891930 48083526 0,635 0,572212936 4
2 TRUE
SP49 T1 SP49T1 22 16348231 51219006 0,793764989 -0,486814052
2 0 TRUE
SP49 T2 SP49T2 1 865628 58996203 0,5 0,131090992 2
2 TRUE
SP49 T2 SP49T2 1 59096479 59096689 0,714 0,249800567 4
1 TRUE
SP49 T2 SP49T2 1 59096693 248814052 0,503 0,137790008 2
2 TRUE
SP49 T2 SP49T2 2 675831 242794191 0,5 0,107970011 2
2 TRUE
SP49 T2 SP49T2 3 386247 174814920 0,5 -0,236668762 1
1 TRUE
SP49 T2 SP49T2 3 174974177 179689173 0,873 1,525401307 15
1 TRUE
SP49 T2 SP49T2 3 180630565 186395113 0,929 2,356762342 30
1 TRUE
SP49 T2 SP49T2 3 186395572 191107445 0,8485 1,363430321 13
1 TRUE
SP49 T2 SP49T2 3 192125768 197581147 0,5 -0,336844544 1
1 TRUE
SP49 T2 SP49T2 4 64892 189065441 0,5 0,116517325 2 2
TRUE
SP49 T2 SP49T2 5 163205 180660723 0,5 0,144881016 2
2 TRUE
SP49 T2 SP49T2 6 335251 170878886 0,583 -0,092165701 2
1 TRUE
SP49 T2 SP49T2 7 331427 76949920 0,612 0,479768388 4
2 TRUE
SP49 T2 SP49T2 7 76950686 159024638 0,556 0,28123158 3
2 TRUE
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SP49 T2 SP49T2 8 182934 146171437 0,6945 -0,344832779 2
0 TRUE
SP49 T2 SP49T2 9 214706 43875942 0,5 0,116758706 2
2 TRUE
SP49 T2 SP49T2 9 65973404 69120693 0,6 -0,05749896 2
1 TRUE
SP49 T2 SP49T2 9 69238268 130341095 0,5 0,146501766 2
2 TRUE
SP49 T2 SP49T2 9 130341253 141069978 0,566 0,374760445 3
2 TRUE
SP49 T2 SP49T2 10 93945 114496687 0,6920005 -0,353156757 2
0 TRUE
SP49 T2 SP49T2 10 115334124 135272948 0,733 -0,082314816 3
0 FALSE
SP49 T2 SP49T2 11 193865 134238518 0,585 -0,028360423 2
1 TRUE
SP49 T2 SP49T2 12 176139 34175508 0,5 0,128040141 2
2 TRUE
SP49 T2 SP49T2 12 37969194 57592909 0,7 -0,298263924 2
0 TRUE
SP49 T2 SP49T2 12 57627717 62864417 0,91 1,84701751 20
1 TRUE
SP49 T2 SP49T2 12 62887608 133795960 0,506 0,106222028 2
2 TRUE
SP49 T2 SP49T2 13 19526019 115047700 0,578 -0,108294829 2
1 TRUE
SP49 T2 SP49T2 14 19188622 107283076 0,582 -0,092337472 2
1 TRUE
SP49 T2 SP49T2 15 20170150 102313869 0,579 -0,085063924 2
1 TRUE
SP49 T2 SP49T2 16 105325 90142087 0,5 0,138205603 2
2 TRUE
SP49 T2 SP49T2 17 177359 19959693 0,73784939 -0,120624652
3 0 TRUE
SP49 T2 SP49T2 17 20000131 81052407 0,586 -0,061927394 2
1 TRUE
SP49 T2 SP49T2 18 48228 77918221 0,5 0,10416159 2 2
TRUE
SP49 T2 SP49T2 19 288062 59082605 0,5 0,056862079 2
2 TRUE
SP49 T2 SP49T2 20 76962 62904542 0,59 -0,039149745 2 1
TRUE
SP49 T2 SP49T2 21 9891930 48083526 0,611 0,450444094 4
2 TRUE
SP49 T2 SP49T2 22 16348231 23077555 0,681 -0,286916513 2
0 TRUE
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SP49 T2 SP49T2 22 23089759 51219006 0,700712168 -0,311762373
2 0 TRUE
SP49 T3 SP49T3 1 865628 248605395 0,5 0,107839017 2
2 TRUE
SP49 T3 SP49T3 1 248722611 248814052 0,679 0,203759822 4
1 TRUE
SP49 T3 SP49T3 2 675831 242794191 0,503 0,103163278 2
2 TRUE
SP49 T3 SP49T3 3 386247 174814920 0,5 -0,220324305 1
1 TRUE
SP49 T3 SP49T3 3 174974177 186362643 0,884 1,727738606 19
1 TRUE
SP49 T3 SP49T3 3 186390627 191107445 0,8075 1,035351803 10
1 TRUE
SP49 T3 SP49T3 3 192125768 197581147 0,5 -0,214575582 1
1 TRUE
SP49 T3 SP49T3 4 64892 54011526 0,505 0,163413854 2 2
TRUE
SP49 T3 SP49T3 4 54292004 56840846 0,681 0,918854009 7
2 FALSE
SP49 T3 SP49T3 4 56874517 189065441 0,505 0,109435743 2
2 TRUE
SP49 T3 SP49T3 5 163205 180660723 0,5 0,15153347 2
2 TRUE
SP49 T3 SP49T3 6 335251 29855706 0,565 -0,089029169 2
1 TRUE
SP49 T3 SP49T3 6 29855849 29856092 0,686239895 -0,257620431
2 0 FALSE
SP49 T3 SP49T3 6 29856633 29912517 0,559 0,001431976 2
1 TRUE
SP49 T3 SP49T3 6 29912668 29921242 0,667 -0,137868173 2
0 TRUE
SP49 T3 SP49T3 6 29924996 170878886 0,571 -0,064365094 2
1 TRUE
SP49 T3 SP49T3 7 331427 75044830 0,605 0,45136754 4
2 TRUE
SP49 T3 SP49T3 7 75145495 159024638 0,558 0,29118523 3
2 TRUE
SP49 T3 SP49T3 8 182934 146171437 0,657 -0,264643001 2
0 FALSE
SP49 T3 SP49T3 9 214706 43875942 0,503 0,11423469 2
2 TRUE
SP49 T3 SP49T3 9 65973404 69777287 0,607 0,017760411 3
1 TRUE
SP49 T3 SP49T3 9 69846339 132377900 0,5 0,124843661 2
2 TRUE
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SP49 T3 SP49T3 9 132381749 141069978 0,5325 0,252006285 3
2 FALSE
SP49 T3 SP49T3 10 93945 114427981 0,66819873 -0,338277916 2
0 TRUE
SP49 T3 SP49T3 10 114496687 135272948 0,7465 0,055877687 4
0 FALSE
SP49 T3 SP49T3 11 193865 134238518 0,57 -0,040945184 2
1 TRUE
SP49 T3 SP49T3 12 176139 34175508 0,5 0,104705285 2
2 TRUE
SP49 T3 SP49T3 12 37969194 57592909 0,677 -0,286886426 2
0 TRUE
SP49 T3 SP49T3 12 57627717 62864417 0,914 1,840807444 21
0 FALSE
SP49 T3 SP49T3 12 62887608 133795960 0,5 0,070637598 2
2 TRUE
SP49 T3 SP49T3 13 19526019 115047700 0,558 -0,06939029 2
1 FALSE
SP49 T3 SP49T3 14 19188622 107283076 0,571 -0,069053916 2
1 TRUE
SP49 T3 SP49T3 15 20170150 102313869 0,565 -0,115646199 2
1 TRUE
SP49 T3 SP49T3 16 105325 90142087 0,5 0,086059853 2
2 TRUE
SP49 T3 SP49T3 17 177359 19861458 0,712893987 -0,129542051
3 0 TRUE
SP49 T3 SP49T3 17 19959693 81052407 0,57 -0,093907298 2
1 TRUE
SP49 T3 SP49T3 18 48228 77918221 0,503 0,065859221 2 2
TRUE
SP49 T3 SP49T3 19 288062 59082605 0,5 0,006604478 2
2 TRUE
SP49 T3 SP49T3 20 76962 62904542 0,573 -0,0566987 2 1
TRUE
SP49 T3 SP49T3 21 9891930 48083526 0,6015 0,400523483 4
2 TRUE
SP49 T3 SP49T3 22 16348231 51219006 0,671812449 -0,322479023
2 0 TRUE
SP49 T4 SP49T4 1 865628 58996203 0,5 0,177529012 2
2 TRUE
SP49 T4 SP49T4 1 59096479 59096693 0,677 0,430674426 3
1 TRUE
SP49 T4 SP49T4 1 59125894 248814052 0,5 0,187687974 2
2 TRUE
SP49 T4 SP49T4 2 675831 242794191 0,5 0,085929778 2
2 TRUE
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SP49 T4 SP49T4 3 386247 47555142 0,516 -0,523252369 1
1 FALSE
SP49 T4 SP49T4 3 47823549 48754583 0,675 0,097955154 3
1 TRUE
SP49 T4 SP49T4 3 48845251 174814920 0,522 -0,559376505 1
1 FALSE
SP49 T4 SP49T4 3 174974177 186390627 0,954 2,680764999 25
1 TRUE
SP49 T4 SP49T4 3 186395113 191107445 0,906 1,73980423 13
1 TRUE
SP49 T4 SP49T4 3 192125768 197581147 0,5825 -0,649926563 1
1 FALSE
SP49 T4 SP49T4 4 64892 189065441 0,508 0,123805669 2 2
TRUE
SP49 T4 SP49T4 5 163205 180660723 0,506 0,187663707 2
2 TRUE
SP49 T4 SP49T4 6 335251 29913344 0,639 -0,148669335 2
1 TRUE
SP49 T4 SP49T4 6 29921064 29921242 0,862 -0,335089422 2
0 TRUE
SP49 T4 SP49T4 6 29924996 32331998 0,626 -0,118769456 2
1 TRUE
SP49 T4 SP49T4 6 32332996 32333439 0,782 -0,001478187 3
1 FALSE
SP49 T4 SP49T4 6 32333542 32551948 0,657 -0,195191946 2
1 TRUE
SP49 T4 SP49T4 6 32552029 32628751 0,579 -0,107176129 2
1 FALSE
SP49 T4 SP49T4 6 32628764 170878886 0,637 -0,179141874 2
1 TRUE
SP49 T4 SP49T4 7 331427 75044830 0,659 0,732012322 4
2 TRUE
SP49 T4 SP49T4 7 75145495 159024638 0,58 0,420454278 3
2 TRUE
SP49 T4 SP49T4 8 182934 7215484 0,860301951 -0,682960174
2 0 TRUE
SP49 T4 SP49T4 8 7277060 7720995 0,6085 -0,900163156 1
1 FALSE
SP49 T4 SP49T4 8 8176221 11891805 0,871160692 -0,566221122
2 0 TRUE
SP49 T4 SP49T4 8 11990314 12426158 0,571 -0,961706494 1
1 TRUE
SP49 T4 SP49T4 8 12483982 146171437 0,865666156 -0,626471124
2 0 TRUE
SP49 T4 SP49T4 9 214706 131568363 0,5 0,187086572 2
2 TRUE
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SP49 T4 SP49T4 9 131586913 141069978 0,594 0,506194674 3
2 TRUE
SP49 T4 SP49T4 10 93945 46194652 0,862690651 -0,65807816 2
0 TRUE
SP49 T4 SP49T4 10 46963951 46999863 0,643 -0,564064447 2
1 TRUE
SP49 T4 SP49T4 10 47605468 114496687 0,864860913 -0,635093318
2 0 TRUE
SP49 T4 SP49T4 10 115334124 135272948 0,927 0,240329425 4
0 TRUE
SP49 T4 SP49T4 11 193865 134238518 0,636 -0,133829258 2
1 TRUE
SP49 T4 SP49T4 12 176139 34175508 0,5 0,200569694 2
2 TRUE
SP49 T4 SP49T4 12 37969194 62864417 0,8745 -0,511352243 2
0 TRUE
SP49 T4 SP49T4 12 62887608 133795960 0,5 0,152604749 2
2 TRUE
SP49 T4 SP49T4 13 19526019 115047700 0,639 -0,224629444 2
1 TRUE
SP49 T4 SP49T4 14 19188622 107283076 0,635 -0,168462138 2
1 TRUE
SP49 T4 SP49T4 15 20170150 102313869 0,636 -0,200492054 2
1 TRUE
SP49 T4 SP49T4 16 105325 90142087 0,5 0,200537077 2
2 TRUE
SP49 T4 SP49T4 17 177359 2930339 0,9035 -0,149899485 3
0 TRUE
SP49 T4 SP49T4 17 2930438 2966308 0,528 -0,1887451 1
1 TRUE
SP49 T4 SP49T4 17 3019790 18284262 0,900963073 -0,186686758
3 0 TRUE
SP49 T4 SP49T4 17 18301096 18314964 0,611 0,049395543 2
1 FALSE
SP49 T4 SP49T4 17 18417838 19959693 0,901851206 -0,173690741
3 0 TRUE
SP49 T4 SP49T4 17 20000131 81052407 0,635 -0,148564795 2
1 TRUE
SP49 T4 SP49T4 18 48228 77918221 0,5 0,174476401 2 2
TRUE
SP49 T4 SP49T4 19 288062 59082605 0,5 0,137301863 2
2 TRUE
SP49 T4 SP49T4 20 76962 62904542 0,638 -0,110127838 2 1
TRUE
SP49 T4 SP49T4 21 9891930 48083526 0,648 0,653045192 4
2 TRUE
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SP49 T4 SP49T4 22 16348231 16436533 0,7035 -0,642386092 1
0 TRUE
SP49 T4 SP49T4 22 16906273 45622351 0,871 -0,586246177 2
0 TRUE
SP49 T4 SP49T4 22 45723960 45724214 0,6 -0,438151075 2
1 TRUE
SP49 T4 SP49T4 22 45897997 51219006 0,873316224 -0,541880078
2 0 TRUE
SP52 M SP52M 1 878253 249110906 0,502 -0,006717529 1
1 TRUE
SP52 M SP52M 2 224970 242758203 0,5 0,01246444 1
1 TRUE
SP52 M SP52M 2 242758326 242758475 0,737 -0,539949857 1
1 TRUE
SP52 M SP52M 3 361508 197581147 0,504 -0,002570191 1
1 TRUE
SP52 M SP52M 4 49846 190328957 0,5 0,024761693 1 1
TRUE
SP52 M SP52M 5 163205 180687212 0,505 0,003344715 1
1 TRUE
SP52 M SP52M 6 335251 29704259 0,503 -0,009514313 1
1 TRUE
SP52 M SP52M 6 29709402 29768917 0,615 -0,091498432 1
1 FALSE
SP52 M SP52M 6 29768957 29897061 0,507 0,102291943 1
1 TRUE
SP52 M SP52M 6 29897301 29910866 0,632 0,052413908 2
1 TRUE
SP52 M SP52M 6 29911011 170892848 0,5 0,031407125 1
1 TRUE
SP52 M SP52M 7 330104 159053596 0,5 -0,012457853 1
1 TRUE
SP52 M SP52M 8 182934 146220940 0,5 0,019205256 1
1 TRUE
SP52 M SP52M 9 117713 141071552 0,5 0,001378552 1
1 TRUE
SP52 M SP52M 10 132135 135197419 0,5 -0,004058041 1
1 TRUE
SP52 M SP52M 11 193096 134252121 0,5 0,015802146 1
1 TRUE
SP52 M SP52M 12 247900 133808275 0,5 0,000596005 1
1 TRUE
SP52 M SP52M 13 19241342 115064542 0,5 0,023887144 1
1 TRUE
SP52 M SP52M 14 19114712 107137063 0,506 -0,003301581 1
1 TRUE
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SP52 M SP52M 14 107156824 107169755 0,823 0,439491959 2
1 TRUE
SP52 M SP52M 15 20086442 102304770 0,5 -0,013936584 1
1 TRUE
SP52 M SP52M 16 81639 90109711 0,505 -0,060417918 1 1
TRUE
SP52 M SP52M 17 6115 81006629 0,5 -0,040830849 1 1
TRUE
SP52 M SP52M 18 12893 77893683 0,506 0,031120645 1 1
TRUE
SP52 M SP52M 19 291184 58991638 0,5 -0,084632586 1
1 TRUE
SP52 M SP52M 20 168781 62904542 0,504 -0,013625537 1
1 TRUE
SP52 M SP52M 21 9912042 9912117 0,796 -0,313253932 1
0 FALSE
SP52 M SP52M 21 10793702 48083526 0,5 -0,025521962 1
1 TRUE
SP52 M SP52M 22 16348231 51211392 0,505 -0,054248811 1
1 TRUE
SP52 SVZ SP52SVZ 1 878253 16976679 0,5 -0,094572857 1
1 TRUE
SP52 SVZ SP52SVZ 1 17026087 17083685 0,587842377 -0,218810497
1 0 TRUE
SP52 SVZ SP52SVZ 1 17083872 249110906 0,505 0,007334007 1
1 TRUE
SP52 SVZ SP52SVZ 2 224970 242758475 0,5 0,010018141 1
1 TRUE
SP52 SVZ SP52SVZ 3 361508 192874117 0,504 0,010609071 1
1 TRUE
SP52 SVZ SP52SVZ 3 193016895 197581147 0,576859879 -0,256749802
1 0 FALSE
SP52 SVZ SP52SVZ 4 49846 190328957 0,5 0,034267136 1 1
TRUE
SP52 SVZ SP52SVZ 5 163205 180687212 0,5 0,000433078 1
1 TRUE
SP52 SVZ SP52SVZ 6 335251 29704259 0,51 0,011897635 1
1 FALSE
SP52 SVZ SP52SVZ 6 29709402 29709665 0,6465 0,191625944 2
0 TRUE
SP52 SVZ SP52SVZ 6 29712878 170892848 0,5 0,037775974 1
1 TRUE
SP52 SVZ SP52SVZ 7 330104 159053596 0,554 0,18709868 2
1 FALSE
SP52 SVZ SP52SVZ 8 182934 146220940 0,5 0,007068582 1
1 TRUE
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SP52 SVZ SP52SVZ 9 117713 31254567 0,588 -0,205570489 1
0 TRUE
SP52 SVZ SP52SVZ 9 32333630 132863158 0,503 -0,000821327 1
1 TRUE
SP52 SVZ SP52SVZ 9 132891113 139091797 0,576168874 -0,259103861
1 0 TRUE
SP52 SVZ SP52SVZ 9 139142808 141071552 0,511 -0,040094533 1
1 TRUE
SP52 SVZ SP52SVZ 10 132135 135197419 0,584 -0,232605052 1
0 TRUE
SP52 SVZ SP52SVZ 11 193096 134252121 0,5 0,011033234 1
1 TRUE
SP52 SVZ SP52SVZ 12 247900 133808275 0,5 0,017168508 1
1 TRUE
SP52 SVZ SP52SVZ 13 19241342 107863171 0,590407827 -0,209802464
1 0 TRUE
SP52 SVZ SP52SVZ 13 108861913 111980537 0,922 2,574638735 34
1 TRUE
SP52 SVZ SP52SVZ 13 112315737 115064542 0,569 -0,22900752 1
0 FALSE
SP52 SVZ SP52SVZ 14 19114712 107169755 0,505 -0,000357884 1
1 TRUE
SP52 SVZ SP52SVZ 15 20086442 102304770 0,586 -0,213645969 1
0 TRUE
SP52 SVZ SP52SVZ 16 81639 90109711 0,5 -0,039208994 1 1
TRUE
SP52 SVZ SP52SVZ 17 6115 22066776 0,505 -0,020640928 1 1
TRUE
SP52 SVZ SP52SVZ 17 25352308 39134659 0,5505 -0,10911124 1
0 FALSE
SP52 SVZ SP52SVZ 17 39135084 39135322 0,533489568 -0,397523662
0 0 FALSE
SP52 SVZ SP52SVZ 17 39137104 40375309 0,589622318 -0,212566591
1 0 TRUE
SP52 SVZ SP52SVZ 17 41046440 81006629 0,5 -0,029419331 1
1 TRUE
SP52 SVZ SP52SVZ 18 12893 77893683 0,507 0,026360599 1 1
TRUE
SP52 SVZ SP52SVZ 19 291184 50453317 0,5 -0,049596285 1
1 TRUE
SP52 SVZ SP52SVZ 19 50455351 58991638 0,5595 0,174699933 2
1 TRUE
SP52 SVZ SP52SVZ 20 168781 62904542 0,564 0,186518782 2
1 TRUE
SP52 SVZ SP52SVZ 21 9912042 11181699 0,576 -0,078435857 1
0 TRUE
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SP52 SVZ SP52SVZ 21 14414959 48083526 0,5 -0,021708681 1
1 TRUE
SP52 SVZ SP52SVZ 22 16348231 51211392 0,5 -0,035898109 1
1 TRUE
SP52 T1 SP52T1 1 878253 5935162 0,5 0,028955134 1
1 TRUE
SP52 T1 SP52T1 1 6100458 9416346 0,699 -0,485141708 1
0 TRUE
SP52 T1 SP52T1 1 9627521 249110906 0,5 -0,016164421 1
1 TRUE
SP52 T1 SP52T1 2 224970 87106108 0,5 -0,027375841 1
1 TRUE
SP52 T1 SP52T1 2 88005546 89309762 0,717 -0,339991018 1
0 TRUE
SP52 T1 SP52T1 2 89319834 91872945 0,5195 -0,375851874 1
1 TRUE
SP52 T1 SP52T1 2 91873005 91886089 0,778040558 -0,080888997
2 0 TRUE
SP52 T1 SP52T1 2 95527944 242758475 0,504 -0,01023547 1
1 TRUE
SP52 T1 SP52T1 3 361508 90276661 0,5 -0,022632395 1
1 TRUE
SP52 T1 SP52T1 3 93593119 97753931 0,696 -0,504530039 1
0 TRUE
SP52 T1 SP52T1 3 97806616 191107192 0,505 -0,02165992 1
1 TRUE
SP52 T1 SP52T1 3 192053274 197581147 0,672 -0,515669578 1
0 FALSE
SP52 T1 SP52T1 4 49846 190328957 0,5 -0,006701493 1 1
TRUE
SP52 T1 SP52T1 5 163205 180687212 0,5 -0,01763196 1
1 TRUE
SP52 T1 SP52T1 6 335251 29709402 0,504 -0,00051531 1
1 TRUE
SP52 T1 SP52T1 6 29709445 29709665 0,667 -0,322313682 1
0 FALSE
SP52 T1 SP52T1 6 29712878 29897061 0,5 0,036425257 1
1 TRUE
SP52 T1 SP52T1 6 29897301 29910562 0,676 -0,033296304 1
0 FALSE
SP52 T1 SP52T1 6 29910742 31324615 0,51 0,097180027 1
1 TRUE
SP52 T1 SP52T1 6 31324702 31324750 0,791 0,607218336 3
0 FALSE
SP52 T1 SP52T1 6 31324864 170892848 0,5 0,005406043 1
1 TRUE
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SP52 T1 SP52T1 7 330104 73150511 0,615 0,351833521 2
1 TRUE
SP52 T1 SP52T1 7 73151644 159053596 0,5395 0,155230587 1
1 FALSE
SP52 T1 SP52T1 8 182934 146220940 0,5 0,000870583 1
1 TRUE
SP52 T1 SP52T1 9 117713 32334264 0,696 -0,518162539 1
0 TRUE
SP52 T1 SP52T1 9 32384825 132662786 0,507 -0,028657845 1
1 TRUE
SP52 T1 SP52T1 9 132845689 138416565 0,699 -0,521825874 1
0 TRUE
SP52 T1 SP52T1 9 138440525 138662309 0,517 -0,086102527 1
1 TRUE
SP52 T1 SP52T1 9 138662661 138903671 0,696 -0,438183285 1
0 TRUE
SP52 T1 SP52T1 9 139008803 141071552 0,507 0,059339806 1
1 TRUE
SP52 T1 SP52T1 10 132135 46280866 0,697 -0,547696681 1
0 TRUE
SP52 T1 SP52T1 10 46960084 47087501 0,509 -0,549169379 0
0 TRUE
SP52 T1 SP52T1 10 47605468 51582894 0,7055 -0,458137726 1
0 TRUE
SP52 T1 SP52T1 10 51620231 51633027 0,517 -0,812493705 0
0 TRUE
SP52 T1 SP52T1 10 52086939 135197419 0,7 -0,515245951 1
0 TRUE
SP52 T1 SP52T1 11 193096 134252121 0,5035 -0,002768155 1
1 TRUE
SP52 T1 SP52T1 12 247900 133808275 0,508 -0,015419737 1
1 TRUE
SP52 T1 SP52T1 13 19241342 24384129 0,665250825 -0,673673416
1 0 TRUE
SP52 T1 SP52T1 13 24436475 25029113 0,52 -0,426334998 1
1 TRUE
SP52 T1 SP52T1 13 25030447 99092179 0,700581867 -0,512754509
1 0 TRUE
SP52 T1 SP52T1 13 99098318 107863171 0,675 -0,499250155 1
0 FALSE
SP52 T1 SP52T1 13 108861913 111980537 0,958 3,647623548 41
1 TRUE
SP52 T1 SP52T1 13 112315737 115064542 0,6825 -0,488023451 1
0 TRUE
SP52 T1 SP52T1 14 19114712 64886426 0,503 -0,01612975 1
1 TRUE
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SP52 T1 SP52T1 14 64894362 64907994 0,656 -0,365583954 1
0 TRUE
SP52 T1 SP52T1 14 64908651 107169755 0,5 -0,01368599 1
1 TRUE
SP52 T1 SP52T1 15 20086442 22929906 0,5 -0,231818414 1
1 TRUE
SP52 T1 SP52T1 15 22933528 102304770 0,7 -0,519464046 1
0 TRUE
SP52 T1 SP52T1 16 81639 90109711 0,5 -0,030260493 1 1
TRUE
SP52 T1 SP52T1 17 6115 30822034 0,5 -0,024039688 1 1
TRUE
SP52 T1 SP52T1 17 31319033 35783812 0,667 -0,457327413 1
0 FALSE
SP52 T1 SP52T1 17 35896123 36358847 0,509 -0,057211401 1
1 TRUE
SP52 T1 SP52T1 17 36398000 39969549 0,686022503 -0,581254081
1 0 TRUE
SP52 T1 SP52T1 17 40021498 81006629 0,521 0,190999588 1
1 FALSE
SP52 T1 SP52T1 18 12893 77893683 0,5 -0,021070015 1 1
TRUE
SP52 T1 SP52T1 19 291184 50475114 0,5 -0,037632949 1
1 TRUE
SP52 T1 SP52T1 19 50475174 58991638 0,61 0,318349939 2
1 TRUE
SP52 T1 SP52T1 20 168781 62904542 0,606 0,331273023 2
1 TRUE
SP52 T1 SP52T1 21 9912042 48083526 0,5 -0,019948224 1
1 TRUE
SP52 T1 SP52T1 22 16348231 51211392 0,503 -0,020468265 1
1 TRUE
SP52 T2 SP52T2 1 878253 5935162 0,508 -0,075423556 1
1 TRUE
SP52 T2 SP52T2 1 6100458 9009214 0,772975834 -0,711398262
1 0 TRUE
SP52 T2 SP52T2 1 9009406 9324213 0,5 -1,744394892 0
0 TRUE
SP52 T2 SP52T2 1 9416346 10708300 0,745 -0,651449246 1
0 FALSE
SP52 T2 SP52T2 1 11018723 16748432 0,5 -0,095426925 1
1 TRUE
SP52 T2 SP52T2 1 16767359 17083888 0,63 -0,020109461 1
0 FALSE
SP52 T2 SP52T2 1 17084006 249110906 0,5 0,003820945 1
1 TRUE
Page 65 of 185 Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
SP52 T2 SP52T2 2 224970 87106108 0,5 0,013153146 1
1 TRUE
SP52 T2 SP52T2 2 88005546 89319834 0,799497398 -0,532173345
1 0 TRUE
SP52 T2 SP52T2 2 89339720 91872945 0,522 -0,360464436 1
1 FALSE
SP52 T2 SP52T2 2 91873005 91873025 0,844 0,157722924 2
0 TRUE
SP52 T2 SP52T2 2 91885946 242758475 0,5 0,020710123 1
1 TRUE
SP52 T2 SP52T2 3 361508 97611916 0,5 -0,015273783 1
1 TRUE
SP52 T2 SP52T2 3 97634253 97753931 0,767 -0,698063076 1
0 TRUE
SP52 T2 SP52T2 3 97806616 191107192 0,5 0,018952493 1
1 TRUE
SP52 T2 SP52T2 3 192053274 195395272 0,779434124 -0,669761989
1 0 TRUE
SP52 T2 SP52T2 3 195395328 195453243 0,6105 -0,217465562 1
1 FALSE
SP52 T2 SP52T2 3 195466972 197581147 0,773 -0,744128779 1
0 TRUE
SP52 T2 SP52T2 4 49846 190328957 0,5 0,035370769 1 1
TRUE
SP52 T2 SP52T2 5 163205 180687212 0,506 0,001607123 1
1 TRUE
SP52 T2 SP52T2 6 335251 29704259 0,5055 0,004996301 1
1 TRUE
SP52 T2 SP52T2 6 29709402 29712878 0,671 0,242923746 2
1 FALSE
SP52 T2 SP52T2 6 29718578 31324615 0,509 0,003035422 1
1 TRUE
SP52 T2 SP52T2 6 31324702 31324750 0,8 -0,434532034 1
0 TRUE
SP52 T2 SP52T2 6 31324864 116720487 0,5 0,014897063 1
1 TRUE
SP52 T2 SP52T2 6 116774259 116774616 0,8305 -0,252143817 2
0 TRUE
SP52 T2 SP52T2 6 116836720 170892848 0,5 0,036893354 1
1 TRUE
SP52 T2 SP52T2 7 330104 159053596 0,634 0,447157969 2
1 TRUE
SP52 T2 SP52T2 8 182934 146220940 0,503 0,011843367 1
1 TRUE
SP52 T2 SP52T2 9 117713 21441116 0,783 -0,647622525 1
0 TRUE
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SP52 T2 SP52T2 9 21861903 22748135 0,5 -1,881790968 0
0 TRUE
SP52 T2 SP52T2 9 23705108 31254567 0,793 -0,579655677 1
0 TRUE
SP52 T2 SP52T2 9 32333630 132662786 0,5 -0,011888769 1
1 TRUE
SP52 T2 SP52T2 9 132845689 138415238 0,773810869 -0,706081988
1 0 TRUE
SP52 T2 SP52T2 9 138416565 138555161 0,55 -0,201121683 1
1 TRUE
SP52 T2 SP52T2 9 138662309 138903671 0,785 -0,592769062 1
0 TRUE
SP52 T2 SP52T2 9 139008803 141071552 0,507 -0,035501813 1
1 TRUE
SP52 T2 SP52T2 10 132135 19780543 0,777678045 -0,681202808
1 0 TRUE
SP52 T2 SP52T2 10 20506326 20507790 0,5 -1,489271305 0
0 TRUE
SP52 T2 SP52T2 10 21076100 46280866 0,781521648 -0,656042719
1 0 TRUE
SP52 T2 SP52T2 10 46960084 47087501 0,5 -0,75339897 0
0 TRUE
SP52 T2 SP52T2 10 47605468 47668747 0,797347589 -0,547559724
1 0 TRUE
SP52 T2 SP52T2 10 47677955 51582894 0,794 -0,588225244 1
0 TRUE
SP52 T2 SP52T2 10 51620231 51633027 0,594 -0,809955017 0
0 FALSE
SP52 T2 SP52T2 10 52086939 135197419 0,78053145 -0,662566601
1 0 TRUE
SP52 T2 SP52T2 11 193096 134252121 0,5 -0,012387956 1
1 TRUE
SP52 T2 SP52T2 12 247900 133808275 0,5 0,014472121 1
1 TRUE
SP52 T2 SP52T2 13 19241342 107863171 0,788381882 -0,610015538
1 0 TRUE
SP52 T2 SP52T2 13 108861913 111980537 0,967 3,802593217 37
1 TRUE
SP52 T2 SP52T2 13 112315737 115064542 0,787 -0,566688458 1
0 TRUE
SP52 T2 SP52T2 14 19114712 107169755 0,5 0,012278492 1
1 TRUE
SP52 T2 SP52T2 15 20086442 22567365 0,507 -0,197133668 1
1 TRUE
SP52 T2 SP52T2 15 22777680 34782508 0,783 -0,621621502 1
0 TRUE
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SP52 T2 SP52T2 15 34848715 34848959 0,554 -0,85096268 0
0 TRUE
SP52 T2 SP52T2 15 35141453 102304770 0,78138873 -0,656920161
1 0 TRUE
SP52 T2 SP52T2 16 81639 90109711 0,5 -0,027876045 1 1
TRUE
SP52 T2 SP52T2 17 6115 30822034 0,5 -0,020891445 1 1
TRUE
SP52 T2 SP52T2 17 31319033 35783812 0,777 -0,617130431 1
0 FALSE
SP52 T2 SP52T2 17 35896123 36358847 0,508 -0,055099465 1
1 TRUE
SP52 T2 SP52T2 17 36398000 40375309 0,771052061 -0,723571964
1 0 TRUE
SP52 T2 SP52T2 17 41046440 81006629 0,5 -0,032239499 1
1 TRUE
SP52 T2 SP52T2 18 12893 77893683 0,5 0,008280437 1 1
TRUE
SP52 T2 SP52T2 19 291184 47969394 0,5 -0,051998592 1
1 TRUE
SP52 T2 SP52T2 19 48182787 48382157 0,695 0,078326012 2
1 FALSE
SP52 T2 SP52T2 19 48389363 50542359 0,5 -0,075245195 1
1 TRUE
SP52 T2 SP52T2 19 50562372 58991638 0,636 0,428760239 2
1 TRUE
SP52 T2 SP52T2 20 168781 26189088 0,627 0,46830051 2
1 TRUE
SP52 T2 SP52T2 20 29449333 62904542 0,634 0,417107179 2
1 TRUE
SP52 T2 SP52T2 21 9912042 48083526 0,5 -0,029652392 1
1 TRUE
SP52 T2 SP52T2 22 16348231 51211392 0,5 -0,037543061 1
1 TRUE
SP52 T3 SP52T3 1 878253 5935162 0,512 -0,049041638 1
1 FALSE
SP52 T3 SP52T3 1 6100458 9416346 0,801492444 -0,740052021
1 0 TRUE
SP52 T3 SP52T3 1 9627521 121116121 0,5 -0,020363917 1
1 TRUE
SP52 T3 SP52T3 1 142688899 143403644 0,625 0,081040872 2
1 TRUE
SP52 T3 SP52T3 1 143767643 249110906 0,577 0,242557766 1
1 FALSE
SP52 T3 SP52T3 2 224970 88327387 0,5 -0,015832158 1
1 TRUE
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SP52 T3 SP52T3 2 88748390 89319834 0,814 -0,57237273 1
0 TRUE
SP52 T3 SP52T3 2 89339720 91886089 0,6235 -0,301945725 1
0 FALSE
SP52 T3 SP52T3 2 95527944 242758475 0,5 0,014714599 1
1 TRUE
SP52 T3 SP52T3 3 361508 97611916 0,5065 -0,017940979 1
1 TRUE
SP52 T3 SP52T3 3 97634253 97753931 0,798512615 -0,761547615
1 0 FALSE
SP52 T3 SP52T3 3 97806616 191107192 0,5 0,009821292 1
1 TRUE
SP52 T3 SP52T3 3 192053274 195395272 0,80855277 -0,687804886
1 0 TRUE
SP52 T3 SP52T3 3 195395328 195426231 0,517 -0,354136172 1
1 TRUE
SP52 T3 SP52T3 3 195452805 197581147 0,784511952 -0,858465952
1 0 TRUE
SP52 T3 SP52T3 4 49846 190328957 0,5 0,033615673 1 1
TRUE
SP52 T3 SP52T3 5 163205 180687212 0,5 0,001779807 1
1 TRUE
SP52 T3 SP52T3 6 335251 170892848 0,5 0,030991648 1
1 TRUE
SP52 T3 SP52T3 7 330104 159053596 0,637 0,465596401 2
1 TRUE
SP52 T3 SP52T3 8 182934 146220940 0,503 0,018642433 1
1 TRUE
SP52 T3 SP52T3 9 117713 21441116 0,806601611 -0,702433877
1 0 TRUE
SP52 T3 SP52T3 9 21861903 22748135 0,52 -2,056169554 0
0 TRUE
SP52 T3 SP52T3 9 23705108 28863459 0,808 -0,663412839 1
0 TRUE
SP52 T3 SP52T3 9 31254567 132662786 0,5 -0,026571883 1
1 TRUE
SP52 T3 SP52T3 9 132845689 138416565 0,8075 -0,722962115 1
0 TRUE
SP52 T3 SP52T3 9 138440525 138662309 0,524 -0,165849513 1
1 FALSE
SP52 T3 SP52T3 9 138662661 138903671 0,811 -0,634340089 1
0 TRUE
SP52 T3 SP52T3 9 139008803 141071552 0,513 -0,034987003 1
1 TRUE
SP52 T3 SP52T3 10 132135 30739058 0,801567836 -0,739503992
1 0 TRUE
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SP52 T3 SP52T3 10 30915590 30978274 0,5 -0,966616749 0
0 TRUE
SP52 T3 SP52T3 10 30987520 46280866 0,804344788 -0,719171641
1 0 TRUE
SP52 T3 SP52T3 10 46960084 47667164 0,511 -0,663492828 1
1 TRUE
SP52 T3 SP52T3 10 47668707 51620231 0,8055 -0,684500044 1
0 TRUE
SP52 T3 SP52T3 10 51623004 51633027 0,531 -0,944833491 0
0 TRUE
SP52 T3 SP52T3 10 52086939 135197419 0,805572302 -0,710091857
1 0 TRUE
SP52 T3 SP52T3 11 193096 134252121 0,5 -0,008978766 1
1 TRUE
SP52 T3 SP52T3 12 247900 133808275 0,5 0,002357976 1
1 TRUE
SP52 T3 SP52T3 13 19241342 24877445 0,792551221 -0,803613266
1 0 TRUE
SP52 T3 SP52T3 13 24895559 24933805 0,619 -0,514882783 1
1 FALSE
SP52 T3 SP52T3 13 25023936 107863171 0,807512053 -0,695626207
1 0 TRUE
SP52 T3 SP52T3 13 108861913 111980537 0,915 2,610035123 14
1 TRUE
SP52 T3 SP52T3 13 112315737 115064542 0,799 -0,701521657 1
0 TRUE
SP52 T3 SP52T3 14 19114712 107169755 0,5 0,008369691 1
1 TRUE
SP52 T3 SP52T3 15 20086442 22567365 0,517 -0,238307218 1
1 TRUE
SP52 T3 SP52T3 15 22777680 34782508 0,805849974 -0,708029996
1 0 TRUE
SP52 T3 SP52T3 15 34848715 34848959 0,545 -0,836972844 0
0 TRUE
SP52 T3 SP52T3 15 35141453 102304770 0,803451563 -0,725742991
1 0 TRUE
SP52 T3 SP52T3 16 81639 33425202 0,509 -0,062711621 1 1
TRUE
SP52 T3 SP52T3 16 47733115 90109711 0,618 -0,349110584 1
1 FALSE
SP52 T3 SP52T3 17 6115 30822034 0,503 -0,013247641 1 1
TRUE
SP52 T3 SP52T3 17 31319033 34432125 0,7815 -0,656970153 1
0 FALSE
SP52 T3 SP52T3 17 34432297 34952964 0,79535802 -0,783960227
1 0 TRUE
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SP52 T3 SP52T3 17 35306312 36398000 0,511 -0,227144443 1
1 TRUE
SP52 T3 SP52T3 17 36520567 40375309 0,797262932 -0,770467989
1 0 TRUE
SP52 T3 SP52T3 17 41046440 81006629 0,5 -0,053582612 1
1 TRUE
SP52 T3 SP52T3 18 12893 77893683 0,5 0,014571975 1 1
TRUE
SP52 T3 SP52T3 19 291184 50563208 0,5 -0,080828048 1
1 TRUE
SP52 T3 SP52T3 19 50563239 58991638 0,64 0,385448711 2
1 TRUE
SP52 T3 SP52T3 20 168781 26189088 0,639 0,428148241 2
1 TRUE
SP52 T3 SP52T3 20 29449333 62904542 0,6335 0,412816041 2
1 TRUE
SP52 T3 SP52T3 21 9912042 15386049 0,606 -0,21155079 1
1 FALSE
SP52 T3 SP52T3 21 15593286 48083526 0,5 -0,007000005 1
1 TRUE
SP52 T3 SP52T3 22 16348231 51211392 0,5 -0,047574549 1
1 TRUE
SP52 T4 SP52T4 1 878253 5935162 0,51 -0,041839875 1
1 TRUE
SP52 T4 SP52T4 1 6100458 9416346 0,788252451 -0,774333957
1 0 TRUE
SP52 T4 SP52T4 1 9627521 121116121 0,5 -0,013061194 1
1 TRUE
SP52 T4 SP52T4 1 142688899 144854454 0,711 0,131199554 2
1 FALSE
SP52 T4 SP52T4 1 144860026 249110906 0,5 0,038034419 1
1 TRUE
SP52 T4 SP52T4 2 224970 88327387 0,5 0,012339127 1
1 TRUE
SP52 T4 SP52T4 2 88748390 89319834 0,810574833 -0,613616707
1 0 TRUE
SP52 T4 SP52T4 2 89339720 91886089 0,5895 -0,298202165 1
1 FALSE
SP52 T4 SP52T4 2 95527944 242758475 0,506 0,030883979 1
1 TRUE
SP52 T4 SP52T4 3 361508 97611916 0,5 0,010411723 1
1 TRUE
SP52 T4 SP52T4 3 97634253 97753931 0,809 -0,55025327 1
0 TRUE
SP52 T4 SP52T4 3 97806616 191107192 0,5 0,023651043 1
1 TRUE
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SP52 T4 SP52T4 3 192053274 195395272 0,800107587 -0,691212397
1 0 TRUE
SP52 T4 SP52T4 3 195395328 195426231 0,603 -0,183118951 1
1 FALSE
SP52 T4 SP52T4 3 195452805 197581147 0,777811881 -0,843770358
1 0 TRUE
SP52 T4 SP52T4 4 49846 190328957 0,5 0,043915721 1 1
TRUE
SP52 T4 SP52T4 5 163205 180687212 0,5 0,012080726 1
1 TRUE
SP52 T4 SP52T4 6 335251 29704259 0,5 0,02136229 1
1 TRUE
SP52 T4 SP52T4 6 29709402 29709602 0,67 0,24593634 2
1 FALSE
SP52 T4 SP52T4 6 29709610 29975775 0,552 0,040695941 1
1 FALSE
SP52 T4 SP52T4 6 29976262 170892848 0,5 0,032130746 1
1 TRUE
SP52 T4 SP52T4 7 330104 159053596 0,638 0,459989635 2
1 TRUE
SP52 T4 SP52T4 8 182934 146220940 0,5 0,044427994 1
1 TRUE
SP52 T4 SP52T4 9 117713 21441116 0,80268654 -0,672478059
1 0 TRUE
SP52 T4 SP52T4 9 21861903 22748135 0,515 -1,833815647 0
0 TRUE
SP52 T4 SP52T4 9 23705108 28863459 0,810780257 -0,612051313
1 0 TRUE
SP52 T4 SP52T4 9 31254567 66711328 0,503 0,007182257 1
1 TRUE
SP52 T4 SP52T4 9 68409659 69120693 0,727 0,012077893 2
1 FALSE
SP52 T4 SP52T4 9 69847032 132662786 0,5 0,017476216 1
1 TRUE
SP52 T4 SP52T4 9 132845689 138415238 0,795999288 -0,720562874
1 0 TRUE
SP52 T4 SP52T4 9 138416565 138555161 0,507 -0,177959263 1
1 TRUE
SP52 T4 SP52T4 9 138662309 138903671 0,813945569 -0,587713432
1 0 TRUE
SP52 T4 SP52T4 9 139008803 141071552 0,504 0,023037478 1
1 TRUE
SP52 T4 SP52T4 10 132135 30739058 0,794186375 -0,733327181
1 0 TRUE
SP52 T4 SP52T4 10 30915590 30978274 0,5 -0,564071808 1
1 TRUE
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SP52 T4 SP52T4 10 30987520 46280866 0,798921331 -0,699748734
1 0 TRUE
SP52 T4 SP52T4 10 46960084 47087501 0,515 -0,721704671 0
0 TRUE
SP52 T4 SP52T4 10 47605468 51582894 0,7965 -0,59541239 1
0 TRUE
SP52 T4 SP52T4 10 51620231 51633027 0,507 -0,60954375 1
1 TRUE
SP52 T4 SP52T4 10 52086939 135197419 0,802190877 -0,676097648
1 0 TRUE
SP52 T4 SP52T4 11 193096 134252121 0,503 0,015347699 1
1 TRUE
SP52 T4 SP52T4 12 247900 133808275 0,5 0,018110495 1
1 TRUE
SP52 T4 SP52T4 13 19241342 107863171 0,807 -0,646002223 1
0 TRUE
SP52 T4 SP52T4 13 108861913 111980537 0,954 3,453225904 27
1 TRUE
SP52 T4 SP52T4 13 112315737 115064542 0,8035 -0,600626469 1
0 TRUE
SP52 T4 SP52T4 14 19114712 107137063 0,503 -0,000285718 1
1 TRUE
SP52 T4 SP52T4 14 107156824 107169755 0,726 0,289049648 2
1 FALSE
SP52 T4 SP52T4 15 20086442 22567365 0,5 -0,195002183 1
1 TRUE
SP52 T4 SP52T4 15 22777680 34782508 0,801773735 -0,679136818
1 0 TRUE
SP52 T4 SP52T4 15 34848715 34848959 0,511 -0,919703128 0
0 TRUE
SP52 T4 SP52T4 15 35141453 101933258 0,800173014 -0,69074011
1 0 TRUE
SP52 T4 SP52T4 15 101968084 102304770 0,571 -1,151068556 0
0 TRUE
SP52 T4 SP52T4 16 81639 90109711 0,5 -0,032209648 1 1
TRUE
SP52 T4 SP52T4 17 6115 30822034 0,507 -0,014946459 1 1
TRUE
SP52 T4 SP52T4 17 31319033 33977538 0,793 -0,686054964 1
0 FALSE
SP52 T4 SP52T4 17 33998904 34067892 0,526 -0,073618152 1
1 TRUE
SP52 T4 SP52T4 17 34097039 35783812 0,797 -0,700131337 1
0 TRUE
SP52 T4 SP52T4 17 35896123 36398000 0,502 -0,152274116 1
1 TRUE
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SP52 T4 SP52T4 17 36520567 40375309 0,786314949 -0,787474669
1 0 TRUE
SP52 T4 SP52T4 17 41046440 81006629 0,5 -0,029886797 1
1 TRUE
SP52 T4 SP52T4 18 12893 77893683 0,5 0,028092274 1 1
TRUE
SP52 T4 SP52T4 19 291184 50542359 0,5 -0,088585686 1
1 TRUE
SP52 T4 SP52T4 19 50562372 58991638 0,642 0,417375691 2
1 TRUE
SP52 T4 SP52T4 20 168781 62904542 0,6525 0,421885855 2
1 FALSE
SP52 T4 SP52T4 21 9912042 48083526 0,504 -0,013741353 1
1 TRUE
SP52 T4 SP52T4 22 16348231 51211392 0,502 -0,041046298 1
1 TRUE
SP54 M1 SP54M1 1 139213 249148399 0,5 0,059531461 1
1 TRUE
SP54 M1 SP54M1 2 224919 242842568 0,5 -0,008361634 1
1 TRUE
SP54 M1 SP54M1 3 361508 197804058 0,5 -0,030223695 1
1 TRUE
SP54 M1 SP54M1 4 64892 191033653 0,5 -0,030166905 1 1
TRUE
SP54 M1 SP54M1 5 163205 180687212 0,5 0,053978258 1
1 TRUE
SP54 M1 SP54M1 6 312023 32557339 0,5 0,019218232 1
1 TRUE
SP54 M1 SP54M1 6 32557365 32605451 0,687 -0,09311811 1
0 FALSE
SP54 M1 SP54M1 6 32609009 170190659 0,5 -0,011757484 1
1 TRUE
SP54 M1 SP54M1 7 286402 53854818 0,5 0,041127114 1
1 TRUE
SP54 M1 SP54M1 7 54610293 55242609 0,7115 1,00646511 3
1 FALSE
SP54 M1 SP54M1 7 55433880 159024799 0,5 0,036021946 1
1 TRUE
SP54 M1 SP54M1 8 182934 27729713 0,5 0,024706978 1
1 TRUE
SP54 M1 SP54M1 8 27776285 27776335 0,818 0,351132624 2
0 FALSE
SP54 M1 SP54M1 8 27779811 146229040 0,503 0,00479506 1
1 TRUE
SP54 M1 SP54M1 9 117713 141071475 0,505 -0,010257137 1
1 TRUE
Page 74 of 185Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
SP54 M1 SP54M1 10 282897 18691018 0,5 -0,127703592 1
1 TRUE
SP54 M1 SP54M1 10 18697657 18828663 0,689 -0,467699966 1
0 FALSE
SP54 M1 SP54M1 10 18837285 135281637 0,5 -0,076033158 1
1 TRUE
SP54 M1 SP54M1 11 193096 134856661 0,5 -0,004270337 1
1 TRUE
SP54 M1 SP54M1 12 92252 57588838 0,505 -0,020059389 1 1
TRUE
SP54 M1 SP54M1 12 58089413 58217927 0,82 1,540675908 5
1 TRUE
SP54 M1 SP54M1 12 58335626 114261053 0,5 -0,065923463 1
1 TRUE
SP54 M1 SP54M1 12 114261237 133758539 0,503 -0,098826186 1
1 TRUE
SP54 M1 SP54M1 13 19042581 115064542 0,5 -0,037525139 1
1 TRUE
SP54 M1 SP54M1 14 19188622 107170207 0,5 -0,016817381 1
1 TRUE
SP54 M1 SP54M1 15 20173160 102304498 0,5 -0,033933809 1
1 TRUE
SP54 M1 SP54M1 16 97610 90161753 0,5 -0,039172637 1 1
TRUE
SP54 M1 SP54M1 17 6115 39305956 0,554 -0,004604679 1 1
FALSE
SP54 M1 SP54M1 17 39383012 39394807 0,767 0,506528725 2
1 FALSE
SP54 M1 SP54M1 17 39406409 81083660 0,5 0,021168054 1
1 TRUE
SP54 M1 SP54M1 18 196829 77736579 0,5 -0,031151721 1
1 TRUE
SP54 M1 SP54M1 19 288246 59059729 0,5 -0,000239319 1
1 TRUE
SP54 M1 SP54M1 20 239688 62904542 0,5 -0,022765765 1
1 TRUE
SP54 M1 SP54M1 21 9907097 11181645 0,538 -0,068477369 1
1 TRUE
SP54 M1 SP54M1 21 14418486 48080896 0,5 -0,001420144 1
1 TRUE
SP54 M1 SP54M1 22 16366264 51183255 0,5 -0,013556929 1
1 TRUE
SP54 T1 SP54T1 1 139213 249148399 0,574 0,106157138 2
1 FALSE
SP54 T1 SP54T1 2 224919 242842568 0,5 -0,126049784 1
1 TRUE
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SP54 T1 SP54T1 3 361508 47762030 0,5 -0,097517954 1
1 TRUE
SP54 T1 SP54T1 3 47770380 49463287 0,612 0,175691827 2
1 TRUE
SP54 T1 SP54T1 3 49570882 197804058 0,5 -0,127872505 1
1 TRUE
SP54 T1 SP54T1 4 64892 191033653 0,5 -0,158164205 1 1
TRUE
SP54 T1 SP54T1 5 163205 180687212 0,653 0,182811874 2
1 FALSE
SP54 T1 SP54T1 6 312023 32546965 0,5 -0,091991408 1
1 TRUE
SP54 T1 SP54T1 6 32547019 32629859 0,596 0,027879633 2
1 FALSE
SP54 T1 SP54T1 6 32634331 32709346 0,7 -0,065767528 2
1 FALSE
SP54 T1 SP54T1 6 32713030 170190659 0,503 -0,105768168 1
1 TRUE
SP54 T1 SP54T1 7 286402 53854818 0,623 0,297344244 2
1 TRUE
SP54 T1 SP54T1 7 54610293 55242609 0,874 2,275369161 14
2 FALSE
SP54 T1 SP54T1 7 55433880 57529392 0,628 0,274518117 2
1 TRUE
SP54 T1 SP54T1 7 62599308 102874211 0,597 0,253994868 2
1 FALSE
SP54 T1 SP54T1 7 102898934 159024799 0,619 0,286702875 2
1 TRUE
SP54 T1 SP54T1 8 182934 146229040 0,5 -0,029080445 1
1 TRUE
SP54 T1 SP54T1 9 117713 141071475 0,5 -0,054795458 1
1 TRUE
SP54 T1 SP54T1 10 282897 51592727 0,764 -0,432452037 1
0 FALSE
SP54 T1 SP54T1 10 51623004 51633027 0,52 -0,391979943 1
1 TRUE
SP54 T1 SP54T1 10 52086939 135281637 0,7655 -0,391073586 1
0 FALSE
SP54 T1 SP54T1 11 193096 134856661 0,5025 -0,113522811 1
1 TRUE
SP54 T1 SP54T1 12 92252 57588838 0,5 -0,097440052 1 1
TRUE
SP54 T1 SP54T1 12 58089413 58217927 0,964 3,603725081 40
1 TRUE
SP54 T1 SP54T1 12 58335626 133758539 0,5 -0,106318805 1
1 TRUE
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SP54 T1 SP54T1 13 19042581 115064542 0,54 -0,404915631 1
1 FALSE
SP54 T1 SP54T1 14 19188622 107170207 0,504 -0,095986387 1
1 TRUE
SP54 T1 SP54T1 15 20173160 42632262 0,5 -0,300423152 1
1 TRUE
SP54 T1 SP54T1 15 42635124 42635160 0,640487744 -1,043518223
1 0 TRUE
SP54 T1 SP54T1 15 42635395 102304498 0,5 -0,231412396 1
1 TRUE
SP54 T1 SP54T1 16 97610 32630184 0,5 -0,092649673 1 1
TRUE
SP54 T1 SP54T1 16 32633233 33424638 0,667 -0,406418128 1
0 FALSE
SP54 T1 SP54T1 16 33489895 90161753 0,5 -0,06446769 1
1 TRUE
SP54 T1 SP54T1 17 6115 13928093 0,7015 0,086237585 2 1
FALSE
SP54 T1 SP54T1 17 13928124 21206556 0,657 0,267307194 2
1 FALSE
SP54 T1 SP54T1 17 21312562 21319943 0,515 0,151603262 1
1 TRUE
SP54 T1 SP54T1 17 21407858 81083660 0,658 0,168173889 2
1 FALSE
SP54 T1 SP54T1 18 196829 77736579 0,5 -0,145610496 1
1 TRUE
SP54 T1 SP54T1 19 288246 59059729 0,6225 0,305975527 2
1 TRUE
SP54 T1 SP54T1 20 239688 62904542 0,505 -0,099927062 1
1 TRUE
SP54 T1 SP54T1 21 9907097 48080896 0,5 -0,21430452 1
1 TRUE
SP54 T1 SP54T1 22 16366264 51183255 0,5 -0,056482688 1
1 TRUE
SP54 T2 SP54T2 1 139213 121124362 0,627 0,278108986 2
1 TRUE
SP54 T2 SP54T2 1 142634897 145115810 0,503 0,402431648 2
2 TRUE
SP54 T2 SP54T2 1 145298186 249148399 0,629 0,305218018 2
1 TRUE
SP54 T2 SP54T2 2 224919 240923050 0,504 -0,081574528 1
1 TRUE
SP54 T2 SP54T2 2 240946766 242842568 0,673 -0,60464776 1
0 FALSE
SP54 T2 SP54T2 3 361508 47770380 0,5 -0,086648628 1
1 TRUE
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SP54 T2 SP54T2 3 47953405 49570882 0,617 0,21306555 2
1 TRUE
SP54 T2 SP54T2 3 49689210 197804058 0,504 -0,089851589 1
1 TRUE
SP54 T2 SP54T2 4 64892 191033653 0,5 -0,085427563 1 1
TRUE
SP54 T2 SP54T2 5 163205 180687212 0,628 0,303815269 2
1 TRUE
SP54 T2 SP54T2 6 312023 32557655 0,5 -0,079747728 1
1 TRUE
SP54 T2 SP54T2 6 32605189 32605451 0,742699116 -0,6623922
1 0 TRUE
SP54 T2 SP54T2 6 32609009 32628835 0,6 0,004930615 2
1 FALSE
SP54 T2 SP54T2 6 32628841 170190659 0,502 -0,080227796 1
1 TRUE
SP54 T2 SP54T2 7 286402 57529392 0,628 0,317207758 2
1 TRUE
SP54 T2 SP54T2 7 62599308 91570290 0,5 -0,05648795 1
1 TRUE
SP54 T2 SP54T2 7 91599825 147926734 0,63 0,303036435 2
1 TRUE
SP54 T2 SP54T2 7 147926888 151478187 0,691 0,549404203 3
1 TRUE
SP54 T2 SP54T2 7 151483445 159024799 0,653 0,247827716 2
1 FALSE
SP54 T2 SP54T2 8 182934 146229040 0,5 -0,067044937 1
1 TRUE
SP54 T2 SP54T2 9 117713 141071475 0,556 0,103886054 1
1 FALSE
SP54 T2 SP54T2 10 282897 51592727 0,792 -0,379113867 1
0 FALSE
SP54 T2 SP54T2 10 51623004 51633027 0,518 -0,103795068 1
1 TRUE
SP54 T2 SP54T2 10 52086939 135281637 0,793634998 -0,344134104
1 0 FALSE
SP54 T2 SP54T2 11 193096 134856661 0,5 -0,087906586 1
1 TRUE
SP54 T2 SP54T2 12 92252 57588838 0,5 -0,078841621 1 1
TRUE
SP54 T2 SP54T2 12 58089413 58217927 0,957 3,527804657 35
1 TRUE
SP54 T2 SP54T2 12 58335626 133758539 0,5 -0,113295633 1
1 TRUE
SP54 T2 SP54T2 13 19042581 115064542 0,5 -0,140300703 1
1 TRUE
Page 78 of 185Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
SP54 T2 SP54T2 14 19188622 107170207 0,5 -0,094327288 1
1 TRUE
SP54 T2 SP54T2 15 20173160 102304498 0,505 -0,218383951 1
1 TRUE
SP54 T2 SP54T2 16 97610 57057679 0,505 -0,148525348 1 1
TRUE
SP54 T2 SP54T2 16 57062177 57551966 0,6365 0,352835527 2
1 FALSE
SP54 T2 SP54T2 16 57552088 90161753 0,5 -0,119940456 1
1 TRUE
SP54 T2 SP54T2 17 6115 12018851 0,825039686 -0,1059635 2
0 TRUE
SP54 T2 SP54T2 17 12606826 21312678 0,653 0,260018205 2
1 FALSE
SP54 T2 SP54T2 17 21318586 21519033 0,506 0,297857972 1
1 TRUE
SP54 T2 SP54T2 17 21535937 81083660 0,661 0,280313564 2
1 FALSE
SP54 T2 SP54T2 18 196829 74962645 0,5 -0,082579813 1
1 TRUE
SP54 T2 SP54T2 18 76934104 77736579 0,661 0,342897124 2
1 TRUE
SP54 T2 SP54T2 19 288246 59059729 0,627 0,227565759 2
1 TRUE
SP54 T2 SP54T2 20 239688 62904542 0,5 -0,10979866 1
1 TRUE
SP54 T2 SP54T2 21 9907097 48080896 0,5 -0,123955891 1
1 TRUE
SP54 T2 SP54T2 22 16366264 51183255 0,5 -0,15123928 1
1 TRUE
SP54 T3 SP54T3 1 139213 120611876 0,583 0,134620442 2
1 FALSE
SP54 T3 SP54T3 1 121115761 142634897 0,758 -0,035850793 2
0 TRUE
SP54 T3 SP54T3 1 143767643 145075854 0,507 0,113528612 1
1 TRUE
SP54 T3 SP54T3 1 145075923 249148399 0,588 0,115700244 2
1 FALSE
SP54 T3 SP54T3 2 224919 242842568 0,507 -0,164436167 1
1 TRUE
SP54 T3 SP54T3 3 361508 197804058 0,5 -0,175327125 1
1 TRUE
SP54 T3 SP54T3 4 64892 191033653 0,5 -0,211756426 1 1
TRUE
SP54 T3 SP54T3 5 163205 180687212 0,584 0,092496674 2
1 FALSE
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SP54 T3 SP54T3 6 312023 29855401 0,5 -0,164367199 1
1 TRUE
SP54 T3 SP54T3 6 29855856 29855864 0,773 0,019723311 2
0 TRUE
SP54 T3 SP54T3 6 29855940 32627976 0,5 -0,012423113 1
1 TRUE
SP54 T3 SP54T3 6 32627992 32629331 0,6535 0,087074786 2
1 FALSE
SP54 T3 SP54T3 6 32629380 170190659 0,5 -0,16249618 1
1 TRUE
SP54 T3 SP54T3 7 286402 53854818 0,584 0,136996013 2
1 FALSE
SP54 T3 SP54T3 7 54610293 55242609 0,8355 2,102363522 12
2 TRUE
SP54 T3 SP54T3 7 55433880 91503228 0,5 -0,099522633 1
1 TRUE
SP54 T3 SP54T3 7 91570290 159024799 0,596 0,155254304 2
1 FALSE
SP54 T3 SP54T3 8 182934 146229040 0,5 -0,147135256 1
1 TRUE
SP54 T3 SP54T3 9 117713 141071475 0,5 0,008358764 1
1 TRUE
SP54 T3 SP54T3 10 282897 51623866 0,661 -0,354938466 1
0 FALSE
SP54 T3 SP54T3 10 51631453 51633027 0,5 -0,17023817 1
1 TRUE
SP54 T3 SP54T3 10 52086939 135281637 0,672 -0,301955157 1
0 FALSE
SP54 T3 SP54T3 11 193096 134856661 0,5 -0,115705129 1
1 TRUE
SP54 T3 SP54T3 12 92252 57588838 0,5 -0,151226574 1 1
TRUE
SP54 T3 SP54T3 12 58089413 58217927 0,935 2,841700292 21
1 TRUE
SP54 T3 SP54T3 12 58335626 133758539 0,5 -0,180690566 1
1 TRUE
SP54 T3 SP54T3 13 19042581 115064542 0,5 -0,270494743 1
1 TRUE
SP54 T3 SP54T3 14 19188622 107170207 0,505 -0,119921344 1
1 TRUE
SP54 T3 SP54T3 15 20173160 102304498 0,5 -0,166821801 1
1 TRUE
SP54 T3 SP54T3 16 97610 90161753 0,5 -0,037486075 1 1
TRUE
SP54 T3 SP54T3 17 6115 12620897 0,722 0,063287738 2 0
FALSE
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SP54 T3 SP54T3 17 12799985 81083660 0,649 0,227955523 2
1 FALSE
SP54 T3 SP54T3 18 196829 74962645 0,5 -0,228218013 1
1 TRUE
SP54 T3 SP54T3 18 76934104 77513841 0,714 0,723231582 3
1 TRUE
SP54 T3 SP54T3 18 77703299 77736579 0,519 0,143670734 1
1 TRUE
SP54 T3 SP54T3 19 288246 7572169 0,59 0,306198776 2
1 FALSE
SP54 T3 SP54T3 19 7573098 7573301 0,769 -0,218557241 1
0 TRUE
SP54 T3 SP54T3 19 7584483 59059729 0,586 0,224713257 2
1 FALSE
SP54 T3 SP54T3 20 239688 25900078 0,51 -0,104296783 1
1 FALSE
SP54 T3 SP54T3 20 29449333 62904542 0,5 -0,038553697 1
1 TRUE
SP54 T3 SP54T3 21 9907097 15516898 0,531 -0,287996656 1
1 TRUE
SP54 T3 SP54T3 21 15516948 45978592 0,5 -0,112229135 1
1 TRUE
SP54 T3 SP54T3 21 46057391 46057634 0,786 -0,135192383 2
0 FALSE
SP54 T3 SP54T3 21 46058060 48080896 0,5 0,043896449 1
1 TRUE
SP54 T3 SP54T3 22 16366264 51183255 0,5 -0,020572771 1
1 TRUE
SP54 T4 SP54T4 1 139213 16910064 0,643 0,379045018 2
1 TRUE
SP54 T4 SP54T4 1 16918502 17273444 0,507 0,345588973 1
1 TRUE
SP54 T4 SP54T4 1 17531582 121124362 0,65 0,362434385 2
1 TRUE
SP54 T4 SP54T4 1 142634897 145507826 0,507 0,419734505 2
2 TRUE
SP54 T4 SP54T4 1 145517561 249148399 0,65 0,38719288 2
1 TRUE
SP54 T4 SP54T4 2 224919 90458594 0,5 -0,155855114 1
1 TRUE
SP54 T4 SP54T4 2 91678867 92129749 0,6135 -0,066167532 2
1 FALSE
SP54 T4 SP54T4 2 95527944 240923050 0,5 -0,14223026 1
1 TRUE
SP54 T4 SP54T4 2 240946766 242842568 0,8559983 -0,979298047
1 0 FALSE
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SP54 T4 SP54T4 3 361508 47770380 0,5 -0,125574874 1
1 TRUE
SP54 T4 SP54T4 3 47953405 49463287 0,665 0,359603884 2
1 TRUE
SP54 T4 SP54T4 3 49570882 197804058 0,505 -0,111158396 1
1 TRUE
SP54 T4 SP54T4 4 64892 49553059 0,5 -0,123055865 1 1
TRUE
SP54 T4 SP54T4 4 52714244 191033653 0,507 -0,143122043 1
1 TRUE
SP54 T4 SP54T4 5 163205 180687212 0,639 0,291992424 2
1 FALSE
SP54 T4 SP54T4 6 312023 29855401 0,5 -0,07832865 1
1 TRUE
SP54 T4 SP54T4 6 29855856 29855864 0,767 -0,624196151 1
0 FALSE
SP54 T4 SP54T4 6 29855940 170190659 0,5 -0,107980554 1
1 TRUE
SP54 T4 SP54T4 7 286402 57529392 0,656 0,401428714 2
1 TRUE
SP54 T4 SP54T4 7 62599308 90747315 0,507 -0,171483677 1
1 TRUE
SP54 T4 SP54T4 7 91503228 159024799 0,65 0,360738752 2
1 TRUE
SP54 T4 SP54T4 8 182934 100994389 0,5 -0,11245366 1
1 TRUE
SP54 T4 SP54T4 8 100999575 101542205 0,658 0,411304034 2
1 TRUE
SP54 T4 SP54T4 8 101586133 146229040 0,5 -0,068747259 1
1 TRUE
SP54 T4 SP54T4 9 117713 141071475 0,571 0,162368315 1
1 FALSE
SP54 T4 SP54T4 10 282897 30902048 0,887924781 -0,617679522
1 0 FALSE
SP54 T4 SP54T4 10 30915618 30915906 0,625 -0,641135316 1
1 TRUE
SP54 T4 SP54T4 10 30960716 51592727 0,891303015 -0,57352413
1 0 FALSE
SP54 T4 SP54T4 10 51623004 51633027 0,5 -0,296339162 1
1 TRUE
SP54 T4 SP54T4 10 52086939 135281637 0,894379096 -0,532107602
1 0 FALSE
SP54 T4 SP54T4 11 193096 134856661 0,503 -0,097990134 1
1 TRUE
SP54 T4 SP54T4 12 92252 57588838 0,5 -0,108422257 1 1
TRUE
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SP54 T4 SP54T4 12 58089413 58217927 0,959 3,530081045 28
1 TRUE
SP54 T4 SP54T4 12 58335626 133758539 0,5 -0,133725453 1
1 TRUE
SP54 T4 SP54T4 13 19042581 115064542 0,5 -0,145924094 1
1 TRUE
SP54 T4 SP54T4 14 19188622 107170207 0,5 -0,102270664 1
1 TRUE
SP54 T4 SP54T4 15 20173160 22145401 0,577 -0,803967666 1
1 FALSE
SP54 T4 SP54T4 15 22345038 42619508 0,7 -0,591444568 1
0 FALSE
SP54 T4 SP54T4 15 42630896 42696158 0,5 -0,725830815 1
1 TRUE
SP54 T4 SP54T4 15 42698291 50087964 0,71 -0,59275281 1
0 FALSE
SP54 T4 SP54T4 15 50152166 50152274 0,999813597 -1,150695739
1000 0 TRUE
SP54 T4 SP54T4 15 50158695 102304498 0,692 -0,61332404 1
0 FALSE
SP54 T4 SP54T4 16 97610 56928470 0,559 -0,322798516 1 1
FALSE
SP54 T4 SP54T4 16 56994528 57159402 0,736 0,244806746 2
1 FALSE
SP54 T4 SP54T4 16 57494178 72991286 0,541 -0,250171472 1
1 FALSE
SP54 T4 SP54T4 16 72993831 74666634 0,71 0,272257762 2
1 FALSE
SP54 T4 SP54T4 16 74694692 90161753 0,574 -0,310128446 1
1 FALSE
SP54 T4 SP54T4 17 6115 12018851 0,920936654 -0,114293119 2
0 TRUE
SP54 T4 SP54T4 17 12606826 21206556 0,659 0,433987565 2
1 TRUE
SP54 T4 SP54T4 17 21312562 21319943 0,505 0,514897882 2
2 TRUE
SP54 T4 SP54T4 17 21407858 81083660 0,667 0,431178451 2
1 FALSE
SP54 T4 SP54T4 18 196829 77736579 0,5 -0,107060216 1
1 TRUE
SP54 T4 SP54T4 19 288246 59059729 0,653 0,383416011 2
1 TRUE
SP54 T4 SP54T4 20 239688 62904542 0,5 -0,105229471 1
1 TRUE
SP54 T4 SP54T4 21 9907097 11181645 0,572 -0,30980393 1
1 FALSE
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SP54 T4 SP54T4 21 14418486 48080896 0,5 -0,138873604 1
1 TRUE
SP54 T4 SP54T4 22 16366264 51183255 0,5 -0,112902959 1
1 TRUE
SP54 T5 SP54T5 1 139213 16902894 0,653 0,290409084 2
1 TRUE
SP54 T5 SP54T5 1 16910064 17531582 0,505 0,387212594 1
1 TRUE
SP54 T5 SP54T5 1 17550303 121124362 0,667 0,345258582 2
1 FALSE
SP54 T5 SP54T5 1 142634897 145109583 0,505 0,428054845 1
1 TRUE
SP54 T5 SP54T5 1 145109897 249148399 0,664 0,343388528 2
1 FALSE
SP54 T5 SP54T5 2 224919 240923050 0,5 -0,140545538 1
1 TRUE
SP54 T5 SP54T5 2 240946766 242842568 0,889 -0,957780695 1
0 TRUE
SP54 T5 SP54T5 3 361508 47770380 0,5 -0,076518152 1
1 TRUE
SP54 T5 SP54T5 3 47953405 48463711 0,667 0,465235189 2
1 FALSE
SP54 T5 SP54T5 3 48474249 197804058 0,5 -0,062588998 1
1 TRUE
SP54 T5 SP54T5 4 64892 191033653 0,502 -0,077866015 1 1
TRUE
SP54 T5 SP54T5 5 163205 180687212 0,626 0,266757589 2
1 FALSE
SP54 T5 SP54T5 6 312023 32557655 0,5 -0,070059332 1
1 TRUE
SP54 T5 SP54T5 6 32605189 32605451 0,85 -0,269879531 1
0 TRUE
SP54 T5 SP54T5 6 32609009 32724305 0,575 -0,015166353 1
1 FALSE
SP54 T5 SP54T5 6 32724312 170190659 0,5 -0,066692776 1
1 TRUE
SP54 T5 SP54T5 7 286402 54610293 0,645 0,422124052 2
1 TRUE
SP54 T5 SP54T5 7 54614582 55242609 0,782 1,093409534 4
1 TRUE
SP54 T5 SP54T5 7 55433880 57529392 0,647 0,412669111 2
1 TRUE
SP54 T5 SP54T5 7 62599308 90747315 0,5 -0,090976248 1
1 TRUE
SP54 T5 SP54T5 7 91503228 159024799 0,635 0,387521916 2
1 FALSE
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SP54 T5 SP54T5 8 182934 27729713 0,5 -0,070375966 1
1 TRUE
SP54 T5 SP54T5 8 27776285 27776335 0,8055 -0,970533304 0
0 FALSE
SP54 T5 SP54T5 8 27779811 100994389 0,505 -0,075939224 1
1 TRUE
SP54 T5 SP54T5 8 100999575 101542205 0,679 0,462957479 2
1 TRUE
SP54 T5 SP54T5 8 101586133 146229040 0,513 -0,049178896 1
1 FALSE
SP54 T5 SP54T5 9 117713 141071475 0,506 0,068608921 1
1 TRUE
SP54 T5 SP54T5 10 282897 51592727 0,900178979 -0,724490406
1 0 TRUE
SP54 T5 SP54T5 10 51623004 51633027 0,512 -0,467290572 1
1 TRUE
SP54 T5 SP54T5 10 52086939 135281637 0,902677697 -0,687917213
1 0 TRUE
SP54 T5 SP54T5 11 193096 134856661 0,5 -0,093395159 1
1 TRUE
SP54 T5 SP54T5 12 92252 57588838 0,5 -0,063689382 1 1
TRUE
SP54 T5 SP54T5 12 58089413 58217927 0,948 3,280494297 22
1 TRUE
SP54 T5 SP54T5 12 58335626 133758539 0,5 -0,079174779 1
1 TRUE
SP54 T5 SP54T5 13 19042581 115064542 0,5 -0,0973199 1
1 TRUE
SP54 T5 SP54T5 14 19188622 107170207 0,5 -0,057897593 1
1 TRUE
SP54 T5 SP54T5 15 20173160 20477289 0,517 -1,154681573 0
0 TRUE
SP54 T5 SP54T5 15 21137321 21902874 0,863910309 -1,171632628
1 0 TRUE
SP54 T5 SP54T5 15 21903156 21938082 0,515 -0,926285504 1
1 TRUE
SP54 T5 SP54T5 15 21938163 34813947 0,869 -0,904503279 1
0 FALSE
SP54 T5 SP54T5 15 34848553 34848887 0,538 -0,777141349 1
1 TRUE
SP54 T5 SP54T5 15 35044757 77907784 0,873 -0,862287314 1
0 FALSE
SP54 T5 SP54T5 15 78189163 78191543 0,571 -0,895654548 1
1 TRUE
SP54 T5 SP54T5 15 78208880 102304498 0,869 -0,870113888 1
0 FALSE
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SP54 T5 SP54T5 16 97610 56928470 0,594 -0,348619447 1 1
FALSE
SP54 T5 SP54T5 16 56994528 57503773 0,7545 0,249794262 2
1 FALSE
SP54 T5 SP54T5 16 57551966 72993831 0,597 -0,31334436 1
1 FALSE
SP54 T5 SP54T5 16 74321225 74695079 0,725 0,283119995 2
1 FALSE
SP54 T5 SP54T5 16 74706298 90161753 0,595 -0,349828771 1
1 FALSE
SP54 T5 SP54T5 17 6115 12018851 0,935442625 -0,095728673 2
0 TRUE
SP54 T5 SP54T5 17 12606826 21206556 0,661 0,44301319 2
1 TRUE
SP54 T5 SP54T5 17 21312562 21319943 0,515 0,425145257 1
1 TRUE
SP54 T5 SP54T5 17 21407858 81083660 0,665 0,457872385 2
1 FALSE
SP54 T5 SP54T5 18 196829 77736579 0,5 -0,041777376 1
1 TRUE
SP54 T5 SP54T5 19 288246 59059729 0,654 0,43101189 2
1 TRUE
SP54 T5 SP54T5 20 239688 62904542 0,5 -0,068361072 1
1 TRUE
SP54 T5 SP54T5 21 9907097 14917610 0,522 -0,170018399 1
1 TRUE
SP54 T5 SP54T5 21 15281853 15281957 0,775 -0,456332739 1
0 FALSE
SP54 T5 SP54T5 21 15289026 48080896 0,5 -0,069011434 1
1 TRUE
SP54 T5 SP54T5 22 16366264 51183255 0,5 -0,089410712 1
1 TRUE
SP54 T6 SP54T6 1 139213 121124362 0,573 0,350694207 2
1 FALSE
SP54 T6 SP54T6 1 142634897 146791020 0,511 0,358719616 2
2 TRUE
SP54 T6 SP54T6 1 146791289 249148399 0,58 0,347716569 2
1 FALSE
SP54 T6 SP54T6 2 224919 240923050 0,503 -0,077173984 1
1 TRUE
SP54 T6 SP54T6 2 240946766 242842568 0,621 -0,450958826 1
0 FALSE
SP54 T6 SP54T6 3 361508 47770380 0,5 -0,102382164 1
1 TRUE
SP54 T6 SP54T6 3 47953405 48474249 0,65 0,430596744 2
1 TRUE
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SP54 T6 SP54T6 3 48481647 197804058 0,5 -0,079605277 1
1 TRUE
SP54 T6 SP54T6 4 64892 1388413 0,51 -0,124097946 1 1
TRUE
SP54 T6 SP54T6 4 1389070 1389156 0,75 -0,388387611 1
0 TRUE
SP54 T6 SP54T6 4 1397611 191033653 0,5 -0,122449595 1
1 TRUE
SP54 T6 SP54T6 5 163205 180687212 0,625 0,314480958 2
1 TRUE
SP54 T6 SP54T6 6 312023 32489792 0,5 -0,086729748 1
1 TRUE
SP54 T6 SP54T6 6 32489825 32489973 0,761 0,313060142 2
0 FALSE
SP54 T6 SP54T6 6 32497905 32634508 0,59 -0,000880691 2
1 FALSE
SP54 T6 SP54T6 6 32634514 170190659 0,504 -0,088412206 1
1 TRUE
SP54 T6 SP54T6 7 286402 53854818 0,665 0,284690532 2
1 FALSE
SP54 T6 SP54T6 7 54610293 55242609 0,8105 1,366855773 6
1 TRUE
SP54 T6 SP54T6 7 55433880 57529392 0,662 0,243087085 2
1 FALSE
SP54 T6 SP54T6 7 62599308 91671853 0,589 0,037687994 2
1 FALSE
SP54 T6 SP54T6 7 91674302 147674912 0,667 0,307453543 2
1 FALSE
SP54 T6 SP54T6 7 147926734 151478187 0,855 1,385720086 7
1 TRUE
SP54 T6 SP54T6 7 151483445 159024799 0,667 0,231105341 2
1 FALSE
SP54 T6 SP54T6 8 182934 146229040 0,5 -0,091509896 1
1 TRUE
SP54 T6 SP54T6 9 117713 141071475 0,5 -0,037906383 1
1 TRUE
SP54 T6 SP54T6 10 282897 49763618 0,789 -0,66701184 1
0 TRUE
SP54 T6 SP54T6 10 49763677 49763717 0,5 -0,841891441 0
0 TRUE
SP54 T6 SP54T6 10 49790972 51623004 0,786 -0,608482227 1
0 TRUE
SP54 T6 SP54T6 10 51623061 51633027 0,556 -0,422287227 1
1 TRUE
SP54 T6 SP54T6 10 52086939 135281637 0,794 -0,655945531 1
0 FALSE
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SP54 T6 SP54T6 11 193096 82443817 0,5 -0,086851617 1
1 TRUE
SP54 T6 SP54T6 11 82444021 82444226 0,553 -1,517927173 0
0 TRUE
SP54 T6 SP54T6 11 82704967 134856661 0,5 -0,070703674 1
1 TRUE
SP54 T6 SP54T6 12 92252 57588838 0,5 -0,076761684 1 1
TRUE
SP54 T6 SP54T6 12 58089413 58217927 0,97 4,024232585 46
1 TRUE
SP54 T6 SP54T6 12 58335626 133758539 0,5 -0,080000247 1
1 TRUE
SP54 T6 SP54T6 13 19042581 115064542 0,507 -0,321914125 1
1 TRUE
SP54 T6 SP54T6 14 19188622 107170207 0,5 -0,129953269 1
1 TRUE
SP54 T6 SP54T6 15 20173160 102304498 0,5 -0,199763179 1
1 TRUE
SP54 T6 SP54T6 16 97610 31580272 0,5045 -0,099901472 1 1
TRUE
SP54 T6 SP54T6 16 31580530 33424637 0,608 -0,428444744 1
1 FALSE
SP54 T6 SP54T6 16 33424638 56928470 0,506 -0,190489076 1
1 TRUE
SP54 T6 SP54T6 16 56994528 57499902 0,629 0,284546025 2
1 TRUE
SP54 T6 SP54T6 16 57503213 72993831 0,5 -0,023386436 1
1 TRUE
SP54 T6 SP54T6 16 74321225 74695079 0,656 0,448763976 2
1 TRUE
SP54 T6 SP54T6 16 74706298 90161753 0,5 -0,112997932 1
1 TRUE
SP54 T6 SP54T6 17 6115 12018851 0,879284866 0,150144284 2
0 FALSE
SP54 T6 SP54T6 17 12606826 21206556 0,734 0,335110719 2
0 FALSE
SP54 T6 SP54T6 17 21312562 21319943 0,52 0,302582366 1
1 TRUE
SP54 T6 SP54T6 17 21407858 44160050 0,741 0,390231384 3
1 FALSE
SP54 T6 SP54T6 17 44344822 44626347 0,54 0,942820566 2
2 TRUE
SP54 T6 SP54T6 17 44788310 81083660 0,742 0,386177481 3
1 FALSE
SP54 T6 SP54T6 18 196829 77736579 0,505 -0,080843653 1
1 TRUE
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SP54 T6 SP54T6 19 288246 24115369 0,624 0,379367342 2
1 TRUE
SP54 T6 SP54T6 19 28418794 59059729 0,632 0,352618497 2
1 TRUE
SP54 T6 SP54T6 20 239688 62904542 0,5 -0,077177387 1
1 TRUE
SP54 T6 SP54T6 21 9907097 14917610 0,514 -0,129738324 1
1 TRUE
SP54 T6 SP54T6 21 15281853 15481365 0,701 -0,377202386 1
0 FALSE
SP54 T6 SP54T6 21 15516330 48080896 0,5 -0,090089871 1
1 TRUE
SP54 T6 SP54T6 22 16366264 48023297 0,5 -0,100466352 1
1 TRUE
SP54 T6 SP54T6 22 48896580 48972536 0,676 -0,798832821 1
0 TRUE
SP54 T6 SP54T6 22 49176220 51183255 0,52 -0,209896557 1
1 TRUE
SP55 S SP55S 1 69511 249141454 0,5 -0,024949102 1 1 TRUE
SP55 S SP55S 2 41366 242842568 0,504 -0,025000225 1 1 TRUE
SP55 S SP55S 3 361493 193220219 0,503 -0,00145555 1 1
TRUE
SP55 S SP55S 3 194080648 194387300 0,6475 0,414464978 2 1
FALSE
SP55 S SP55S 3 194390617 197838039 0,5 -0,022629652 1 1
TRUE
SP55 S SP55S 4 60400 190863027 0,5 -0,01905845 1 1 TRUE
SP55 S SP55S 5 181660 180582604 0,5 0,051241995 1 1
TRUE
SP55 S SP55S 6 203878 32547053 0,503 -0,053987911 1 1
TRUE
SP55 S SP55S 6 32547980 32548489 0,745 0,30301569 2 0
FALSE
SP55 S SP55S 6 32548507 32632638 0,582 0,04283656 2 1
FALSE
SP55 S SP55S 6 32632647 32634192 0,745 -0,293558153 1 0
TRUE
SP55 S SP55S 6 32634226 170892848 0,5 -0,039749032 1 1
TRUE
SP55 S SP55S 7 286534 54724286 0,618 0,360443963 2 1
TRUE
SP55 S SP55S 7 55001472 55272826 0,981 4,673148078 82 1
TRUE
SP55 S SP55S 7 55466002 57529392 0,63 0,272332662 2 1
FALSE
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SP55 S SP55S 7 62669789 158827414 0,622 0,360624437 2 1
TRUE
SP55 S SP55S 8 183002 146105917 0,5 0,006017259 1 1
TRUE
SP55 S SP55S 9 214706 3324206 0,51 -0,061316448 1 1
TRUE
SP55 S SP55S 9 3829188 7174430 0,7345 -0,487829504 1 0
TRUE
SP55 S SP55S 9 8319806 13987678 0,528 -0,016990308 1 1
TRUE
SP55 S SP55S 9 14125908 21186931 0,709235192 -0,612694745 1
0 FALSE
SP55 S SP55S 9 21187121 30559335 0,571 -0,89812396 0 0
FALSE
SP55 S SP55S 9 31254567 32542204 0,721344808 -0,551323112 1
0 TRUE
SP55 S SP55S 9 32567655 38453992 0,5 -0,008734777 1 1
TRUE
SP55 S SP55S 9 40503085 68433462 0,67 -0,296167347 1 0
FALSE
SP55 S SP55S 9 69002200 141015351 0,5 0,010917562 1 1
TRUE
SP55 S SP55S 10 93816 5246584 0,728182245 -0,515481769 1 0
TRUE
SP55 S SP55S 10 5247631 46148326 0,727 -0,542834381 1 0
TRUE
SP55 S SP55S 10 46272679 47000239 0,509 -0,543979223 1 1
TRUE
SP55 S SP55S 10 47605468 135279810 0,71996845 -0,558431453 1
0 TRUE
SP55 S SP55S 11 193096 134244322 0,503 -0,027773883 1 1
TRUE
SP55 S SP55S 11 134251777 134927578 0,559 -0,657531099 0 0
TRUE
SP55 S SP55S 12 92252 133770096 0,5 -0,012591941 1 1 TRUE
SP55 S SP55S 13 19042705 115064542 0,5 -0,073001675 1 1
TRUE
SP55 S SP55S 14 19118067 107283160 0,505 -0,016426452 1 1
TRUE
SP55 S SP55S 15 20433755 33446947 0,504 -0,079708518 1 1
TRUE
SP55 S SP55S 15 33842260 50782703 0,603 -0,281992522 1 0
FALSE
SP55 S SP55S 15 50821945 102388991 0,5 -0,023273518 1 1
TRUE
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SP55 S SP55S 16 215106 90161231 0,5 -0,029925088 1 1
TRUE
SP55 S SP55S 17 6115 81052423 0,5 0,001689916 1 1 TRUE
SP55 S SP55S 18 166819 77927028 0,5 0,017548664 1 1
TRUE
SP55 S SP55S 19 311988 43922300 0,619 0,287049754 2 1
TRUE
SP55 S SP55S 19 43999634 44515514 0,697 0,730307572 3 1
TRUE
SP55 S SP55S 19 44535999 58806083 0,617 0,290505521 2 1
TRUE
SP55 S SP55S 20 76962 62903729 0,5 -0,017648174 1 1 TRUE
SP55 S SP55S 21 9907222 48080896 0,5 -0,042727935 1 1
TRUE
SP55 S SP55S 22 16287789 51137094 0,5 -0,042127591 1 1
TRUE
SP55 T1 SP55T1 1 69511 225699681 0,5 -0,002011714 1 1
TRUE
SP55 T1 SP55T1 1 225965832 226626684 0,653 -0,3923913 1
0 TRUE
SP55 T1 SP55T1 1 226923706 249141454 0,507 -0,014425251 1
1 TRUE
SP55 T1 SP55T1 2 41366 242842568 0,5 -0,032643545 1 1
TRUE
SP55 T1 SP55T1 3 361493 197838039 0,5 -0,044749782 1
1 TRUE
SP55 T1 SP55T1 4 60400 3526786 0,63 -0,434387649 1 0
FALSE
SP55 T1 SP55T1 4 3589893 190863027 0,504 -0,014109703 1
1 TRUE
SP55 T1 SP55T1 5 181660 180582604 0,504 0,022992562 1
1 TRUE
SP55 T1 SP55T1 6 203878 32546986 0,505 -0,060716053 1
1 TRUE
SP55 T1 SP55T1 6 32547053 32548155 0,724 0,40553771 3
1 TRUE
SP55 T1 SP55T1 6 32548178 32632689 0,571 0,013069808 2
1 FALSE
SP55 T1 SP55T1 6 32632694 32634192 0,719 -0,189263855 1
0 FALSE
SP55 T1 SP55T1 6 32634226 170892848 0,5 -0,047404026 1
1 TRUE
SP55 T1 SP55T1 7 286534 54724286 0,612 0,323564304 2
1 TRUE
SP55 T1 SP55T1 7 55001472 55272826 0,981 4,333687754 73
1 TRUE
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SP55 T1 SP55T1 7 55466002 57529392 0,616 0,291917506 2
1 TRUE
SP55 T1 SP55T1 7 62669789 158827414 0,609 0,315153022 2
1 TRUE
SP55 T1 SP55T1 8 183002 146105917 0,5 -0,025294175 1
1 TRUE
SP55 T1 SP55T1 9 214706 3324206 0,522 0,119192333 1
1 TRUE
SP55 T1 SP55T1 9 3829188 7105651 0,738542977 -0,23826116
1 0 FALSE
SP55 T1 SP55T1 9 7170006 8521244 0,523 0,099989648 1
1 TRUE
SP55 T1 SP55T1 9 12287727 21166004 0,743 -0,15593485 2
0 FALSE
SP55 T1 SP55T1 9 21186931 31254567 0,5 -0,537162508 0
0 TRUE
SP55 T1 SP55T1 9 31254672 32542204 0,744 -0,177059159 2
0 TRUE
SP55 T1 SP55T1 9 32567655 141015351 0,572 0,161130314 2
1 FALSE
SP55 T1 SP55T1 10 93816 18691018 0,6895 -0,456363046 1 0
TRUE
SP55 T1 SP55T1 10 18789724 26518418 0,512 -1,029306716 0
0 TRUE
SP55 T1 SP55T1 10 26939401 46952667 0,667 -0,419923532 1
0 FALSE
SP55 T1 SP55T1 10 46960084 47000239 0,533 -0,310185235 1
1 TRUE
SP55 T1 SP55T1 10 47605468 135279810 0,677 -0,492729699 1
0 FALSE
SP55 T1 SP55T1 11 193096 830487 0,512 -0,114962799 1
1 TRUE
SP55 T1 SP55T1 11 831122 134927578 0,5 -0,052094842 1
1 TRUE
SP55 T1 SP55T1 12 92252 133770096 0,5 -0,015298601 1 1
TRUE
SP55 T1 SP55T1 13 19042705 115064542 0,503 -0,044818307 1
1 TRUE
SP55 T1 SP55T1 14 19118067 107283160 0,505 -0,053377496 1
1 TRUE
SP55 T1 SP55T1 15 20433755 102388991 0,5 -0,054537453 1
1 TRUE
SP55 T1 SP55T1 16 215106 84907670 0,5 -0,079010267 1
1 TRUE
SP55 T1 SP55T1 16 84911195 85722560 0,692808373 -0,470826234
1 0 TRUE
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SP55 T1 SP55T1 16 85968282 90161231 0,5 -0,078212677 1
1 TRUE
SP55 T1 SP55T1 17 6115 17326605 0,5 -0,019315973 1 1
TRUE
SP55 T1 SP55T1 17 18041507 18243873 0,618 0,324168986 2
1 TRUE
SP55 T1 SP55T1 17 18252010 22214959 0,53 -0,053483757 1
1 FALSE
SP55 T1 SP55T1 17 25628820 81052423 0,5 -0,043350805 1
1 TRUE
SP55 T1 SP55T1 18 166819 77927028 0,5 0,005809685 1
1 TRUE
SP55 T1 SP55T1 19 311988 58806083 0,617 0,245842088 2
1 TRUE
SP55 T1 SP55T1 20 76962 62903729 0,5 -0,066426179 1 1
TRUE
SP55 T1 SP55T1 21 9907222 48080896 0,5 -0,04781931 1
1 TRUE
SP55 T1 SP55T1 22 16287789 43088549 0,5 -0,137521429 1
1 TRUE
SP55 T1 SP55T1 22 43088971 51137094 0,66 -0,45927 1
0 FALSE
SP55 T2 SP55T2 1 69511 249141454 0,5 -0,056038671 1 1
TRUE
SP55 T2 SP55T2 2 41366 242842568 0,5 -0,047306912 1 1
TRUE
SP55 T2 SP55T2 3 361493 194080916 0,506 -0,035738495 1
1 TRUE
SP55 T2 SP55T2 3 194080983 194393034 0,667 0,528419257 2
1 TRUE
SP55 T2 SP55T2 3 194999996 197838039 0,511 -0,102232461 1
1 TRUE
SP55 T2 SP55T2 4 60400 190863027 0,5 -0,034143456 1 1
TRUE
SP55 T2 SP55T2 5 181660 180582604 0,503 -0,030095268 1
1 TRUE
SP55 T2 SP55T2 6 203878 32547053 0,504 -0,083446053 1
1 TRUE
SP55 T2 SP55T2 6 32547980 32628845 0,596 0,023473245 2
1 FALSE
SP55 T2 SP55T2 6 32628917 170892848 0,5 -0,037748249 1
1 TRUE
SP55 T2 SP55T2 7 286534 54724286 0,656 0,484005286 2
1 TRUE
SP55 T2 SP55T2 7 55001472 55272826 0,984 4,794898012 66
1 TRUE
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SP55 T2 SP55T2 7 55466002 158827414 0,651 0,482194126 2
1 TRUE
SP55 T2 SP55T2 8 183002 146105917 0,5 -0,044614127 1
1 TRUE
SP55 T2 SP55T2 9 214706 3324206 0,596 0,237200594 2
1 FALSE
SP55 T2 SP55T2 9 3829188 7174430 0,917508588 -0,311778641
2 0 FALSE
SP55 T2 SP55T2 9 8319806 13987678 0,544 0,211132163 1
1 TRUE
SP55 T2 SP55T2 9 14125908 21166004 0,922 -0,301487496 2
0 FALSE
SP55 T2 SP55T2 9 21186931 23705108 0,5 -3,167624657 0
0 TRUE
SP55 T2 SP55T2 9 25677933 26998090 0,921801018 -0,234684539
2 0 TRUE
SP55 T2 SP55T2 9 27195595 30559335 0,623 0,356098346 2
1 FALSE
SP55 T2 SP55T2 9 31254567 32542204 0,9125 -0,294347912 1
0 FALSE
SP55 T2 SP55T2 9 32567655 141015351 0,608 0,28172265 2
1 FALSE
SP55 T2 SP55T2 10 93816 30901628 0,881371568 -0,835912636 1
0 TRUE
SP55 T2 SP55T2 10 30915882 30978282 0,7 -1,018332016 0
0 FALSE
SP55 T2 SP55T2 10 30978377 46952667 0,887 -0,833263172 1
0 TRUE
SP55 T2 SP55T2 10 46960084 47000239 0,526 -0,773328363 1
1 TRUE
SP55 T2 SP55T2 10 47605468 135279810 0,876847131 -0,88991305
1 0 TRUE
SP55 T2 SP55T2 11 193096 134927578 0,503 -0,058294758 1
1 TRUE
SP55 T2 SP55T2 12 92252 3948718 0,508 -0,127613801 1 1
TRUE
SP55 T2 SP55T2 12 4388084 4873163 0,638 0,419440616 2
1 TRUE
SP55 T2 SP55T2 12 4877689 133770096 0,5 -0,040456863 1
1 TRUE
SP55 T2 SP55T2 13 19042705 115064542 0,504 -0,045709709 1
1 TRUE
SP55 T2 SP55T2 14 19118067 107283160 0,506 -0,047314194 1
1 TRUE
SP55 T2 SP55T2 15 20433755 102388991 0,5 -0,074205248 1
1 TRUE
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SP55 T2 SP55T2 16 215106 90161231 0,5 -0,076114594 1
1 TRUE
SP55 T2 SP55T2 17 6115 6607389 0,5 -0,077625156 1 1
TRUE
SP55 T2 SP55T2 17 6610536 7246940 0,665 0,424222215 2
1 TRUE
SP55 T2 SP55T2 17 7251605 17326605 0,5 -0,044585321 1
1 TRUE
SP55 T2 SP55T2 17 18041507 18291559 0,666 0,436617216 2
1 TRUE
SP55 T2 SP55T2 17 18301096 73127217 0,5 -0,033819201 1
1 TRUE
SP55 T2 SP55T2 17 73497697 73750847 0,797 1,246933191 4
1 FALSE
SP55 T2 SP55T2 17 73811138 81052423 0,5 -0,087330955 1
1 TRUE
SP55 T2 SP55T2 18 166819 77927028 0,5 -0,029644232 1
1 TRUE
SP55 T2 SP55T2 19 311988 43920612 0,652 0,452750751 2
1 TRUE
SP55 T2 SP55T2 19 43922061 44515514 0,73 0,849604191 3
1 TRUE
SP55 T2 SP55T2 19 44535999 58806083 0,6565 0,438146096 2
1 TRUE
SP55 T2 SP55T2 20 76962 62903729 0,5 -0,059913503 1 1
TRUE
SP55 T2 SP55T2 21 9907222 48080896 0,5 -0,074823262 1
1 TRUE
SP55 T2 SP55T2 22 16287789 21424414 0,5 -0,098156396 1
1 TRUE
SP55 T2 SP55T2 22 21576082 21983260 0,802 0,292749439 2
0 TRUE
SP55 T2 SP55T2 22 22025462 51137094 0,5 -0,059963308 1
1 TRUE
SP55 T3 SP55T3 1 69511 26385003 0,508 -0,129319189 1 1
TRUE
SP55 T3 SP55T3 1 26385150 249141454 0,5 -0,038501798 1
1 TRUE
SP55 T3 SP55T3 2 41366 242842568 0,5 -0,050369465 1 1
TRUE
SP55 T3 SP55T3 3 361493 197838039 0,5 -0,03436346 1
1 TRUE
SP55 T3 SP55T3 4 60400 3231661 0,5975 -0,301669855 1 0
TRUE
SP55 T3 SP55T3 4 3234828 4128926 0,553749626 -0,487048363
0 0 FALSE
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SP55 T3 SP55T3 4 4199760 190863027 0,508 -0,03024204 1
1 TRUE
SP55 T3 SP55T3 5 181660 180582604 0,503 -0,040015167 1
1 TRUE
SP55 T3 SP55T3 6 203878 32489794 0,504 -0,013194752 1
1 TRUE
SP55 T3 SP55T3 6 32520683 32628917 0,611 -0,013486201 2
1 FALSE
SP55 T3 SP55T3 6 32629193 32632694 0,524 0,084554125 1
1 TRUE
SP55 T3 SP55T3 6 32632864 32634192 0,596470412 -0,341869447
1 0 TRUE
SP55 T3 SP55T3 6 32634226 170892848 0,5 -0,025568809 1
1 TRUE
SP55 T3 SP55T3 7 286534 54724286 0,574 0,197378501 2
1 TRUE
SP55 T3 SP55T3 7 55001472 55272826 0,971 3,752252522 75
0 TRUE
SP55 T3 SP55T3 7 55466002 158827414 0,5755 0,195555101 2
1 TRUE
SP55 T3 SP55T3 8 183002 146105917 0,5 -0,034842272 1
1 TRUE
SP55 T3 SP55T3 9 214706 3324206 0,566 -0,1031661 1
0 FALSE
SP55 T3 SP55T3 9 3829188 21029330 0,6245 -0,219013787 1
0 FALSE
SP55 T3 SP55T3 9 21166004 141015351 0,5 -0,002180744 1
1 TRUE
SP55 T3 SP55T3 10 93816 135279810 0,59869156 -0,333906485 1
0 TRUE
SP55 T3 SP55T3 11 193096 134927578 0,5 -0,059467196 1
1 TRUE
SP55 T3 SP55T3 12 92252 133770096 0,504 -0,046301115 1 1
TRUE
SP55 T3 SP55T3 13 19042705 115064542 0,5025 -0,044848251 1
1 TRUE
SP55 T3 SP55T3 14 19118067 107283160 0,5 -0,046511387 1
1 TRUE
SP55 T3 SP55T3 15 20433755 102388991 0,5 -0,056035556 1
1 TRUE
SP55 T3 SP55T3 16 215106 90161231 0,5 -0,054615497 1
1 TRUE
SP55 T3 SP55T3 17 6115 39389354 0,5 -0,019594752 1 1
TRUE
SP55 T3 SP55T3 17 39394674 39394807 0,5 -0,699126249 0
0 TRUE
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SP55 T3 SP55T3 17 39406104 81052423 0,5 -0,039800094 1
1 TRUE
SP55 T3 SP55T3 18 166819 77927028 0,5 -0,030960523 1
1 TRUE
SP55 T3 SP55T3 19 311988 58806083 0,568 0,174956482 2
1 TRUE
SP55 T3 SP55T3 20 76962 62903729 0,5 -0,066170341 1 1
TRUE
SP55 T3 SP55T3 21 9907222 48080896 0,5 -0,055356196 1
1 TRUE
SP55 T3 SP55T3 22 16287789 42539105 0,5 -0,117850098 1
1 TRUE
SP55 T3 SP55T3 22 42547135 51137094 0,6 -0,307012203 1
0 TRUE
SP55 T4 SP55T4 1 69511 12082926 0,589 -0,207137679 1 1
FALSE
SP55 T4 SP55T4 1 12164391 12253965 0,702793883 -0,867538476
1 0 TRUE
SP55 T4 SP55T4 1 12339744 93306317 0,5 -0,046458968 1
1 TRUE
SP55 T4 SP55T4 1 93646418 106435371 0,607 -0,27025167 1
0 FALSE
SP55 T4 SP55T4 1 108116051 249141454 0,5 -0,035316968 1
1 TRUE
SP55 T4 SP55T4 2 41366 242842568 0,562 0,13151131 1 1
FALSE
SP55 T4 SP55T4 3 361493 49832788 0,5 -0,030844995 1
1 TRUE
SP55 T4 SP55T4 3 49833029 53892641 0,594 -0,272985961 1
1 FALSE
SP55 T4 SP55T4 3 53905308 193220219 0,5 -0,02155534 1
1 TRUE
SP55 T4 SP55T4 3 194080648 194393034 0,6575 0,431360201 2
1 FALSE
SP55 T4 SP55T4 3 194999996 197838039 0,504 -0,122488175 1
1 TRUE
SP55 T4 SP55T4 4 60400 190863027 0,5 -0,049117016 1 1
TRUE
SP55 T4 SP55T4 5 181660 180582604 0,5 -0,046641312 1
1 TRUE
SP55 T4 SP55T4 6 203878 32608991 0,506 -0,064252449 1
1 TRUE
SP55 T4 SP55T4 6 32609057 32628045 0,676 0,419190171 3
1 FALSE
SP55 T4 SP55T4 6 32628420 32632694 0,519 0,212080772 1
1 TRUE
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SP55 T4 SP55T4 6 32632864 32634263 0,7 0,0441203 2
1 FALSE
SP55 T4 SP55T4 6 32634264 170892848 0,5 -0,048977384 1
1 TRUE
SP55 T4 SP55T4 7 286534 54724286 0,628 0,360546563 2
1 TRUE
SP55 T4 SP55T4 7 55001472 55272826 0,984 4,91007051 91
1 TRUE
SP55 T4 SP55T4 7 55466002 158827414 0,629 0,362965345 2
1 TRUE
SP55 T4 SP55T4 8 183002 146105917 0,5 -0,061040088 1
1 TRUE
SP55 T4 SP55T4 9 214706 3829212 0,52 0,091146666 1
1 TRUE
SP55 T4 SP55T4 9 3932283 7174430 0,785145838 -0,399432391
1 0 FALSE
SP55 T4 SP55T4 9 8319806 8521244 0,531 0,076175311 1
1 TRUE
SP55 T4 SP55T4 9 12287727 21166004 0,785579109 -0,396520142
1 0 FALSE
SP55 T4 SP55T4 9 21186931 30559335 0,6 -1,074021929 0
0 FALSE
SP55 T4 SP55T4 9 31254567 32542204 0,781633595 -0,422825589
1 0 FALSE
SP55 T4 SP55T4 9 32567655 38397355 0,5 0,155713066 1
1 TRUE
SP55 T4 SP55T4 9 38453992 46912964 0,672 0,150401611 2
1 FALSE
SP55 T4 SP55T4 9 65973265 141015351 0,547 0,130465418 1
1 FALSE
SP55 T4 SP55T4 10 93816 46148326 0,747572559 -0,631943417 1
0 TRUE
SP55 T4 SP55T4 10 46272679 47667164 0,505 -0,707692251 0
0 TRUE
SP55 T4 SP55T4 10 47667380 71052083 0,744401956 -0,649951465
1 0 TRUE
SP55 T4 SP55T4 10 71060418 71060707 0,576 -0,860398521 0
0 TRUE
SP55 T4 SP55T4 10 71098376 135279810 0,743985023 -0,652302877
1 0 TRUE
SP55 T4 SP55T4 11 193096 134927578 0,505 -0,053576907 1
1 TRUE
SP55 T4 SP55T4 12 92252 133770096 0,5 -0,040313368 1 1
TRUE
SP55 T4 SP55T4 13 19042705 115064542 0,574 -0,265298448 1
1 FALSE
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SP55 T4 SP55T4 14 19118067 107283160 0,505 -0,05279213 1
1 TRUE
SP55 T4 SP55T4 15 20433755 33446947 0,506 -0,097554667 1
1 TRUE
SP55 T4 SP55T4 15 33842260 50782335 0,609 -0,357889653 1
0 FALSE
SP55 T4 SP55T4 15 50782703 102388991 0,5 -0,051489242 1
1 TRUE
SP55 T4 SP55T4 16 215106 33372666 0,5 -0,0768927 1
1 TRUE
SP55 T4 SP55T4 16 33373381 33401997 0,722 0,006178503 2
0 FALSE
SP55 T4 SP55T4 16 33412679 90161231 0,503 -0,075964095 1
1 TRUE
SP55 T4 SP55T4 17 6115 18044893 0,506 -0,013576414 1 1
TRUE
SP55 T4 SP55T4 17 18057167 18291559 0,639 0,357643438 2
1 TRUE
SP55 T4 SP55T4 17 18301096 48186817 0,5 -0,021540438 1
1 TRUE
SP55 T4 SP55T4 17 48193233 81052423 0,572 0,158519427 2
1 FALSE
SP55 T4 SP55T4 18 166819 77927028 0,5 -0,033061488 1
1 TRUE
SP55 T4 SP55T4 19 311988 43922300 0,63 0,351151931 2
1 TRUE
SP55 T4 SP55T4 19 43999634 44515514 0,698 0,811456982 3
1 TRUE
SP55 T4 SP55T4 19 44535999 58806083 0,634 0,338638104 2
1 TRUE
SP55 T4 SP55T4 20 76962 62903729 0,5 -0,058926443 1 1
TRUE
SP55 T4 SP55T4 21 9907222 48080896 0,5 -0,066373161 1
1 TRUE
SP55 T4 SP55T4 22 16287789 51137094 0,5 -0,075268009 1
1 TRUE
SP56 M SP56M 1 878314 59042001 0,5 -0,068906644 2
2 TRUE
SP56 M SP56M 1 59096479 59096693 0,656 -0,204594582 2
0 FALSE
SP56 M SP56M 1 59125683 248845458 0,5 0,079644049 2
2 TRUE
SP56 M SP56M 2 173150 61191995 0,504 0,034053995 2
2 TRUE
SP56 M SP56M 2 61235855 71351487 0,684 -0,439616103 2
0 TRUE
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SP56 M SP56M 2 71357417 242836535 0,5055 0,063831106 2
2 TRUE
SP56 M SP56M 3 367757 197762623 0,5 0,058498523 2
2 TRUE
SP56 M SP56M 4 47658 190395259 0,5 0,072516371 2 2
TRUE
SP56 M SP56M 5 140532 73091228 0,5 0,044108135 2
2 TRUE
SP56 M SP56M 5 73144845 73339114 0,688214834 -0,478963146
2 0 FALSE
SP56 M SP56M 5 73985121 180649486 0,503 0,06066904 2
2 TRUE
SP56 M SP56M 6 348051 170878886 0,5 0,046019825 2
2 TRUE
SP56 M SP56M 7 195501 80804928 0,609 0,340619785 4
2 TRUE
SP56 M SP56M 7 80805175 159053596 0,5 0,040076584 2
2 TRUE
SP56 M SP56M 8 191076 146222122 0,5 0,052178389 2
2 TRUE
SP56 M SP56M 9 304478 19120752 0,697 -0,348007949 2
0 TRUE
SP56 M SP56M 9 19619509 28889060 0,5 -1,033218966 0
0 TRUE
SP56 M SP56M 9 29825106 66457267 0,69 -0,436102039 2
0 TRUE
SP56 M SP56M 9 66457388 141069927 0,5 0,01600415 2
2 TRUE
SP56 M SP56M 10 1018585 46280866 0,685311525 -0,4923352
2 0 TRUE
SP56 M SP56M 10 46963738 47087830 0,526 -0,41634425 1
1 TRUE
SP56 M SP56M 10 47663227 51620231 0,6955 -0,336789911 2
0 TRUE
SP56 M SP56M 10 51620278 51633027 0,515 -0,38503437 1
1 TRUE
SP56 M SP56M 10 51785694 135381766 0,694 -0,450052002 2
0 TRUE
SP56 M SP56M 11 192997 134244123 0,5 0,066627307 2
2 TRUE
SP56 M SP56M 12 92252 133727843 0,5 0,030995632 2 2
TRUE
SP56 M SP56M 13 19042919 115064542 0,5 0,070359432 2
2 TRUE
SP56 M SP56M 14 19117262 107198901 0,697 -0,418581271 2
0 TRUE
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SP56 M SP56M 15 20170449 20489310 0,6455 -0,046396119 3
1 TRUE
SP56 M SP56M 15 21106528 33927764 0,503 0,106182567 2
2 TRUE
SP56 M SP56M 15 33951910 40397936 0,6945 -0,409330144 2
0 TRUE
SP56 M SP56M 15 40457431 40595627 0,5 -0,195061696 1
1 TRUE
SP56 M SP56M 15 41101124 53809958 0,69 -0,434470145 2
0 FALSE
SP56 M SP56M 15 53994493 102312835 0,5 0,016805053 2
2 TRUE
SP56 M SP56M 16 81779 15116400 0,5 -0,122950269 2 2
TRUE
SP56 M SP56M 16 15128416 28608341 0,679033208 -0,520834897
2 0 TRUE
SP56 M SP56M 16 28618037 31004812 0,512 -0,159826669 2
2 TRUE
SP56 M SP56M 16 31044683 32046359 0,6825 -0,451276868 2
0 TRUE
SP56 M SP56M 16 32190861 46391255 0,525 -0,827841218 0
0 TRUE
SP56 M SP56M 16 46392238 46408060 0,5 -3,218652453 0
0 TRUE
SP56 M SP56M 16 46408583 90161852 0,5 -0,078898699 2
2 TRUE
SP56 M SP56M 17 6115 5487164 0,505 -0,151425783 2 2
TRUE
SP56 M SP56M 17 5629700 7095090 0,678 -0,386973074 2
0 TRUE
SP56 M SP56M 17 7132192 7318935 0,519 -0,195277173 1
1 TRUE
SP56 M SP56M 17 7329632 7721231 0,640765823 -0,683335471
1 0 FALSE
SP56 M SP56M 17 7750010 22252214 0,504 -0,009575982 2
2 TRUE
SP56 M SP56M 17 22253112 22261659 0,5 -3,955413518 0
0 TRUE
SP56 M SP56M 17 25308788 81082463 0,503 -0,080727696 2
2 TRUE
SP56 M SP56M 18 120645 15270908 0,511 0,02794999 2
2 TRUE
SP56 M SP56M 18 18983766 77895192 0,5 0,069410592 2
2 TRUE
SP56 M SP56M 19 335946 3645947 0,61 0,077780852 3
1 FALSE
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SP56 M SP56M 19 3653525 6713291 0,5 -0,274053918 1
1 TRUE
SP56 M SP56M 19 6718534 12958360 0,615 0,13538136 3
1 FALSE
SP56 M SP56M 19 12963143 15014719 0,507 -0,120298849 2
2 TRUE
SP56 M SP56M 19 15027433 24015602 0,602 0,182361747 3
1 FALSE
SP56 M SP56M 19 29567134 36164108 0,5 -0,116373865 2
2 TRUE
SP56 M SP56M 19 36164436 45873942 0,592 0,177741906 3
2 FALSE
SP56 M SP56M 19 45883554 47109011 0,515 -0,22224632 1
1 TRUE
SP56 M SP56M 19 47111663 50926126 0,616449179 -0,777828606
1 0 TRUE
SP56 M SP56M 19 50962062 59082605 0,5 -0,073864345 2
2 TRUE
SP56 M SP56M 20 76962 13939805 0,6 0,360152976 4 2
TRUE
SP56 M SP56M 20 13971235 26113643 0,517 0,074348057 2
2 TRUE
SP56 M SP56M 20 29449353 37396262 0,616 0,319578465 4
2 TRUE
SP56 M SP56M 20 37524450 62737318 0,774716273 -0,010153961
4 0 FALSE
SP56 M SP56M 21 9650104 14917605 0,528 -0,13202133 2
2 TRUE
SP56 M SP56M 21 15281853 15281957 0,5 -1,311321679 0
0 TRUE
SP56 M SP56M 21 15516898 48072916 0,5 -0,029651593 2
2 TRUE
SP56 M SP56M 22 16414200 51219006 0,5 -0,059063457 2
2 TRUE
SP56 S SP56S 1 878314 1582202 0,505 -0,109310823 1 1
TRUE
SP56 S SP56S 1 1582841 1583003 0,571409542 -0,264794927 2
0 FALSE
SP56 S SP56S 1 1585597 248845458 0,5 -0,013205062 2 2
TRUE
SP56 S SP56S 2 173150 61191995 0,5 0,03177742 2 2
TRUE
SP56 S SP56S 2 61235855 71743984 0,58 -0,178682016 2 0
TRUE
SP56 S SP56S 2 71748088 242836535 0,5 0,019857889 2 2
TRUE
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SP56 S SP56S 3 367757 197762623 0,505 0,018793478 2 2
TRUE
SP56 S SP56S 4 47658 49245009 0,503 -0,057259457 2 2 TRUE
SP56 S SP56S 4 52752812 58969622 0,608 0,496785202 7 3
TRUE
SP56 S SP56S 4 62445190 190395259 0,5 0,061980674 2 2
TRUE
SP56 S SP56S 5 140532 180649486 0,5 0,01680205 2 2
TRUE
SP56 S SP56S 6 348051 32497914 0,5 0,011008468 2 2
TRUE
SP56 S SP56S 6 32498033 32522408 0,689819192 0,20169538 6
0 TRUE
SP56 S SP56S 6 32522464 170878886 0,504 0,047461982 2 2
TRUE
SP56 S SP56S 7 195501 80434918 0,561 0,15784537 4 2
TRUE
SP56 S SP56S 7 80804928 159053596 0,5 0,006370978 2 2
TRUE
SP56 S SP56S 8 191076 146222122 0,504 0,001955392 2 2
TRUE
SP56 S SP56S 9 304478 27296705 0,558 -0,25550545 1 0
FALSE
SP56 S SP56S 9 27330514 66457388 0,646 0,008386662 4 0
TRUE
SP56 S SP56S 9 66457475 141069927 0,5 -0,097830276 2 2
TRUE
SP56 S SP56S 10 1018585 38737254 0,571861072 -0,263274216 2
0 FALSE
SP56 S SP56S 10 42680864 135381766 0,579 -0,23209867 2 0
TRUE
SP56 S SP56S 11 192997 134244123 0,5 0,011031422 2 2
TRUE
SP56 S SP56S 12 92252 133727843 0,5 -0,01107203 2 2 TRUE
SP56 S SP56S 13 19042919 115064542 0,5 0,017956368 2 2
TRUE
SP56 S SP56S 14 19117262 107198901 0,5 -0,010729564 2 2
TRUE
SP56 S SP56S 15 20170449 34115088 0,587788726 -0,208579161 2
0 TRUE
SP56 S SP56S 15 34517466 102312835 0,5 -0,051013083 2 2
TRUE
SP56 S SP56S 16 81779 28608341 0,5 -0,079465845 2 2 TRUE
SP56 S SP56S 16 28618037 28618071 0,671598058 0,119342145 5
0 TRUE
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SP56 S SP56S 16 29790709 34274796 0,521 -0,129945442 2 1
FALSE
SP56 S SP56S 16 46388407 46427047 0,5 -2,667808341 0 0
TRUE
SP56 S SP56S 16 46602819 90161852 0,5 -0,054171574 2 2
TRUE
SP56 S SP56S 17 6115 22214959 0,5 -0,101359672 2 2 TRUE
SP56 S SP56S 17 22252214 22261659 0,5 -2,818521981 0 0
TRUE
SP56 S SP56S 17 25308788 81082463 0,504 -0,074759473 2 2
TRUE
SP56 S SP56S 18 120645 15270908 0,503 -0,008253365 2 2
TRUE
SP56 S SP56S 18 18983766 77895192 0,5095 0,028902501 2 2
TRUE
SP56 S SP56S 19 335946 24015602 0,551 0,007891943 3 2
FALSE
SP56 S SP56S 19 29567134 36003430 0,5 -0,151533819 1 1
TRUE
SP56 S SP56S 19 36015491 51191003 0,6 0,049126598 4 1
TRUE
SP56 S SP56S 19 51191172 59082605 0,5 -0,079778904 2 2
TRUE
SP56 S SP56S 20 76962 26113643 0,557 0,027265302 3 1
FALSE
SP56 S SP56S 20 29449353 37396262 0,592 0,036523836 4 1
TRUE
SP56 S SP56S 20 37524450 62737318 0,629350068 -0,055252446 3
0 FALSE
SP56 S SP56S 21 9650104 11181645 0,575 -0,001985504 3 1
TRUE
SP56 S SP56S 21 14433036 48072916 0,5 -0,043937336 2 2
TRUE
SP56 S SP56S 22 16414200 51219006 0,5 -0,073080743 2 2
TRUE
SP56 T1 SP56T1 1 878314 59042001 0,5 -0,051421671 2
2 TRUE
SP56 T1 SP56T1 1 59096479 59096693 0,712 -0,069136526 3
1 FALSE
SP56 T1 SP56T1 1 59125683 248845458 0,5 0,039428341 2
2 TRUE
SP56 T1 SP56T1 2 173150 61191995 0,503 0,183643649 2
2 TRUE
SP56 T1 SP56T1 2 61235855 71351487 0,764044023 -0,387090095
3 0 FALSE
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SP56 T1 SP56T1 2 71357417 242836535 0,556 0,106574932 3
2 FALSE
SP56 T1 SP56T1 3 367757 197762623 0,5 0,121381503 2
2 TRUE
SP56 T1 SP56T1 4 47658 49245009 0,5 -0,184614493 2 2
TRUE
SP56 T1 SP56T1 4 52752812 58969622 0,904 2,781614915 38
3 TRUE
SP56 T1 SP56T1 4 62445190 140640703 0,512 -0,127408644 2
2 FALSE
SP56 T1 SP56T1 4 140810637 149358014 0,6585 0,239271171 4
2 FALSE
SP56 T1 SP56T1 4 151141918 190395259 0,553 -0,135370528 2
1 FALSE
SP56 T1 SP56T1 5 140532 73091228 0,506 0,069086485 2
2 TRUE
SP56 T1 SP56T1 5 73144845 73339114 0,687833344 -0,790888825
1 0 FALSE
SP56 T1 SP56T1 5 73985121 180649486 0,5 -0,033657663 2
2 TRUE
SP56 T1 SP56T1 6 348051 32497914 0,5 -0,002005537 2
2 TRUE
SP56 T1 SP56T1 6 32498033 32521233 0,739 -0,367703928 2
0 TRUE
SP56 T1 SP56T1 6 32522397 170878886 0,506 0,025843295 2
2 TRUE
SP56 T1 SP56T1 7 195501 80805263 0,623 0,377827749 4
2 TRUE
SP56 T1 SP56T1 7 80805381 159053596 0,5 0,005220108 2
2 TRUE
SP56 T1 SP56T1 8 191076 146222122 0,5 -0,008884666 2
2 TRUE
SP56 T1 SP56T1 9 304478 19087154 0,742154623 -0,515078558
2 0 TRUE
SP56 T1 SP56T1 9 19119737 28889060 0,509 -1,397341848 0
0 TRUE
SP56 T1 SP56T1 9 29825106 44175535 0,843014671 0,200797884
5 0 TRUE
SP56 T1 SP56T1 9 45372291 69002200 0,601 0,001306755 3
2 FALSE
SP56 T1 SP56T1 9 69002538 135930735 0,764 -0,398923039 3
0 FALSE
SP56 T1 SP56T1 9 135937248 135962585 0,516 -0,487826261 1
1 TRUE
SP56 T1 SP56T1 9 135974100 141069927 0,745 -0,43579703 2
0 FALSE
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SP56 T1 SP56T1 10 1018585 46147545 0,72681921 -0,598428419
2 0 TRUE
SP56 T1 SP56T1 10 46148266 47087830 0,509 -0,535982569 1
1 TRUE
SP56 T1 SP56T1 10 47663227 51592744 0,747 -0,486204291 2
0 TRUE
SP56 T1 SP56T1 10 51620231 51633027 0,525 -0,361826628 1
1 FALSE
SP56 T1 SP56T1 10 51785694 135381766 0,736709649 -0,545227031
2 0 TRUE
SP56 T1 SP56T1 11 192997 134244123 0,504 -0,016189662 2
2 TRUE
SP56 T1 SP56T1 12 92252 133727843 0,505 0,069842926 2 2
TRUE
SP56 T1 SP56T1 13 19042919 115064542 0,5 -0,004036919 2
2 TRUE
SP56 T1 SP56T1 14 19117262 107198901 0,5 -0,004051697 2
2 TRUE
SP56 T1 SP56T1 15 20170449 22383189 0,588 -0,283208635 2
1 TRUE
SP56 T1 SP56T1 15 22466002 38857631 0,736496008 -0,546397199
2 0 TRUE
SP56 T1 SP56T1 15 40030440 102312835 0,5 -0,034607368 2
2 TRUE
SP56 T1 SP56T1 16 81779 34274796 0,5 0,014913975 2 2
TRUE
SP56 T1 SP56T1 16 46388407 46394424 0,5 -3,063275624 0
0 TRUE
SP56 T1 SP56T1 16 46394533 46408060 0,5 -3,137730647 0
0 TRUE
SP56 T1 SP56T1 16 46408583 46427047 0,5 -3,099348895 0
0 TRUE
SP56 T1 SP56T1 16 46602819 90161852 0,5 0,031910166 2
2 TRUE
SP56 T1 SP56T1 17 6115 5487164 0,5 -0,125437706 2 2
TRUE
SP56 T1 SP56T1 17 5629700 6546259 0,714586056 -0,661628202
2 0 TRUE
SP56 T1 SP56T1 17 6553583 6561192 0,533 -0,012390655 2
2 TRUE
SP56 T1 SP56T1 17 6562141 7132192 0,735899874 -0,54965737
2 0 TRUE
SP56 T1 SP56T1 17 7133609 7318935 0,5 0,017994837 2
2 TRUE
SP56 T1 SP56T1 17 7329632 7721231 0,704129567 -0,713537914
2 0 TRUE
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SP56 T1 SP56T1 17 7750010 22252214 0,502 -0,048725682 2
2 TRUE
SP56 T1 SP56T1 17 22253112 22253231 0,998864912 -4,105997203
1000 0 TRUE
SP56 T1 SP56T1 17 25308788 34813271 0,512 -0,030621035 2
2 TRUE
SP56 T1 SP56T1 17 34842521 37009072 0,648 -0,501198888 2
1 FALSE
SP56 T1 SP56T1 17 37075042 81082463 0,506 -0,06415496 2
2 TRUE
SP56 T1 SP56T1 18 120645 15270908 0,505 -0,051689838 2
2 TRUE
SP56 T1 SP56T1 18 18983766 77895192 0,5 0,010109658 2
2 TRUE
SP56 T1 SP56T1 19 335946 3452683 0,649 0,261536512 4
2 FALSE
SP56 T1 SP56T1 19 3527110 6679511 0,5 -0,096633425 2
2 TRUE
SP56 T1 SP56T1 19 6679563 12985576 0,647 0,33389991 4
2 FALSE
SP56 T1 SP56T1 19 13220703 15014719 0,5 0,004515854 2
2 TRUE
SP56 T1 SP56T1 19 15027433 30314459 0,633 0,333016998 4
2 FALSE
SP56 T1 SP56T1 19 31038995 36045772 0,5 -0,112586868 2
2 TRUE
SP56 T1 SP56T1 19 36142296 40901011 0,716 0,719554716 7
2 TRUE
SP56 T1 SP56T1 19 40904602 41387907 0,655 0,526807042 5
2 TRUE
SP56 T1 SP56T1 19 41397370 41532133 0,748 0,807652305 7
2 FALSE
SP56 T1 SP56T1 19 41533112 44012880 0,663 0,536273196 5
2 TRUE
SP56 T1 SP56T1 19 44047550 46142053 0,72 0,800493823 7
2 TRUE
SP56 T1 SP56T1 19 46216642 47028898 0,509 -0,147459075 2
2 TRUE
SP56 T1 SP56T1 19 47109011 50926126 0,701773953 -0,72497865
2 0 TRUE
SP56 T1 SP56T1 19 50962062 59082605 0,5 -0,087112231 2
2 TRUE
SP56 T1 SP56T1 20 76962 14066276 0,817 -0,002506505 4 0
TRUE
SP56 T1 SP56T1 20 14306953 29625720 0,7375 -0,503455064 2
0 TRUE
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SP56 T1 SP56T1 20 29625788 29652000 0,518 -0,000522438 2
2 TRUE
SP56 T1 SP56T1 20 29873577 62737318 0,816037214 -0,027986329
4 0 TRUE
SP56 T1 SP56T1 21 9650104 11181645 0,614 -0,172139528 2
1 TRUE
SP56 T1 SP56T1 21 14433036 48072916 0,5 -0,063814308 2
2 TRUE
SP56 T1 SP56T1 22 16414200 51219006 0,5 -0,064062728 2
2 TRUE
SP56 T2 SP56T2 1 878314 59042001 0,5 0,006042429 2
2 TRUE
SP56 T2 SP56T2 1 59096479 59096693 0,574185241 -0,056202373
3 0 TRUE
SP56 T2 SP56T2 1 59125683 248845458 0,5 0,026453954 2
2 TRUE
SP56 T2 SP56T2 2 173150 242836535 0,5 0,024021096 2
2 TRUE
SP56 T2 SP56T2 3 367757 197762623 0,5 0,037571872 2
2 TRUE
SP56 T2 SP56T2 4 47658 190395259 0,5 0,033707541 2 2
TRUE
SP56 T2 SP56T2 5 140532 180649486 0,5 0,008579241 2
2 TRUE
SP56 T2 SP56T2 6 348051 32498033 0,5 0,028981362 2
2 TRUE
SP56 T2 SP56T2 6 32521022 32521179 0,619079548 0,104533831
6 0 TRUE
SP56 T2 SP56T2 6 32521230 170878886 0,503 0,015328094 2
2 TRUE
SP56 T2 SP56T2 7 195501 57642490 0,545 0,139078472 4
2 TRUE
SP56 T2 SP56T2 7 62669789 76916010 0,5695 0,053377805 4
1 TRUE
SP56 T2 SP56T2 7 76916046 159053596 0,5 0,017340946 2
2 TRUE
SP56 T2 SP56T2 8 191076 146222122 0,5 0,022293244 2
2 TRUE
SP56 T2 SP56T2 9 304478 29825925 0,505 -0,147393137 1
1 TRUE
SP56 T2 SP56T2 9 31254567 69777408 0,611585231 0,076425524
5 0 TRUE
SP56 T2 SP56T2 9 69846339 140638416 0,521 -0,06335198 2
1 TRUE
SP56 T2 SP56T2 9 140648742 141069927 0,531 -0,068843023 2
1 TRUE
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SP56 T2 SP56T2 10 1018585 135381766 0,54 -0,120610134 2
0 FALSE
SP56 T2 SP56T2 11 192997 134244123 0,5 0,046231497 2
2 TRUE
SP56 T2 SP56T2 12 92252 133727843 0,5 0,015633923 2 2
TRUE
SP56 T2 SP56T2 13 19042919 115064542 0,502 0,012230628 2
2 TRUE
SP56 T2 SP56T2 14 19117262 107198901 0,5 0,043653321 2
2 TRUE
SP56 T2 SP56T2 15 20170449 20446256 0,581885042 -0,029876074
4 0 TRUE
SP56 T2 SP56T2 15 20447987 102312835 0,5 -0,007797829 2
2 TRUE
SP56 T2 SP56T2 16 81779 34274796 0,5 -0,01768108 2 2
TRUE
SP56 T2 SP56T2 16 46388407 46405410 0,5 -3,255172873 0
0 TRUE
SP56 T2 SP56T2 16 46405874 46406598 0,991149399 -4,223973733
1000 0 TRUE
SP56 T2 SP56T2 16 46407745 90161852 0,5 -0,055669213 2
2 TRUE
SP56 T2 SP56T2 17 6115 22214959 0,5 -0,037516669 2 2
TRUE
SP56 T2 SP56T2 17 22252214 22253128 0,991149399 -3,597716328
1000 0 TRUE
SP56 T2 SP56T2 17 22253134 22261659 0,5 -3,427599568 0
0 TRUE
SP56 T2 SP56T2 17 25308788 81082463 0,503 -0,013665231 2
2 TRUE
SP56 T2 SP56T2 18 120645 15270908 0,507 -0,053132353 2
2 TRUE
SP56 T2 SP56T2 18 18983766 77895192 0,504 0,009021151 2
2 TRUE
SP56 T2 SP56T2 19 335946 36044524 0,5 0,017050017 2
2 TRUE
SP56 T2 SP56T2 19 36045772 50662529 0,5765 0,070178493 5
1 TRUE
SP56 T2 SP56T2 19 50662726 59082605 0,5 -0,042838869 2
2 TRUE
SP56 T2 SP56T2 20 76962 13912309 0,592 0,060041297 4 0
TRUE
SP56 T2 SP56T2 20 13939805 26113643 0,512 -0,070910548 1
1 FALSE
SP56 T2 SP56T2 20 29449353 62737318 0,6055 0,087683774 5
0 TRUE
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SP56 T2 SP56T2 21 9650104 11181645 0,541961639 -0,161444847
2 0 TRUE
SP56 T2 SP56T2 21 14433036 48072916 0,5 0,004427208 2
2 TRUE
SP56 T2 SP56T2 22 16414200 51219006 0,5 0,002745821 2
2 TRUE
SP56 T3 SP56T3 1 878314 59042001 0,5 -0,097883576 2
2 TRUE
SP56 T3 SP56T3 1 59096479 59096693 0,694 -0,011764672 3
0 TRUE
SP56 T3 SP56T3 1 59125683 248845458 0,5 0,038502276 2
2 TRUE
SP56 T3 SP56T3 2 173150 61191995 0,5 0,149958573 2
2 TRUE
SP56 T3 SP56T3 2 61235855 71357417 0,679 -0,2602233 2
0 FALSE
SP56 T3 SP56T3 2 71360282 242836535 0,5 0,097625253 2
2 TRUE
SP56 T3 SP56T3 3 367757 197762623 0,505 0,102385759 2
2 TRUE
SP56 T3 SP56T3 4 47658 49245009 0,5 -0,106760163 2 2
TRUE
SP56 T3 SP56T3 4 52752812 58969622 0,904 2,337125696 37
2 TRUE
SP56 T3 SP56T3 4 62445190 190395259 0,5 -0,028727871 2
2 TRUE
SP56 T3 SP56T3 5 140532 43609343 0,504 0,07383469 2
2 TRUE
SP56 T3 SP56T3 5 49929151 150322270 0,5 0,053917236 2
2 TRUE
SP56 T3 SP56T3 5 150400587 150407783 0,5 -1,073619707 0
0 TRUE
SP56 T3 SP56T3 5 150409477 180649486 0,5 -0,066087759 2
2 TRUE
SP56 T3 SP56T3 6 348051 170878886 0,5 0,004326134 2
2 TRUE
SP56 T3 SP56T3 7 195501 80805518 0,596 0,262958369 4
2 TRUE
SP56 T3 SP56T3 7 81372156 159053596 0,503 -0,027696524 2
2 TRUE
SP56 T3 SP56T3 8 191076 146222122 0,5 -0,008165142 2
2 TRUE
SP56 T3 SP56T3 9 304478 19705432 0,649 -0,364134525 2
0 TRUE
SP56 T3 SP56T3 9 20620575 28889060 0,514 -0,769680372 0
0 FALSE
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SP56 T3 SP56T3 9 29825106 45372357 0,760858019 0,137119414
5 0 TRUE
SP56 T3 SP56T3 9 65973265 69002538 0,509 0,147888735 2
2 TRUE
SP56 T3 SP56T3 9 69120693 141069927 0,680319927 -0,281641991
3 0 FALSE
SP56 T3 SP56T3 10 1018585 46224381 0,64502211 -0,432742344
2 0 TRUE
SP56 T3 SP56T3 10 46280866 47087830 0,519 -0,418833786 1
1 TRUE
SP56 T3 SP56T3 10 47663227 135381766 0,652 -0,392826362 2
0 TRUE
SP56 T3 SP56T3 11 192997 134244123 0,5 -0,002497294 2
2 TRUE
SP56 T3 SP56T3 12 92252 133727843 0,509 0,06179708 2 2
TRUE
SP56 T3 SP56T3 13 19042919 115064542 0,5 0,015298517 2
2 TRUE
SP56 T3 SP56T3 14 19117262 107198901 0,508 0,006475367 2
2 TRUE
SP56 T3 SP56T3 15 20170449 22383189 0,506 -0,312216975 1
1 TRUE
SP56 T3 SP56T3 15 22466002 38857631 0,65287657 -0,40046192
2 0 TRUE
SP56 T3 SP56T3 15 40030440 102312835 0,5 -0,021316859 2
2 TRUE
SP56 T3 SP56T3 16 81779 34274796 0,5 -0,045717151 2 2
TRUE
SP56 T3 SP56T3 16 46388407 46408060 0,5 -4,340230915 0
0 TRUE
SP56 T3 SP56T3 16 46408583 90161852 0,5 -0,01758899 2
2 TRUE
SP56 T3 SP56T3 17 6115 5485367 0,506 -0,17953903 2 2
TRUE
SP56 T3 SP56T3 17 5487164 7132192 0,652 -0,308424742 2
0 TRUE
SP56 T3 SP56T3 17 7133609 22066914 0,5 -0,083832072 2
2 TRUE
SP56 T3 SP56T3 17 22214959 22253121 0,5 -3,762807151 0
0 TRUE
SP56 T3 SP56T3 17 22253128 81082463 0,5 -0,121608392 2
2 TRUE
SP56 T3 SP56T3 18 120645 77895192 0,505 -0,004242314 2
2 TRUE
SP56 T3 SP56T3 19 335946 3534696 0,628 0,154427144 4
1 FALSE
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SP56 T3 SP56T3 19 3538654 6896344 0,506 -0,175941289 2
2 TRUE
SP56 T3 SP56T3 19 7129086 8321182 0,619 0,10109525 3
1 TRUE
SP56 T3 SP56T3 19 8321937 8326999 0,767785767 0,179530425
5 0 TRUE
SP56 T3 SP56T3 19 8402599 12975608 0,615 0,199668343 4
2 FALSE
SP56 T3 SP56T3 19 12985576 14992042 0,508 -0,073317959 2
2 TRUE
SP56 T3 SP56T3 19 14997907 24015602 0,613 0,184218423 4
2 FALSE
SP56 T3 SP56T3 19 29567134 30156601 0,6725 0,495085205 6
2 TRUE
SP56 T3 SP56T3 19 30156797 36045772 0,5 -0,183709793 2
2 TRUE
SP56 T3 SP56T3 19 36142296 40929363 0,686 0,492840559 6
2 FALSE
SP56 T3 SP56T3 19 40947448 44047550 0,6455 0,357843201 5
2 TRUE
SP56 T3 SP56T3 19 44049881 45924692 0,696 0,535289758 6
1 FALSE
SP56 T3 SP56T3 19 46057081 47137459 0,513 -0,205838004 1
1 TRUE
SP56 T3 SP56T3 19 47137972 50779151 0,591341052 -0,635910499
1 0 TRUE
SP56 T3 SP56T3 19 50863275 59082605 0,504 -0,169276834 2
2 TRUE
SP56 T3 SP56T3 20 76962 13912309 0,739 0,01459706 4 0
TRUE
SP56 T3 SP56T3 20 13939805 29625720 0,643 -0,354752186 2
0 TRUE
SP56 T3 SP56T3 20 29625788 29652000 0,509 0,170367398 3
3 TRUE
SP56 T3 SP56T3 20 29873577 62737318 0,725245044 -0,06315868
4 0 FALSE
SP56 T3 SP56T3 21 9650104 48072916 0,5 -0,050435417 2
2 TRUE
SP56 T3 SP56T3 22 16414200 51219006 0,5 -0,095393832 2
2 TRUE
SP56 T4 SP56T4 1 878314 59042001 0,5 0,012010435 2
2 TRUE
SP56 T4 SP56T4 1 59096479 59096689 0,686 0,192412207 3
1 TRUE
SP56 T4 SP56T4 1 59096693 248845458 0,5 0,032359123 2
2 TRUE
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SP56 T4 SP56T4 2 173150 61191995 0,556 0,022977083 2
1 FALSE
SP56 T4 SP56T4 2 61235855 71351487 0,81 -0,485503587 2
0 TRUE
SP56 T4 SP56T4 2 71357417 242836535 0,5 0,157877008 2
2 TRUE
SP56 T4 SP56T4 3 367757 197762623 0,5 0,156948149 2
2 TRUE
SP56 T4 SP56T4 4 47658 49245009 0,541 -0,037340624 2 2
FALSE
SP56 T4 SP56T4 4 52752812 139482765 0,5 0,057909801 2
2 TRUE
SP56 T4 SP56T4 4 140616462 144940333 0,7765 1,341076981 9
2 TRUE
SP56 T4 SP56T4 4 145020647 146016997 0,529 0,044690085 2
2 TRUE
SP56 T4 SP56T4 4 146048554 149358014 0,7855 1,225788418 9
2 TRUE
SP56 T4 SP56T4 4 151141918 190395259 0,571 0,232398509 3
2 TRUE
SP56 T4 SP56T4 5 140532 43609343 0,5 -0,105090706 2
2 TRUE
SP56 T4 SP56T4 5 49929151 73091228 0,566 -0,292385118 1
1 FALSE
SP56 T4 SP56T4 5 73144845 73207372 0,759646987 -0,938758123
1 0 TRUE
SP56 T4 SP56T4 5 73339114 180649486 0,598 -0,146174721 2
1 FALSE
SP56 T4 SP56T4 6 348051 170878886 0,5 0,035770274 2
2 TRUE
SP56 T4 SP56T4 7 195501 80805518 0,649 0,482208445 4
2 FALSE
SP56 T4 SP56T4 7 81372156 159053596 0,5 0,027601695 2
2 TRUE
SP56 T4 SP56T4 8 191076 42865753 0,5 0,019906548 2
2 TRUE
SP56 T4 SP56T4 8 43172409 46849355 0,679795529 -1,352596687
1 0 TRUE
SP56 T4 SP56T4 8 48033794 146222122 0,5 0,010237947 2
2 TRUE
SP56 T4 SP56T4 9 304478 19120752 0,8035 -0,617789489 2
0 TRUE
SP56 T4 SP56T4 9 19619509 28889060 0,5 -1,975793707 0
0 TRUE
SP56 T4 SP56T4 9 29825106 44175535 0,8885 0,186212907 4
0 TRUE
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SP56 T4 SP56T4 9 45372291 69002538 0,636 0,071138766 3
1 FALSE
SP56 T4 SP56T4 9 69120693 135930735 0,816 -0,511669423 2
0 FALSE
SP56 T4 SP56T4 9 135937248 135962585 0,516 -0,051171086 2
2 TRUE
SP56 T4 SP56T4 9 135974100 141069927 0,815 -0,516510955 2
0 TRUE
SP56 T4 SP56T4 10 1018585 46280866 0,816 -0,563241202 2
0 FALSE
SP56 T4 SP56T4 10 46963738 47087830 0,505 -0,419860669 1
1 TRUE
SP56 T4 SP56T4 10 47663227 51620317 0,814 -0,47853921 2
0 TRUE
SP56 T4 SP56T4 10 51620499 51633027 0,522 -0,902109307 1
1 TRUE
SP56 T4 SP56T4 10 51785694 135381766 0,817870903 -0,538564661
2 0 FALSE
SP56 T4 SP56T4 11 192997 102398729 0,5 -0,119958337 2
2 TRUE
SP56 T4 SP56T4 11 102464451 134244123 0,567 0,4370437 3
2 FALSE
SP56 T4 SP56T4 12 92252 133727843 0,505 0,13522794 2 2
TRUE
SP56 T4 SP56T4 13 19042919 115064542 0,5 -0,077342875 2
2 TRUE
SP56 T4 SP56T4 14 19117262 23389796 0,502 0,031340034 2
2 TRUE
SP56 T4 SP56T4 14 23394007 23467664 0,721 -0,431545587 2
0 TRUE
SP56 T4 SP56T4 14 23504021 107198901 0,5 0,020739917 2
2 TRUE
SP56 T4 SP56T4 15 20170449 22383189 0,5815 -0,600777928 2
1 TRUE
SP56 T4 SP56T4 15 22466002 38857631 0,744 -0,966717225 1
0 FALSE
SP56 T4 SP56T4 15 40030440 102312835 0,583 -0,147730079 2
1 FALSE
SP56 T4 SP56T4 16 81779 34274796 0,5 0,008071807 2 2
TRUE
SP56 T4 SP56T4 16 46388407 46393052 0,5 -3,361406354 0
0 TRUE
SP56 T4 SP56T4 16 46393218 46394221 0,999351491 -4,370109042
1000 0 TRUE
SP56 T4 SP56T4 16 46394410 46405874 0,5 -4,120399881 0
0 TRUE
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SP56 T4 SP56T4 16 46406219 46408610 0,5 -4,164324378 0
0 TRUE
SP56 T4 SP56T4 16 46427047 90161852 0,5 -0,015552545 2
2 TRUE
SP56 T4 SP56T4 17 6115 5487164 0,514 -0,033615801 2 2
FALSE
SP56 T4 SP56T4 17 5629700 6546259 0,756 -0,780040335 1
0 FALSE
SP56 T4 SP56T4 17 6553583 6560977 0,511 0,071914935 2
2 TRUE
SP56 T4 SP56T4 17 6561192 7132192 0,72 -0,467786574 2
0 TRUE
SP56 T4 SP56T4 17 7133609 7318935 0,511 -0,04144656 2
2 TRUE
SP56 T4 SP56T4 17 7329632 7721231 0,772853349 -0,857227271
2 0 TRUE
SP56 T4 SP56T4 17 7750010 22252214 0,504 -0,0395951 2
2 TRUE
SP56 T4 SP56T4 17 22253112 22261659 0,5 -3,696815315 0
0 TRUE
SP56 T4 SP56T4 17 25308788 81082463 0,5 -0,038436975 2
2 TRUE
SP56 T4 SP56T4 18 120645 15270908 0,589 -0,240918821 2
1 FALSE
SP56 T4 SP56T4 18 18983766 77895192 0,515 0,056361561 2
2 FALSE
SP56 T4 SP56T4 19 335946 3645947 0,645 0,492385515 4
2 TRUE
SP56 T4 SP56T4 19 3653525 6478925 0,505 0,106092456 2
2 TRUE
SP56 T4 SP56T4 19 6677989 12985576 0,656 0,54081831 4
2 FALSE
SP56 T4 SP56T4 19 13220703 14997907 0,5 0,137826043 2
2 TRUE
SP56 T4 SP56T4 19 15014719 30314459 0,6545 0,541491604 4
2 FALSE
SP56 T4 SP56T4 19 31038995 36038390 0,506 0,029720757 2
2 TRUE
SP56 T4 SP56T4 19 36044524 40327312 0,729 0,920022514 6
2 FALSE
SP56 T4 SP56T4 19 40328327 44047550 0,681 0,727002906 5
2 TRUE
SP56 T4 SP56T4 19 44049881 46142053 0,726 0,885082975 6
2 FALSE
SP56 T4 SP56T4 19 46216642 47028898 0,504 0,04857534 2
2 TRUE
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SP56 T4 SP56T4 19 47109011 50863275 0,798583594 -0,683784435
2 0 TRUE
SP56 T4 SP56T4 19 50926126 59082605 0,5 0,00223831 2
2 TRUE
SP56 T4 SP56T4 20 76962 14066276 0,88 0,181930654 4 0
TRUE
SP56 T4 SP56T4 20 14306953 29625701 0,8155 -0,423564238 2
0 TRUE
SP56 T4 SP56T4 20 29625716 29633986 0,507 0,371026426 3
3 TRUE
SP56 T4 SP56T4 20 29652000 62737318 0,8875 0,180741333 4
0 TRUE
SP56 T4 SP56T4 21 9650104 10807898 0,76 -0,183092248 3
1 TRUE
SP56 T4 SP56T4 21 10825608 14917605 0,523 -0,201486714 2
2 TRUE
SP56 T4 SP56T4 21 15281853 15516898 0,7305 -0,536803328 2
0 TRUE
SP56 T4 SP56T4 21 15516948 48072916 0,5 -0,180808195 2
2 TRUE
SP56 T4 SP56T4 22 16414200 51219006 0,5 0,038857687 2
2 TRUE
SP57 M SP57M 1 900298 249212725 0,5 -0,006602941 1
1 TRUE
SP57 M SP57M 2 173150 242946289 0,505 -0,004135949 1
1 TRUE
SP57 M SP57M 3 403690 197762623 0,5 0,011521216 1
1 TRUE
SP57 M SP57M 4 60400 190904031 0,507 0,013605923 1 1
TRUE
SP57 M SP57M 5 163266 180687212 0,502 -0,005571713 1
1 TRUE
SP57 M SP57M 6 203878 170892848 0,5 0,02141131 1
1 TRUE
SP57 M SP57M 7 286534 100608573 0,5 -0,001332391 1
1 TRUE
SP57 M SP57M 7 100615449 100615533 0,697 -0,274980582 1
0 FALSE
SP57 M SP57M 7 100624718 159025494 0,5 -0,00145041 1
1 TRUE
SP57 M SP57M 8 250564 146115367 0,501 -0,001831409 1
1 TRUE
SP57 M SP57M 9 117713 45372357 0,5 -0,009196665 1
1 TRUE
SP57 M SP57M 9 65617649 65973595 0,726 -0,16778481 1
0 FALSE
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SP57 M SP57M 9 66455566 141069978 0,5 -0,005136135 1
1 TRUE
SP57 M SP57M 10 412449 135183608 0,5 -0,0188709 1
1 TRUE
SP57 M SP57M 11 193112 134856661 0,5 0,010000322 1
1 TRUE
SP57 M SP57M 12 247900 133303973 0,5 -0,015100017 1
1 TRUE
SP57 M SP57M 12 133304146 133304174 0,75 0,078456479 2
1 TRUE
SP57 M SP57M 12 133304891 133463969 0,508 -0,13170389 1
1 TRUE
SP57 M SP57M 13 19059494 115064685 0,505 0,008947972 1
1 TRUE
SP57 M SP57M 14 19118067 107183367 0,504 0,000564235 1
1 TRUE
SP57 M SP57M 15 20170150 22148395 0,6 -0,005792966 1
1 FALSE
SP57 M SP57M 15 22319166 102004231 0,5 -0,005068471 1
1 TRUE
SP57 M SP57M 16 240280 90162340 0,5 -0,049366925 1
1 TRUE
SP57 M SP57M 17 6115 81082365 0,504 -0,033324813 1 1
TRUE
SP57 M SP57M 18 348161 77895192 0,5 0,011374211 1
1 TRUE
SP57 M SP57M 19 335946 59074653 0,5 -0,065305478 1
1 TRUE
SP57 M SP57M 20 138125 62899394 0,5 -0,004365777 1
1 TRUE
SP57 M SP57M 21 9891930 10807706 0,6835 0,271468628 2
1 TRUE
SP57 M SP57M 21 10825620 48083526 0,5 -0,011921535 1
1 TRUE
SP57 M SP57M 22 16255826 51182485 0,5 -0,043910346 1
1 TRUE
SP57 S SP57S 1 900298 121124514 0,5 -0,033417626 1 1
TRUE
SP57 S SP57S 1 142620901 144854497 0,653 0,344373424 2 1
TRUE
SP57 S SP57S 1 144854597 249212725 0,5 0,004695721 1 1
TRUE
SP57 S SP57S 2 173150 242946289 0,5 -0,002307533 1 1
TRUE
SP57 S SP57S 3 403690 197762623 0,5 0,00852788 1 1
TRUE
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SP57 S SP57S 4 60400 190904031 0,5 0,018808531 1 1 TRUE
SP57 S SP57S 5 163266 180687212 0,5 -0,005663628 1 1
TRUE
SP57 S SP57S 6 203878 32975869 0,51 0,009228945 1 1
FALSE
SP57 S SP57S 6 33022307 33022368 0,733 0,083444251 2 1
FALSE
SP57 S SP57S 6 33047432 170892848 0,503 0,015193598 1 1
TRUE
SP57 S SP57S 7 286534 5167408 0,5 -0,119371136 1 1
TRUE
SP57 S SP57S 7 5172208 5172295 0,833 -0,777646358 1 0
TRUE
SP57 S SP57S 7 5239139 100608573 0,5 0,031467974 1 1
TRUE
SP57 S SP57S 7 100615449 100615533 0,7 0,032676385 2 1
FALSE
SP57 S SP57S 7 100624718 159025494 0,5 0,015173959 1 1
TRUE
SP57 S SP57S 8 250564 146115367 0,5 -0,007176935 1 1
TRUE
SP57 S SP57S 9 117713 45372357 0,5 -0,012983404 1 1
TRUE
SP57 S SP57S 9 65617649 70731810 0,61 -0,014520267 1 1
FALSE
SP57 S SP57S 9 71224796 141069978 0,5 0,003600114 1 1
TRUE
SP57 S SP57S 10 412449 135183608 0,503 -0,048530691 1 1
TRUE
SP57 S SP57S 11 193112 18267135 0,5065 0,024076427 1 1
TRUE
SP57 S SP57S 11 18267353 18267373 0,828 0,040179809 2 1
TRUE
SP57 S SP57S 11 18267431 134856661 0,504 0,004687684 1 1
TRUE
SP57 S SP57S 12 247900 133463969 0,5 -0,031725055 1 1
TRUE
SP57 S SP57S 13 19059494 19960034 0,515 -0,092810986 1 1
TRUE
SP57 S SP57S 13 19962045 20625876 0,714 -0,500346406 1 0
FALSE
SP57 S SP57S 13 21535586 115064685 0,508 0,011468901 1 1
TRUE
SP57 S SP57S 14 19118067 107183367 0,5 -0,008099383 1 1
TRUE
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SP57 S SP57S 15 20170150 20874667 0,5955 -0,12643898 1 1
FALSE
SP57 S SP57S 15 20874676 102004231 0,5 -0,01208655 1 1
TRUE
SP57 S SP57S 16 240280 90162340 0,503 -0,070627831 1 1
TRUE
SP57 S SP57S 17 6115 81082365 0,5 -0,057563814 1 1 TRUE
SP57 S SP57S 18 348161 77895192 0,5 0,012348781 1 1
TRUE
SP57 S SP57S 19 335946 59074653 0,5 -0,134568931 1 1
TRUE
SP57 S SP57S 20 138125 62899394 0,506 0,006765468 1 1
TRUE
SP57 S SP57S 21 9891930 48083526 0,5 -0,054584649 1 1
TRUE
SP57 S SP57S 22 16255826 51182485 0,5 -0,091581101 1 1
TRUE
SP57 T1 SP57T1 1 900298 249212725 0,5 -0,020001498 1
1 TRUE
SP57 T1 SP57T1 2 173150 242946289 0,5 -0,030387477 1
1 TRUE
SP57 T1 SP57T1 3 403690 197762623 0,5 -0,008359566 1
1 TRUE
SP57 T1 SP57T1 4 60400 190904031 0,5 -0,0052765 1 1
TRUE
SP57 T1 SP57T1 5 163266 180687212 0,5 -0,031328723 1
1 TRUE
SP57 T1 SP57T1 6 203878 57472533 0,5045 -0,005835225 1
1 TRUE
SP57 T1 SP57T1 6 62687960 170892848 0,502 -0,012637114 1
1 TRUE
SP57 T1 SP57T1 7 286534 100608573 0,5 0,153058194 2
2 TRUE
SP57 T1 SP57T1 7 100615449 100615533 0,559156504 -0,235456019
1 0 TRUE
SP57 T1 SP57T1 7 100624718 159025494 0,545 0,13024891 2
1 TRUE
SP57 T1 SP57T1 8 250564 146115367 0,5 -0,022393489 1
1 TRUE
SP57 T1 SP57T1 9 117713 45372357 0,577 -0,061444841 1
0 TRUE
SP57 T1 SP57T1 9 65617649 65973595 0,565536919 -0,21442303
1 0 TRUE
SP57 T1 SP57T1 9 66455566 141069978 0,504 -0,015910647 1
1 TRUE
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SP57 T1 SP57T1 10 412449 135183608 0,569 -0,2035027 1
0 TRUE
SP57 T1 SP57T1 11 193112 51459199 0,504 -0,001381129 1
1 TRUE
SP57 T1 SP57T1 11 55234785 134856661 0,5 -0,016279769 1
1 TRUE
SP57 T1 SP57T1 12 247900 133463969 0,5 -0,033454438 1
1 TRUE
SP57 T1 SP57T1 13 19059494 115064685 0,5 -0,026667167 1
1 TRUE
SP57 T1 SP57T1 14 19118067 107183367 0,502 -0,034308317 1
1 TRUE
SP57 T1 SP57T1 15 20170150 102004231 0,506 -0,026204441 1
1 TRUE
SP57 T1 SP57T1 16 240280 90162340 0,5 -0,04344366 1
1 TRUE
SP57 T1 SP57T1 17 6115 81082365 0,503 -0,041141893 1 1
TRUE
SP57 T1 SP57T1 18 348161 77895192 0,5 -0,016617552 1
1 TRUE
SP57 T1 SP57T1 19 335946 59074653 0,5 -0,069095416 1
1 TRUE
SP57 T1 SP57T1 20 138125 62899394 0,553 0,137358998 2
1 TRUE
SP57 T1 SP57T1 21 9891930 9912194 0,588618078 -0,135667838
1 0 FALSE
SP57 T1 SP57T1 21 10793702 48083526 0,5 -0,036009183 1
1 TRUE
SP57 T1 SP57T1 22 16255826 51182485 0,563243975 -0,222017046
1 0 TRUE
SP57 T2 SP57T2 1 900298 249212725 0,504 0,00758797 1
1 TRUE
SP57 T2 SP57T2 2 173150 233537125 0,5 0,009660613 1
1 TRUE
SP57 T2 SP57T2 2 233594875 234433081 0,657209544 -0,441043556
1 0 TRUE
SP57 T2 SP57T2 2 234457900 242946289 0,505 -0,033531248 1
1 TRUE
SP57 T2 SP57T2 3 403690 197762623 0,5 0,00314352 1
1 TRUE
SP57 T2 SP57T2 4 60400 190904031 0,5 0,010341184 1 1
TRUE
SP57 T2 SP57T2 5 163266 180687212 0,5 0,007019969 1
1 TRUE
SP57 T2 SP57T2 6 203878 168325673 0,503 0,025987159 1
1 TRUE
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SP57 T2 SP57T2 6 168347291 169617840 0,651 -0,295615239 1
0 TRUE
SP57 T2 SP57T2 6 169619687 170892848 0,514 -0,040278044 1
1 TRUE
SP57 T2 SP57T2 7 286534 159025494 0,6 0,30696016 2
1 TRUE
SP57 T2 SP57T2 8 250564 146115367 0,5 -0,007217622 1
1 TRUE
SP57 T2 SP57T2 9 117713 34500821 0,667 -0,065753874 1
0 TRUE
SP57 T2 SP57T2 9 34723744 45372357 0,507 0,026625614 1
1 TRUE
SP57 T2 SP57T2 9 65617649 68728799 0,677 -0,125953116 1
0 TRUE
SP57 T2 SP57T2 9 68779054 141069978 0,5 -0,016968557 1
1 TRUE
SP57 T2 SP57T2 10 412449 135183608 0,660871754 -0,425547565
1 0 TRUE
SP57 T2 SP57T2 11 193112 134856661 0,5 0,008367785 1
1 TRUE
SP57 T2 SP57T2 12 247900 133463969 0,5 -0,001597439 1
1 TRUE
SP57 T2 SP57T2 13 19059494 115064685 0,5 0,00191635 1
1 TRUE
SP57 T2 SP57T2 14 19118067 107183367 0,5 0,00231635 1
1 TRUE
SP57 T2 SP57T2 15 20170150 22148395 0,598 -0,008557599 1
0 FALSE
SP57 T2 SP57T2 15 22319166 102004231 0,5 -0,045877866 1
1 TRUE
SP57 T2 SP57T2 16 240280 90162340 0,5 -0,040583247 1
1 TRUE
SP57 T2 SP57T2 17 6115 81082365 0,5 -0,013017528 1 1
TRUE
SP57 T2 SP57T2 18 348161 77895192 0,5 0,040253986 1
1 TRUE
SP57 T2 SP57T2 19 335946 59074653 0,504 -0,058443766 1
1 TRUE
SP57 T2 SP57T2 20 138125 62899394 0,603 0,298682862 2
1 TRUE
SP57 T2 SP57T2 21 9891930 48083526 0,5 -0,021341887 1
1 TRUE
SP57 T2 SP57T2 22 16255826 16949797 0,5 -0,243916994 1
1 TRUE
SP57 T2 SP57T2 22 16953727 51182485 0,65974096 -0,430350105
1 0 TRUE
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SP57 T3 SP57T3 1 900298 249212725 0,5 0,018492201 1
1 TRUE
SP57 T3 SP57T3 2 173150 233536926 0,5 0,021919802 1
1 TRUE
SP57 T3 SP57T3 2 233537125 234433081 0,653872072 -0,35552363
1 0 TRUE
SP57 T3 SP57T3 2 234457900 242946289 0,507 0,024118614 1
1 TRUE
SP57 T3 SP57T3 3 403690 197762623 0,5 0,040271388 1
1 TRUE
SP57 T3 SP57T3 4 60400 190904031 0,5 0,037783326 1 1
TRUE
SP57 T3 SP57T3 5 163266 180687212 0,5 0,023557595 1
1 TRUE
SP57 T3 SP57T3 6 203878 168352105 0,506 0,033593819 1
1 TRUE
SP57 T3 SP57T3 6 168457966 168479790 0,657200896 -0,341581617
1 0 TRUE
SP57 T3 SP57T3 6 168687815 170892848 0,513 -0,031928916 1
1 TRUE
SP57 T3 SP57T3 7 286534 100608573 0,599 0,307136109 2
1 TRUE
SP57 T3 SP57T3 7 100615449 100615533 0,699056417 -0,153711331
1 0 FALSE
SP57 T3 SP57T3 7 100624718 159025494 0,595 0,306658119 2
1 TRUE
SP57 T3 SP57T3 8 250564 146115367 0,5095 0,022944625 1
1 TRUE
SP57 T3 SP57T3 9 117713 21440994 0,732 0,031377918 2
0 TRUE
SP57 T3 SP57T3 9 21816573 22748135 0,5 -0,9801894 0
0 TRUE
SP57 T3 SP57T3 9 23705108 34500821 0,7215 0,001574094 2
0 FALSE
SP57 T3 SP57T3 9 34723744 45372357 0,516 -0,015088439 1
1 TRUE
SP57 T3 SP57T3 9 65617649 68409631 0,671620001 -0,279584537
1 0 FALSE
SP57 T3 SP57T3 9 68409677 141069844 0,5 0,008540513 1
1 TRUE
SP57 T3 SP57T3 9 141069905 141069978 0,691045818 -0,191611181
1 0 TRUE
SP57 T3 SP57T3 10 412449 51540291 0,653 -0,357961798 1
0 TRUE
SP57 T3 SP57T3 10 51549496 51633027 0,513 -0,262357385 1
1 TRUE
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SP57 T3 SP57T3 10 51785598 135183608 0,647334992 -0,382516714
1 0 TRUE
SP57 T3 SP57T3 11 193112 18267135 0,506 0,060602322 1
1 TRUE
SP57 T3 SP57T3 11 18267353 18267478 0,698 0,179141376 2
0 FALSE
SP57 T3 SP57T3 11 18291063 51459199 0,513 0,023493547 1
1 FALSE
SP57 T3 SP57T3 11 55234785 134856661 0,5 0,025240821 1
1 TRUE
SP57 T3 SP57T3 12 247900 133463969 0,5 0,004387635 1
1 TRUE
SP57 T3 SP57T3 13 19059494 115064685 0,505 0,039346489 1
1 TRUE
SP57 T3 SP57T3 14 19118067 107183367 0,505 0,004386624 1
1 TRUE
SP57 T3 SP57T3 15 20170150 22148395 0,61 -0,073825369 1
0 FALSE
SP57 T3 SP57T3 15 22319166 102004231 0,5 0,011735142 1
1 TRUE
SP57 T3 SP57T3 16 240280 90162340 0,5 -0,034137147 1
1 TRUE
SP57 T3 SP57T3 17 6115 81082365 0,506 -0,016595967 1 1
TRUE
SP57 T3 SP57T3 18 348161 77895192 0,5 0,052039983 1
1 TRUE
SP57 T3 SP57T3 19 335946 59074653 0,5 -0,117228186 1
1 TRUE
SP57 T3 SP57T3 20 138125 62899394 0,5935 0,312633097 2
1 TRUE
SP57 T3 SP57T3 21 9891930 9912194 0,7015 -0,044468141 2
0 TRUE
SP57 T3 SP57T3 21 10793702 48083526 0,5 -0,020807923 1
1 TRUE
SP57 T3 SP57T3 22 16255826 51182485 0,6431819 -0,39940708
1 0 TRUE
SP57 T4 SP57T4 1 900298 203468792 0,5 -0,003144678 1
1 TRUE
SP57 T4 SP57T4 1 203652444 205042115 0,6855 0,682654935 4
1 FALSE
SP57 T4 SP57T4 1 205042939 249212725 0,5 -0,035004703 1
1 TRUE
SP57 T4 SP57T4 2 173150 233429185 0,5 -0,019096161 1
1 TRUE
SP57 T4 SP57T4 2 233536926 234405374 0,628 -0,380911688 1
0 TRUE
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SP57 T4 SP57T4 2 234433081 242946289 0,506 -0,008233492 1
1 TRUE
SP57 T4 SP57T4 3 403690 195397908 0,5 -0,015181377 1
1 TRUE
SP57 T4 SP57T4 3 195410751 195426149 0,540223378 -0,719998123
0 0 FALSE
SP57 T4 SP57T4 3 195475989 197762623 0,5 -0,134276355 1
1 TRUE
SP57 T4 SP57T4 4 60400 190904031 0,5 -0,00912679 1 1
TRUE
SP57 T4 SP57T4 5 163266 180687212 0,5 -0,020299243 1
1 TRUE
SP57 T4 SP57T4 6 203878 29897412 0,5 0,002265255 1
1 TRUE
SP57 T4 SP57T4 6 29909360 29910189 0,671 0,378538746 3
1 TRUE
SP57 T4 SP57T4 6 29910276 170892848 0,504 0,01205705 1
1 TRUE
SP57 T4 SP57T4 7 286534 100608573 0,593 0,261531289 2
1 TRUE
SP57 T4 SP57T4 7 100615449 100615533 0,722 0,433816035 3
0 TRUE
SP57 T4 SP57T4 7 100624718 159025494 0,585 0,248727317 2
1 TRUE
SP57 T4 SP57T4 8 250564 146115367 0,5 -0,016153796 1
1 TRUE
SP57 T4 SP57T4 9 117713 21440994 0,705663443 -0,076531749
2 0 TRUE
SP57 T4 SP57T4 9 21816573 24545695 0,529 -0,641552208 0
0 TRUE
SP57 T4 SP57T4 9 24545957 34500821 0,706 -0,008279899 2
0 FALSE
SP57 T4 SP57T4 9 34723744 45372357 0,5 -0,00146502 1
1 TRUE
SP57 T4 SP57T4 9 65617649 70731810 0,645 0,066903933 2
1 FALSE
SP57 T4 SP57T4 9 71224796 141069978 0,5 -0,002159351 1
1 TRUE
SP57 T4 SP57T4 10 412449 50681033 0,638 -0,372026825 1
0 TRUE
SP57 T4 SP57T4 10 50691009 50857835 0,998720542 -1,091421552
1000 0 TRUE
SP57 T4 SP57T4 10 50863147 135183608 0,638200714 -0,374254571
1 0 TRUE
SP57 T4 SP57T4 11 193112 134856661 0,503 -0,001885627 1
1 TRUE
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SP57 T4 SP57T4 12 247900 113357442 0,505 -0,010912122 1
1 TRUE
SP57 T4 SP57T4 12 113376320 113376388 0,721400433 0,002741976
2 0 TRUE
SP57 T4 SP57T4 12 113376452 133463969 0,5 -0,06580706 1
1 TRUE
SP57 T4 SP57T4 13 19059494 115064685 0,505 -0,019446308 1
1 TRUE
SP57 T4 SP57T4 14 19118067 107183367 0,5 -0,01417549 1
1 TRUE
SP57 T4 SP57T4 15 20170150 22148395 0,61 -0,114428937 1
0 FALSE
SP57 T4 SP57T4 15 22319166 102004231 0,505 -0,028458045 1
1 TRUE
SP57 T4 SP57T4 16 240280 90162340 0,5 -0,038364218 1
1 TRUE
SP57 T4 SP57T4 17 6115 81082365 0,5 -0,006343648 1 1
TRUE
SP57 T4 SP57T4 18 348161 77895192 0,5 -0,032240081 1
1 TRUE
SP57 T4 SP57T4 19 335946 59074653 0,5 -0,045409643 1
1 TRUE
SP57 T4 SP57T4 20 138125 62899394 0,5925 0,263783928 2
1 TRUE
SP57 T4 SP57T4 21 9891930 9912194 0,674884984 -0,2200152
1 0 FALSE
SP57 T4 SP57T4 21 10793702 48083526 0,5 -0,016541719 1
1 TRUE
SP57 T4 SP57T4 22 16255826 28315072 0,643079815 -0,354666504
1 0 TRUE
SP57 T4 SP57T4 22 28316553 28316561 0,709710257 -0,056558607
2 0 FALSE
SP57 T4 SP57T4 22 28559120 51182485 0,64 -0,3606377 1
0 TRUE
A23 recurrent_M A23_recurrent_M 1 13273 227381442 0,5 0,015817657
1 1 TRUE
A23 recurrent_M A23_recurrent_M 1 227681573 227681585 0,81 -
0,286876872 1 0 FALSE
A23 recurrent_M A23_recurrent_M 1 227825508 248814126 0,5 -
0,027450093 1 1 TRUE
A23 recurrent_M A23_recurrent_M 2 45843 243037004 0,5 -0,012336952
1 1 TRUE
A23 recurrent_M A23_recurrent_M 3 403288 197837967 0,5
0,003693336 1 1 TRUE
A23 recurrent_M A23_recurrent_M 4 195436 49554573 0,5
0,00250061 1 1 TRUE
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A23 recurrent_M A23_recurrent_M 4 52714511 190903950 0,5025
0,041196172 1 1 TRUE
A23 recurrent_M A23_recurrent_M 5 163205 180583043 0,5
0,009974594 1 1 TRUE
A23 recurrent_M A23_recurrent_M 6 203722 32522419 0,5 -
0,026318777 1 1 TRUE
A23 recurrent_M A23_recurrent_M 6 32522422 32549780 0,6275
0,106582216 2 1 TRUE
A23 recurrent_M A23_recurrent_M 6 32551872 170892848 0,5 -
0,003700278 1 1 TRUE
A23 recurrent_M A23_recurrent_M 7 295970 159053596 0,506 -
0,005767855 1 1 TRUE
A23 recurrent_M A23_recurrent_M 8 182934 146228622 0,503
0,000814989 1 1 TRUE
A23 recurrent_M A23_recurrent_M 9 214864 141071475 0,5 -
0,016020672 1 1 TRUE
A23 recurrent_M A23_recurrent_M 10 132135 135381592 0,5
0,00415608 1 1 TRUE
A23 recurrent_M A23_recurrent_M 11 192997 134252121 0,5
0,010463417 1 1 TRUE
A23 recurrent_M A23_recurrent_M 12 248202 133795960 0,505
0,003976804 1 1 TRUE
A23 recurrent_M A23_recurrent_M 13 19059494 115030714 0,504 -
0,002835674 1 1 TRUE
A23 recurrent_M A23_recurrent_M 14 19401146 107178965 0,5 -
0,014568802 1 1 TRUE
A23 recurrent_M A23_recurrent_M 15 20173245 102304498 0,5 -
0,00063043 1 1 TRUE
A23 recurrent_M A23_recurrent_M 16 97610 90133064 0,5 -0,047433987
1 1 TRUE
A23 recurrent_M A23_recurrent_M 17 6177 81006629 0,5 -0,035057231
1 1 TRUE
A23 recurrent_M A23_recurrent_M 18 204780 77926862 0,507
0,004150848 1 1 TRUE
A23 recurrent_M A23_recurrent_M 19 312164 59082605 0,5 -
0,061304882 1 1 TRUE
A23 recurrent_M A23_recurrent_M 20 76962 62903550 0,5 -0,003266219
1 1 TRUE
A23 recurrent_M A23_recurrent_M 21 9891930 48078611 0,5 -
0,038168269 1 1 TRUE
A23 recurrent_M A23_recurrent_M 22 16393311 51219006 0,504 -
0,017582104 1 1 TRUE
A23 recurrent_S A23_recurrent_S 1 13273 248814126 0,504 0,028071474
1 1 TRUE
A23 recurrent_S A23_recurrent_S 2 45843 243037004 0,5 0,024081542
1 1 TRUE
Page 126 of 185Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
A23 recurrent_S A23_recurrent_S 3 403288 180490822 0,5
0,020451259 1 1 TRUE
A23 recurrent_S A23_recurrent_S 3 180703663 183904232 0,694
0,662357692 2 1 TRUE
A23 recurrent_S A23_recurrent_S 3 183952773 197837967 0,505 -
0,00058108 1 1 TRUE
A23 recurrent_S A23_recurrent_S 4 195436 190903950 0,5
0,048661668 1 1 TRUE
A23 recurrent_S A23_recurrent_S 5 163205 180583043 0,5
0,031512563 1 1 TRUE
A23 recurrent_S A23_recurrent_S 6 203722 32522413 0,5 -
0,008346488 1 1 TRUE
A23 recurrent_S A23_recurrent_S 6 32522416 32548544 0,6605
0,297740424 2 1 TRUE
A23 recurrent_S A23_recurrent_S 6 32548581 170892848 0,5
0,032981654 1 1 TRUE
A23 recurrent_S A23_recurrent_S 7 295970 53930969 0,5
0,025182383 1 1 TRUE
A23 recurrent_S A23_recurrent_S 7 54826830 55249063 0,772
1,033052541 3 1 TRUE
A23 recurrent_S A23_recurrent_S 7 55433880 159053596 0,5
0,016656327 1 1 TRUE
A23 recurrent_S A23_recurrent_S 8 182934 146228622 0,5
0,02062829 1 1 TRUE
A23 recurrent_S A23_recurrent_S 9 214864 65973564 0,5 -
0,014402553 1 1 TRUE
A23 recurrent_S A23_recurrent_S 9 66059082 66455647 0,745 -
0,035909052 1 0 FALSE
A23 recurrent_S A23_recurrent_S 9 66457475 141071475 0,5 -
0,035642067 1 1 TRUE
A23 recurrent_S A23_recurrent_S 10 132135 135381592 0,5 -
0,001131914 1 1 TRUE
A23 recurrent_S A23_recurrent_S 11 192997 134252121 0,5
0,004030965 1 1 TRUE
A23 recurrent_S A23_recurrent_S 12 248202 133795960 0,5
0,007031411 1 1 TRUE
A23 recurrent_S A23_recurrent_S 13 19059494 115030714 0,5
0,022916495 1 1 TRUE
A23 recurrent_S A23_recurrent_S 14 19401146 107178965 0,5
0,003918778 1 1 TRUE
A23 recurrent_S A23_recurrent_S 15 20173245 102304498 0,5 -
0,000712915 1 1 TRUE
A23 recurrent_S A23_recurrent_S 16 97610 90133064 0,5 -0,040852975
1 1 TRUE
A23 recurrent_S A23_recurrent_S 17 6177 81006629 0,5 -0,022955149
1 1 TRUE
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A23 recurrent_S A23_recurrent_S 18 204780 77926862 0,507
0,009332901 1 1 TRUE
A23 recurrent_S A23_recurrent_S 19 312164 59082605 0,5 -
0,058843755 1 1 TRUE
A23 recurrent_S A23_recurrent_S 20 76962 62903550 0,5 -0,002134446
1 1 TRUE
A23 recurrent_S A23_recurrent_S 21 9891930 48078611 0,5
0,001127176 1 1 TRUE
A23 recurrent_S A23_recurrent_S 22 16393311 51219006 0,5 -
0,017431828 1 1 TRUE
A23 recurrent_T A23_recurrent_T 1 13273 72740634 0,5 -0,017969459
2 2 TRUE
A23 recurrent_T A23_recurrent_T 1 74664149 99753631 0,639 -
0,293158688 2 0 TRUE
A23 recurrent_T A23_recurrent_T 1 100715454 227381442 0,507
0,072834435 2 2 TRUE
A23 recurrent_T A23_recurrent_T 1 227681573 227681585 0,591772815
-0,500010316 1 0 FALSE
A23 recurrent_T A23_recurrent_T 1 227825508 248814126 0,5
0,012873827 2 2 TRUE
A23 recurrent_T A23_recurrent_T 2 45843 91885946 0,604 0,006274487
3 1 TRUE
A23 recurrent_T A23_recurrent_T 2 95824624 243037004 0,509
0,182538454 3 3 TRUE
A23 recurrent_T A23_recurrent_T 3 403288 180703663 0,5
0,034415589 2 2 TRUE
A23 recurrent_T A23_recurrent_T 3 182681740 183056541 0,94
3,204043997 75 2 TRUE
A23 recurrent_T A23_recurrent_T 3 183904232 197837967 0,5 -
0,015727512 2 2 TRUE
A23 recurrent_T A23_recurrent_T 4 195436 190903950 0,5
0,067095517 2 2 TRUE
A23 recurrent_T A23_recurrent_T 5 163205 180583043 0,503
0,05111449 2 2 TRUE
A23 recurrent_T A23_recurrent_T 6 203722 32522419 0,5
0,002210913 2 2 TRUE
A23 recurrent_T A23_recurrent_T 6 32522422 32522425 0,805111503
0,566713006 8 0 TRUE
A23 recurrent_T A23_recurrent_T 6 32522427 33047432 0,5
0,044682619 2 2 TRUE
A23 recurrent_T A23_recurrent_T 6 33048380 33053812 0,632
0,09587161 4 1 TRUE
A23 recurrent_T A23_recurrent_T 6 33060064 57841320 0,503
0,047755816 2 2 TRUE
A23 recurrent_T A23_recurrent_T 6 58776965 58778809 0,5 -
3,20144033 0 0 TRUE
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A23 recurrent_T A23_recurrent_T 6 62407067 170892848 0,5
0,073483566 2 2 TRUE
A23 recurrent_T A23_recurrent_T 7 295970 13911420 0,506
0,081365175 2 2 TRUE
A23 recurrent_T A23_recurrent_T 7 13946316 32529936 0,591
0,34285473 4 2 TRUE
A23 recurrent_T A23_recurrent_T 7 32535437 43686224 0,644
0,252167444 4 1 TRUE
A23 recurrent_T A23_recurrent_T 7 43687296 53930969 0,606
0,301724199 4 2 FALSE
A23 recurrent_T A23_recurrent_T 7 54826830 55249063 0,963
3,773147354 116 2 TRUE
A23 recurrent_T A23_recurrent_T 7 55433880 128312463 0,563
0,144190995 3 2 FALSE
A23 recurrent_T A23_recurrent_T 7 128315882 159053596 0,591
0,359314279 4 2 TRUE
A23 recurrent_T A23_recurrent_T 8 182934 146228622 0,504
0,056607865 2 2 TRUE
A23 recurrent_T A23_recurrent_T 9 214864 90342675 0,5
0,001987417 2 2 TRUE
A23 recurrent_T A23_recurrent_T 9 90343780 141071475 0,514 -
0,154529243 1 1 FALSE
A23 recurrent_T A23_recurrent_T 10 132135 38737254 0,633 -
0,348591374 2 0 TRUE
A23 recurrent_T A23_recurrent_T 10 43315692 62548098 0,516 -
0,078390706 2 2 FALSE
A23 recurrent_T A23_recurrent_T 10 62634621 135381592 0,64 -
0,310602217 2 0 TRUE
A23 recurrent_T A23_recurrent_T 11 192997 134252121 0,554 -
0,116912788 2 1 TRUE
A23 recurrent_T A23_recurrent_T 12 248202 133795960 0,5
0,00075688 2 2 TRUE
A23 recurrent_T A23_recurrent_T 13 19059494 115030714 0,5 -
0,124906757 2 2 TRUE
A23 recurrent_T A23_recurrent_T 14 19401146 107178965 0,5
0,02699028 2 2 TRUE
A23 recurrent_T A23_recurrent_T 15 20173245 20462603 0,503 -
0,387124124 1 1 TRUE
A23 recurrent_T A23_recurrent_T 15 20466604 20489310 0,695153577
-0,078720673 3 0 TRUE
A23 recurrent_T A23_recurrent_T 15 20643927 102304498 0,5
0,019756485 2 2 TRUE
A23 recurrent_T A23_recurrent_T 16 97610 33613219 0,565 -0,252062216
2 1 TRUE
A23 recurrent_T A23_recurrent_T 16 33740747 46405156 0,5 -
2,502044132 0 0 TRUE
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A23 recurrent_T A23_recurrent_T 16 46407745 90133064 0,562 -
0,209498362 2 1 TRUE
A23 recurrent_T A23_recurrent_T 17 6177 81006629 0,5 -0,050998416
2 2 TRUE
A23 recurrent_T A23_recurrent_T 18 204780 77926862 0,505
0,038154148 2 2 TRUE
A23 recurrent_T A23_recurrent_T 19 312164 59082605 0,5 -
0,139500774 1 1 TRUE
A23 recurrent_T A23_recurrent_T 20 76962 62903550 0,5 0,016809432
2 2 TRUE
A23 recurrent_T A23_recurrent_T 21 9891930 48078611 0,5
0,005594123 2 2 TRUE
A23 recurrent_T A23_recurrent_T 22 16393311 51219006 0,55 -
0,158524191 2 1 FALSE
A34 S1 A34S1 1 907609 203317204 0,506 -0,044749403 1 1
TRUE
A34 S1 A34S1 1 203766827 204516025 0,849 2,03229278 7 1
FALSE
A34 S1 A34S1 1 204915347 249107414 0,5 -0,02311113 1 1
TRUE
A34 S1 A34S1 2 224970 242842568 0,5 -0,010526313 1 1
TRUE
A34 S1 A34S1 3 361508 89528477 0,505 0,030055522 1 1
TRUE
A34 S1 A34S1 3 93593119 197402254 0,502 -0,064848986 1 1
TRUE
A34 S1 A34S1 4 60400 49063872 0,5 -0,041947205 1 1 TRUE
A34 S1 A34S1 4 52714511 55593464 0,6935 0,580580441 2 1
TRUE
A34 S1 A34S1 4 55946171 190395259 0,5 0,015031789 1 1
TRUE
A34 S1 A34S1 5 163205 180665998 0,5 0,064808993 1 1
TRUE
A34 S1 A34S1 6 335251 170887693 0,5 -0,059453122 1 1
TRUE
A34 S1 A34S1 7 296739 54621692 0,562 0,12644481 1 1
FALSE
A34 S1 A34S1 7 55214348 55229255 0,8585 1,655938289 6 1
TRUE
A34 S1 A34S1 7 55780176 76126737 0,582 -0,092330174 1 1
FALSE
A34 S1 A34S1 7 76131645 76751357 0,7735 -1,402691865 0 0
TRUE
A34 S1 A34S1 7 76751543 158827326 0,574 0,187482596 1 1
FALSE
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A34 S1 A34S1 8 196274 146228622 0,501 -0,037442141 1 1
TRUE
A34 S1 A34S1 9 154795 141016262 0,5 -0,067944124 1 1
TRUE
A34 S1 A34S1 10 1018585 135381276 0,5 -0,137075568 1 1
TRUE
A34 S1 A34S1 11 193865 134856661 0,506 0,028875112 1 1
TRUE
A34 S1 A34S1 12 250239 133796033 0,504 -0,02840592 1 1
TRUE
A34 S1 A34S1 13 19600475 115064542 0,5 -0,008844078 1 1
TRUE
A34 S1 A34S1 14 19889910 107178965 0,5 0,043843364 1 1
TRUE
A34 S1 A34S1 15 20446043 102312835 0,505 -0,015042837 1 1
TRUE
A34 S1 A34S1 16 129531 90161231 0,5 -0,084941141 1 1
TRUE
A34 S1 A34S1 17 171098 81050982 0,5055 -0,000514558 1 1
TRUE
A34 S1 A34S1 18 203081 77805856 0,507 0,002138314 1 1
TRUE
A34 S1 A34S1 19 288062 59022697 0,5 -0,075676323 1 1
TRUE
A34 S1 A34S1 20 138125 35467713 0,5 -0,010455848 1 1
TRUE
A34 S1 A34S1 20 35559352 36612084 0,871 2,129919273 7 1
TRUE
A34 S1 A34S1 20 36841756 62903550 0,5 -0,093247153 1 1
TRUE
A34 S1 A34S1 21 10793925 47976203 0,505 -0,030724512 1 1
TRUE
A34 S1 A34S1 22 17054291 51207180 0,5 -0,049397962 1 1
TRUE
A34 S2 A34S2 1 907609 203317204 0,5 -0,042663364 1 1
TRUE
A34 S2 A34S2 1 203766827 204516025 0,8655 2,090597554 7 1
TRUE
A34 S2 A34S2 1 204915347 249107414 0,502 0,037048765 1 1
TRUE
A34 S2 A34S2 2 224970 242842568 0,5 0,016168494 1 1
TRUE
A34 S2 A34S2 3 361508 197402254 0,5 0,010728641 1 1
TRUE
A34 S2 A34S2 4 60400 49063872 0,5 -0,046944479 1 1 TRUE
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A34 S2 A34S2 4 52714511 55593464 0,75 0,869460936 3 1
TRUE
A34 S2 A34S2 4 55946171 190395259 0,5 0,077512822 1 1
TRUE
A34 S2 A34S2 5 163205 180665998 0,5 0,086177031 1 1
TRUE
A34 S2 A34S2 6 335251 31085269 0,5 -0,097172772 1 1
TRUE
A34 S2 A34S2 6 31088145 31088241 0,737 -0,844456054 1 1
TRUE
A34 S2 A34S2 6 31097453 57467175 0,503 -0,042077484 1 1
TRUE
A34 S2 A34S2 6 62442604 170887693 0,5 -0,002786999 1 1
TRUE
A34 S2 A34S2 7 296739 5105133 0,58 0,176856776 1 1
FALSE
A34 S2 A34S2 7 5112108 5338770 0,735 -0,007827874 1 0
FALSE
A34 S2 A34S2 7 5340002 54621692 0,57 0,190067276 1 1
FALSE
A34 S2 A34S2 7 55214348 55229255 0,9025 2,109533485 8 1
TRUE
A34 S2 A34S2 7 55780176 158827326 0,583 0,184725228 1 1
FALSE
A34 S2 A34S2 8 196274 146228622 0,5 -0,021780123 1 1
TRUE
A34 S2 A34S2 9 154795 141016262 0,5 -0,054133932 1 1
TRUE
A34 S2 A34S2 10 1018585 38645403 0,507 -0,067815226 1 1
TRUE
A34 S2 A34S2 10 42907201 135381276 0,563 -0,160907285 1 1
FALSE
A34 S2 A34S2 11 193865 134856661 0,504 0,021082155 1 1
TRUE
A34 S2 A34S2 12 250239 133796033 0,502 -0,009296027 1 1
TRUE
A34 S2 A34S2 13 19600475 115064542 0,506 0,048269973 1 1
TRUE
A34 S2 A34S2 14 19889910 107178965 0,503 0,048688651 1 1
TRUE
A34 S2 A34S2 15 20446043 102312835 0,506 0,002038367 1 1
TRUE
A34 S2 A34S2 16 129531 90161231 0,5 -0,104117485 1 1
TRUE
A34 S2 A34S2 17 171098 81050982 0,5 -0,011157076 1 1
TRUE
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A34 S2 A34S2 18 203081 77805856 0,5055 0,063257924 1 1
TRUE
A34 S2 A34S2 19 288062 59022697 0,5 -0,117514349 1 1
TRUE
A34 S2 A34S2 20 138125 35467713 0,5 -0,012114044 1 1
TRUE
A34 S2 A34S2 20 35559352 36612084 0,8645 2,154980006 7 1
TRUE
A34 S2 A34S2 20 36841756 62903550 0,5 -0,064094196 1 1
TRUE
A34 S2 A34S2 21 10793925 47976203 0,506 -0,021019978 1 1
TRUE
A34 S2 A34S2 22 17054291 51207180 0,5 -0,058839791 1 1
TRUE
A34 S3 A34S3 1 907609 1585642 0,504 -0,356991371 1 1
TRUE
A34 S3 A34S3 1 1633004 1635193 0,528 -2,803441637 0 0
TRUE
A34 S3 A34S3 1 1635565 249107414 0,504 -0,027626182 1 1
TRUE
A34 S3 A34S3 2 224970 242842568 0,5 -0,021507729 1 1
TRUE
A34 S3 A34S3 3 361508 197402254 0,5 -0,019421131 1 1
TRUE
A34 S3 A34S3 4 60400 190395259 0,5 -0,006617131 1 1 TRUE
A34 S3 A34S3 5 163205 180665998 0,5015 0,055865451 1 1
TRUE
A34 S3 A34S3 6 335251 29797639 0,503 0,026943666 1 1
TRUE
A34 S3 A34S3 6 29910402 29911228 0,654 -1,84595394 0 0
TRUE
A34 S3 A34S3 6 29912098 170887693 0,5 -0,036994621 1 1
TRUE
A34 S3 A34S3 7 296739 5172223 0,5 -0,038622126 1 1
TRUE
A34 S3 A34S3 7 5338714 5352659 0,781 -0,670334137 1 0
TRUE
A34 S3 A34S3 7 5369522 158827326 0,5 -0,069987741 1 1
TRUE
A34 S3 A34S3 8 196274 146228622 0,503 -0,034370078 1 1
TRUE
A34 S3 A34S3 9 154795 141016262 0,503 -0,048786497 1 1
TRUE
A34 S3 A34S3 10 1018585 26505822 0,503 0,057547867 1 1
TRUE
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A34 S3 A34S3 10 26991037 26993725 0,6 -0,196707569 1 1
TRUE
A34 S3 A34S3 10 26993728 135381276 0,503 -0,025434253 1 1
TRUE
A34 S3 A34S3 11 193865 134856661 0,504 0,028698691 1 1
TRUE
A34 S3 A34S3 12 250239 133796033 0,503 -0,02359901 1 1
TRUE
A34 S3 A34S3 13 19600475 115064542 0,507 0,02516228 1 1
TRUE
A34 S3 A34S3 14 19889910 20444012 0,539 -0,410506845 1 1
TRUE
A34 S3 A34S3 14 20444026 107178965 0,504 0,047060495 1 1
TRUE
A34 S3 A34S3 15 20446043 102312835 0,503 0,033902907 1 1
TRUE
A34 S3 A34S3 16 129531 1275309 0,507 -0,236932233 1 1
TRUE
A34 S3 A34S3 16 1279537 1279574 0,867 -1,544722906 1 0
TRUE
A34 S3 A34S3 16 1306346 90161231 0,5 -0,055995325 1 1
TRUE
A34 S3 A34S3 17 171098 81050982 0,5 0,009557557 1 1
TRUE
A34 S3 A34S3 18 203081 77805856 0,5 0,026573005 1 1
TRUE
A34 S3 A34S3 19 288062 59022697 0,5 -0,050372785 1 1
TRUE
A34 S3 A34S3 20 138125 62903550 0,5 -0,027625919 1 1
TRUE
A34 S3 A34S3 21 10793925 47976203 0,505 -0,012903281 1 1
TRUE
A34 S3 A34S3 22 17054291 51207180 0,5 -0,039557645 1 1
TRUE
A34 T1 A34T1 1 907609 1585597 0,5 -0,328372716 1 1
TRUE
A34 T1 A34T1 1 1585642 1633007 0,541 -2,761429416 0 0
TRUE
A34 T1 A34T1 1 1635193 203317204 0,5 -0,038078634 1 1
TRUE
A34 T1 A34T1 1 203766827 204516025 0,9495 3,430598913 20 1
TRUE
A34 T1 A34T1 1 204915347 249107414 0,5 -0,008998457 1 1
TRUE
A34 T1 A34T1 2 224970 70162534 0,5 0,027423382 1 1
TRUE
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A34 T1 A34T1 2 70677994 91809385 0,711 -0,310441624 1 0
FALSE
A34 T1 A34T1 2 95537330 242842568 0,5 0,010638113 1 1
TRUE
A34 T1 A34T1 3 361508 197402254 0,5 0,001968955 1 1
TRUE
A34 T1 A34T1 4 60400 49063872 0,5 -0,04883049 1 1 TRUE
A34 T1 A34T1 4 52714511 55593464 0,7965 1,456232391 4 1
TRUE
A34 T1 A34T1 4 55946171 190395259 0,507 0,040849067 1 1
TRUE
A34 T1 A34T1 5 163205 180665998 0,5 0,069185644 1 1
TRUE
A34 T1 A34T1 6 335251 170887693 0,5 -0,030277924 1 1
TRUE
A34 T1 A34T1 7 296739 11419378 0,67 0,411969481 2 1
TRUE
A34 T1 A34T1 7 11464297 27566053 0,612 0,342410331 2 1
FALSE
A34 T1 A34T1 7 28449965 54621692 0,667 0,573432761 2 1
TRUE
A34 T1 A34T1 7 55214348 55229255 0,9735 3,932644216 30 1
TRUE
A34 T1 A34T1 7 55780176 158827326 0,668 0,519478861 2 1
TRUE
A34 T1 A34T1 8 196274 146228622 0,503 -0,029395479 1 1
TRUE
A34 T1 A34T1 9 154795 27455095 0,6815 -0,521525357 1 0
FALSE
A34 T1 A34T1 9 27556780 37974743 0,587 -0,268302557 1 1
FALSE
A34 T1 A34T1 9 66499220 141016262 0,5 -0,038093198 1 1
TRUE
A34 T1 A34T1 10 1018585 25888180 0,6915 -0,400763199 1 0
FALSE
A34 T1 A34T1 10 26241025 33552695 0,504 0,035668245 1 1
TRUE
A34 T1 A34T1 10 35320355 38645403 0,68 -0,513921783 1 0
FALSE
A34 T1 A34T1 10 42907201 47000146 0,53 -0,431212497 1 1
TRUE
A34 T1 A34T1 10 47667380 135381276 0,696 -0,487081401 1 0
FALSE
A34 T1 A34T1 11 193865 134856661 0,505 0,030087418 1 1
TRUE
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A34 T1 A34T1 12 250239 133796033 0,5 -0,004838114 1 1
TRUE
A34 T1 A34T1 13 19600475 115064542 0,505 0,034944016 1 1
TRUE
A34 T1 A34T1 14 19889910 20444012 0,517 0,013747426 1 1
TRUE
A34 T1 A34T1 14 20444026 107178965 0,502 0,062151497 1 1
TRUE
A34 T1 A34T1 15 20446043 30008977 0,5 0,005039539 1 1
TRUE
A34 T1 A34T1 15 30018553 60644074 0,585 -0,177183637 1 1
FALSE
A34 T1 A34T1 15 60685176 102312835 0,505 0,050298729 1 1
TRUE
A34 T1 A34T1 16 129531 90161231 0,5 -0,088883184 1 1
TRUE
A34 T1 A34T1 17 171098 81050982 0,5 -0,009525389 1 1
TRUE
A34 T1 A34T1 18 203081 77805856 0,5 0,041242142 1 1
TRUE
A34 T1 A34T1 19 288062 48255804 0,5 -0,085952753 1 1
TRUE
A34 T1 A34T1 19 48258551 48258578 0,895 -0,867801806 1 0
TRUE
A34 T1 A34T1 19 48259220 59022697 0,502 -0,067260015 1 1
TRUE
A34 T1 A34T1 20 138125 35467713 0,5 -0,012503563 1 1
TRUE
A34 T1 A34T1 20 35559352 36612084 0,9525 3,504189102 21 1
TRUE
A34 T1 A34T1 20 36841756 62903550 0,5 -0,078243818 1 1
TRUE
A34 T1 A34T1 21 10793925 47976203 0,506 -0,035668281 1 1
TRUE
A34 T1 A34T1 22 17054291 51207180 0,5 -0,058911667 1 1
TRUE
A34 T2 A34T2 1 907609 203317204 0,5 -0,042476072 1 1
TRUE
A34 T2 A34T2 1 203766827 204516025 0,8275 1,705918345 5 1
TRUE
A34 T2 A34T2 1 204915347 249107414 0,5 -0,002389783 1 1
TRUE
A34 T2 A34T2 2 224970 242842568 0,5 -0,048048464 1 1
TRUE
A34 T2 A34T2 3 361508 73024350 0,505 0,045386348 1 1
TRUE
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A34 T2 A34T2 3 73046544 73110076 0,85 -0,496762815 1 0
TRUE
A34 T2 A34T2 3 73111368 197402254 0,5 -0,07742144 1 1
TRUE
A34 T2 A34T2 4 60400 190395259 0,5 -0,030802273 1 1 TRUE
A34 T2 A34T2 5 163205 180665998 0,502 0,058104619 1 1
TRUE
A34 T2 A34T2 6 335251 170887693 0,5 -0,049195017 1 1
TRUE
A34 T2 A34T2 7 296739 54621692 0,5 0,023998171 1 1
TRUE
A34 T2 A34T2 7 55214348 55229255 0,857 1,580810895 6 1
TRUE
A34 T2 A34T2 7 55780176 158827326 0,533 0,044016043 1 1
FALSE
A34 T2 A34T2 8 196274 146228622 0,5 -0,040401651 1 1
TRUE
A34 T2 A34T2 9 154795 141016262 0,5 -0,063858741 1 1
TRUE
A34 T2 A34T2 10 1018585 135381276 0,505 -0,082258376 1 1
TRUE
A34 T2 A34T2 11 193865 134856661 0,504 0,026489135 1 1
TRUE
A34 T2 A34T2 12 250239 133796033 0,502 -0,018545614 1 1
TRUE
A34 T2 A34T2 13 19600475 115064542 0,504 -0,006885215 1 1
TRUE
A34 T2 A34T2 14 19889910 107178965 0,5 0,04966529 1 1
TRUE
A34 T2 A34T2 15 20446043 102312835 0,505 -0,001743645 1 1
TRUE
A34 T2 A34T2 16 129531 90161231 0,503 -0,080808631 1 1
TRUE
A34 T2 A34T2 17 171098 81050982 0,5 -0,005269794 1 1
TRUE
A34 T2 A34T2 18 203081 77805856 0,5 0,01552285 1 1
TRUE
A34 T2 A34T2 19 288062 59022697 0,5 -0,085996046 1 1
TRUE
A34 T2 A34T2 20 138125 35467713 0,5 -0,000892178 1 1
TRUE
A34 T2 A34T2 20 35559352 36612084 0,82 1,676473718 5 1
TRUE
A34 T2 A34T2 20 36841756 62903550 0,5 -0,068830669 1 1
TRUE
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A34 T2 A34T2 21 10793925 47976203 0,5 -0,037593742 1 1
TRUE
A34 T2 A34T2 22 17054291 51207180 0,5 -0,041365274 1 1
TRUE
A34 T3 A34T3 1 907609 1585642 0,519 -0,180687268 1 1
TRUE
A34 T3 A34T3 1 1633004 1635193 0,55 -2,498407509 0 0
TRUE
A34 T3 A34T3 1 1635565 120539331 0,5 -0,014285646 1 1
TRUE
A34 T3 A34T3 1 120572547 120611964 0,684 -1,264137196 0 0
TRUE
A34 T3 A34T3 1 144854597 203317204 0,502 -0,048360486 1 1
TRUE
A34 T3 A34T3 1 203766827 204516025 0,8895 2,197903713 8 1
TRUE
A34 T3 A34T3 1 204915347 249107414 0,5 -0,060356911 1 1
TRUE
A34 T3 A34T3 2 224970 242842568 0,5 -0,108077146 1 1
TRUE
A34 T3 A34T3 3 361508 197402254 0,505 -0,057013455 1 1
TRUE
A34 T3 A34T3 4 60400 190395259 0,5 -0,115451939 1 1 TRUE
A34 T3 A34T3 5 163205 180665998 0,5 -0,007750512 1 1
TRUE
A34 T3 A34T3 6 335251 170887693 0,5 -0,083565916 1 1
TRUE
A34 T3 A34T3 7 296739 5105133 0,5885 0,363451926 1 1
FALSE
A34 T3 A34T3 7 5112108 5340002 0,667 -0,724175424 1 1
TRUE
A34 T3 A34T3 7 5347914 54621692 0,569 0,104236813 1 1
FALSE
A34 T3 A34T3 7 55214348 55229255 0,888 2,175368057 8 1
TRUE
A34 T3 A34T3 7 55780176 158827326 0,587 0,158173365 1 1
FALSE
A34 T3 A34T3 8 196274 146228622 0,503 -0,095677534 1 1
TRUE
A34 T3 A34T3 9 154795 141016262 0,5 -0,055515651 1 1
TRUE
A34 T3 A34T3 10 1018585 38645403 0,507 -0,163708533 1 1
TRUE
A34 T3 A34T3 10 42907201 135381276 0,536 -0,215894263 1 1
FALSE
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A34 T3 A34T3 11 193865 134856661 0,503 0,037851689 1 1
TRUE
A34 T3 A34T3 12 250239 133796033 0,503 -0,075470985 1 1
TRUE
A34 T3 A34T3 13 19600475 115064542 0,504 -0,100716336 1 1
TRUE
A34 T3 A34T3 14 19889910 107178965 0,5 0,016562565 1 1
TRUE
A34 T3 A34T3 15 20446043 60689995 0,525 -0,163743185 1 1
FALSE
A34 T3 A34T3 15 60690089 102312835 0,505 0,039060526 1 1
TRUE
A34 T3 A34T3 16 129531 1275309 0,504 -0,055067239 1 1
TRUE
A34 T3 A34T3 16 1279537 1279574 0,875 -1,332730303 1 0
TRUE
A34 T3 A34T3 16 1306346 90161231 0,5 -0,010891581 1 1
TRUE
A34 T3 A34T3 17 171098 81050982 0,5 0,046428128 1 1
TRUE
A34 T3 A34T3 18 203081 77805856 0,5 -0,098354396 1 1
TRUE
A34 T3 A34T3 19 288062 59022697 0,5 -0,058183435 1 1
TRUE
A34 T3 A34T3 20 138125 35467713 0,5 0,026676543 1 1
TRUE
A34 T3 A34T3 20 35559352 36612084 0,8885 2,307402189 9 1
FALSE
A34 T3 A34T3 20 36841756 62903550 0,5 0,00303765 1 1
TRUE
A34 T3 A34T3 21 10793925 47976203 0,505 0,009838616 1 1
TRUE
A34 T3 A34T3 22 17054291 51207180 0,5 0,046160442 1 1
TRUE
A34 T4 A34T4 1 907609 120539331 0,5 -0,049077582 1 1
TRUE
A34 T4 A34T4 1 120572547 120611964 0,687 -1,238608882 0 0
TRUE
A34 T4 A34T4 1 144854597 203317204 0,5 -0,036942527 1 1
TRUE
A34 T4 A34T4 1 203766827 204516025 0,934 3,121688703 16 1
TRUE
A34 T4 A34T4 1 204915347 249107414 0,5 -0,023802196 1 1
TRUE
A34 T4 A34T4 2 224970 70162534 0,503 -0,02149379 1 1
TRUE
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A34 T4 A34T4 2 70677994 91809385 0,65 -0,222863899 1 1
FALSE
A34 T4 A34T4 2 95537330 242842568 0,5 -0,016232227 1 1
TRUE
A34 T4 A34T4 3 361508 89528477 0,505 0,02719889 1 1
TRUE
A34 T4 A34T4 3 93593119 197402254 0,502 -0,088217393 1 1
TRUE
A34 T4 A34T4 4 60400 49063872 0,504 -0,068384608 1 1 TRUE
A34 T4 A34T4 4 52714511 55593464 0,8155 1,285701415 4 1
TRUE
A34 T4 A34T4 4 55946171 190395259 0,5045 -0,011425336 1 1
TRUE
A34 T4 A34T4 5 163205 180665998 0,5 0,055585219 1 1
TRUE
A34 T4 A34T4 6 335251 170887693 0,5 -0,060872343 1 1
TRUE
A34 T4 A34T4 7 296739 7613039 0,649 0,39110486 2 1
FALSE
A34 T4 A34T4 7 10973362 27239193 0,591 0,20926734 1 1
FALSE
A34 T4 A34T4 7 27497389 54621692 0,645 0,427226388 2 1
FALSE
A34 T4 A34T4 7 55214348 55229255 0,957 3,1760052 18 1
TRUE
A34 T4 A34T4 7 55780176 158827326 0,644 0,384716496 2 1
FALSE
A34 T4 A34T4 8 196274 146228622 0,5 -0,047011777 1 1
TRUE
A34 T4 A34T4 9 154795 27290984 0,639 -0,439078765 1 1
FALSE
A34 T4 A34T4 9 27296705 141016262 0,503 -0,057229106 1 1
TRUE
A34 T4 A34T4 10 1018585 26505822 0,6405 -0,326443532 1 1
FALSE
A34 T4 A34T4 10 26991037 26993725 0,639 0,126318713 2 1
TRUE
A34 T4 A34T4 10 26993728 47000146 0,529 -0,284324505 1 1
FALSE
A34 T4 A34T4 10 47667380 135381276 0,646 -0,417821307 1 1
FALSE
A34 T4 A34T4 11 193865 134856661 0,502 0,006853732 1 1
TRUE
A34 T4 A34T4 12 250239 133796033 0,5 -0,053329958 1 1
TRUE
Page 140 of 185Annals of Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
A34 T4 A34T4 13 19600475 115064542 0,505 -0,004239228 1 1
TRUE
A34 T4 A34T4 14 19889910 107178965 0,5 0,03582738 1 1
TRUE
A34 T4 A34T4 15 20446043 31793930 0,507 -0,059607169 1 1
TRUE
A34 T4 A34T4 15 32620127 59972372 0,6 -0,269882588 1 1
FALSE
A34 T4 A34T4 15 59981515 102312835 0,5 0,037252699 1 1
TRUE
A34 T4 A34T4 16 129531 90161231 0,504 -0,072014866 1 1
TRUE
A34 T4 A34T4 17 171098 81050982 0,5 0,014475977 1 1
TRUE
A34 T4 A34T4 18 203081 77805856 0,5 0,008024797 1 1
TRUE
A34 T4 A34T4 19 288062 59022697 0,5 -0,050902806 1 1
TRUE
A34 T4 A34T4 20 138125 35467713 0,5 -0,044977978 1 1
TRUE
A34 T4 A34T4 20 35559352 36612084 0,9315 3,188010265 17 1
FALSE
A34 T4 A34T4 20 36841756 62903550 0,504 -0,051053515 1 1
TRUE
A34 T4 A34T4 21 10793925 47976203 0,5 -0,026207014 1 1
TRUE
A34 T4 A34T4 22 17054291 51207180 0,5 -0,031528966 1 1
TRUE
A34 T5 A34T5 1 907609 203317204 0,5 -0,028212121 1 1
TRUE
A34 T5 A34T5 1 203766827 204516025 0,9605 3,872177922 28 1
TRUE
A34 T5 A34T5 1 204915347 249107414 0,502 0,03622707 1 1
TRUE
A34 T5 A34T5 2 224970 70162534 0,5 0,053026891 1 1
TRUE
A34 T5 A34T5 2 70677994 91809385 0,777 -0,376089162 1 0
FALSE
A34 T5 A34T5 2 95537330 242842568 0,5 0,06669349 1 1
TRUE
A34 T5 A34T5 3 361508 197402254 0,5 0,017103982 1 1
TRUE
A34 T5 A34T5 4 60400 49063872 0,5 -0,027591541 1 1 TRUE
A34 T5 A34T5 4 52714511 55593464 0,873 1,894811146 7 1
TRUE
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A34 T5 A34T5 4 55946171 190395259 0,5 0,053102814 1 1
TRUE
A34 T5 A34T5 5 163205 180665998 0,5 0,090087264 1 1
TRUE
A34 T5 A34T5 6 335251 170887693 0,5 -0,036521773 1 1
TRUE
A34 T5 A34T5 7 296739 54621692 0,667 0,539877029 2 1
TRUE
A34 T5 A34T5 7 55214348 55229255 0,9835 4,582564246 47 1
TRUE
A34 T5 A34T5 7 55780176 158827326 0,685 0,600866043 2 1
FALSE
A34 T5 A34T5 8 196274 146228622 0,504 -0,010288144 1 1
TRUE
A34 T5 A34T5 9 154795 27556780 0,742 -0,624774011 1 0
FALSE
A34 T5 A34T5 9 32418237 141016262 0,5 -0,035983405 1 1
TRUE
A34 T5 A34T5 10 1018585 25888180 0,756 -0,515847269 1 0
FALSE
A34 T5 A34T5 10 26241025 33552695 0,579 -0,093729299 1 1
FALSE
A34 T5 A34T5 10 35320355 37505192 0,781 -0,760683112 1 0
FALSE
A34 T5 A34T5 10 38344700 43678796 0,523 -0,397884877 1 1
TRUE
A34 T5 A34T5 10 43695049 45958881 0,739 -0,509425291 1 0
FALSE
A34 T5 A34T5 10 46965018 47000146 0,527 -0,592240173 1 1
TRUE
A34 T5 A34T5 10 47667380 135381276 0,756 -0,62397159 1 0
FALSE
A34 T5 A34T5 11 193865 294537 0,725 0,23248972 2 1
TRUE
A34 T5 A34T5 11 372157 134856661 0,505 0,051724918 1 1
TRUE
A34 T5 A34T5 12 250239 133796033 0,504 -0,013094857 1 1
TRUE
A34 T5 A34T5 13 19600475 115064542 0,504 0,043131792 1 1
TRUE
A34 T5 A34T5 14 19889910 107178965 0,503 0,07165982 1 1
TRUE
A34 T5 A34T5 15 20446043 31453147 0,5 -0,007994401 1 1
TRUE
A34 T5 A34T5 15 31779838 59981590 0,701 -0,458563736 1 0
FALSE
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A34 T5 A34T5 15 60644074 102312835 0,505 0,054869307 1 1
TRUE
A34 T5 A34T5 16 129531 90161231 0,5 -0,115830825 1 1
TRUE
A34 T5 A34T5 17 171098 81050982 0,5 -0,025512703 1 1
TRUE
A34 T5 A34T5 18 203081 77805856 0,5055 0,041982748 1 1
TRUE
A34 T5 A34T5 19 288062 59022697 0,5 -0,148038543 1 1
TRUE
A34 T5 A34T5 20 138125 35467713 0,5 -0,021559771 1 1
TRUE
A34 T5 A34T5 20 35559352 36612084 0,96 3,881490263 28 1
TRUE
A34 T5 A34T5 20 36841756 62903550 0,5 -0,072509356 1 1
TRUE
A34 T5 A34T5 21 10793925 47976203 0,507 -0,025266502 1 1
TRUE
A34 T5 A34T5 22 17054291 51207180 0,5 -0,073564367 1 1
TRUE
A34 T6 A34T6 1 907609 1585642 0,5 -0,296866285 1 1
TRUE
A34 T6 A34T6 1 1633004 1635193 0,5 -3,370303425 0 0
TRUE
A34 T6 A34T6 1 1635565 16382834 0,507 -0,115217611 1 1
TRUE
A34 T6 A34T6 1 16385248 16950449 0,5 -2,651411426 0 0
TRUE
A34 T6 A34T6 1 16974637 203317204 0,5 -0,001328462 1 1
TRUE
A34 T6 A34T6 1 203766827 204516025 0,969 4,127903826 45 1
TRUE
A34 T6 A34T6 1 204915347 249107414 0,5 0,00224944 1 1
TRUE
A34 T6 A34T6 2 224970 70162534 0,5 -0,008041853 1 1
TRUE
A34 T6 A34T6 2 70677994 91809385 0,803 -0,576907335 1 0
TRUE
A34 T6 A34T6 2 95537330 242842568 0,5 -0,017556802 1 1
TRUE
A34 T6 A34T6 3 361508 197402254 0,5 0,003921585 1 1
TRUE
A34 T6 A34T6 4 60400 49063872 0,504 -0,047343406 1 1 TRUE
A34 T6 A34T6 4 52714511 55593464 0,7185 0,670384714 3 1
TRUE
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A34 T6 A34T6 4 55946171 190395259 0,5 0,047863588 1 1
TRUE
A34 T6 A34T6 5 163205 180665998 0,5 0,071165056 1 1
TRUE
A34 T6 A34T6 6 335251 170887693 0,5 -0,030276808 1 1
TRUE
A34 T6 A34T6 7 296739 11419378 0,705 0,557699992 3 1
FALSE
A34 T6 A34T6 7 11464297 24325009 0,631 0,427856082 2 1
TRUE
A34 T6 A34T6 7 24844080 54621692 0,6865 0,704317288 3 1
FALSE
A34 T6 A34T6 7 55214348 55229255 0,98 4,187194678 48 1
TRUE
A34 T6 A34T6 7 55780176 158827326 0,6935 0,636336869 3 1
FALSE
A34 T6 A34T6 8 196274 146228622 0,503 -0,027845402 1 1
TRUE
A34 T6 A34T6 9 154795 27556780 0,792527765 -0,772061015 1
0 TRUE
A34 T6 A34T6 9 32418237 141016262 0,504 -0,048365296 1 1
TRUE
A34 T6 A34T6 10 1018585 25888180 0,8035 -0,675440879 1 0
TRUE
A34 T6 A34T6 10 26241025 33552695 0,5745 -0,096387991 1 1
FALSE
A34 T6 A34T6 10 35320355 37505192 0,784062505 -0,829756509 1
0 TRUE
A34 T6 A34T6 10 38344700 43695049 0,512 -0,280688548 1 1
TRUE
A34 T6 A34T6 10 44340865 45958881 0,758 -0,665669832 1 0
TRUE
A34 T6 A34T6 10 46965018 47000146 0,534 -0,884281512 0 0
TRUE
A34 T6 A34T6 10 47667380 135381276 0,806 -0,702130882 1 0
TRUE
A34 T6 A34T6 11 193865 134856661 0,505 0,026617466 1 1
TRUE
A34 T6 A34T6 12 250239 133796033 0,502 -0,011081271 1 1
TRUE
A34 T6 A34T6 13 19600475 115064542 0,5 0,023472373 1 1
TRUE
A34 T6 A34T6 14 19889910 107178965 0,5 0,066357604 1 1
TRUE
A34 T6 A34T6 15 20446043 31779838 0,509 -0,066476635 1 1
TRUE
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A34 T6 A34T6 15 31793930 59981590 0,782 -0,589984005 1 0
FALSE
A34 T6 A34T6 15 60644074 102312835 0,5 0,04576545 1 1
TRUE
A34 T6 A34T6 16 129531 90161231 0,5 -0,105086031 1 1
TRUE
A34 T6 A34T6 17 171098 81050982 0,5 -0,01869474 1 1
TRUE
A34 T6 A34T6 18 203081 77805856 0,5 0,025268006 1 1
TRUE
A34 T6 A34T6 19 288062 59022697 0,5 -0,110588474 1 1
TRUE
A34 T6 A34T6 20 138125 35467713 0,5 -0,02556477 1 1
TRUE
A34 T6 A34T6 20 35559352 36612084 0,97 4,150399965 45 1
TRUE
A34 T6 A34T6 20 36841756 62903550 0,5 -0,063186955 1 1
TRUE
A34 T6 A34T6 21 10793925 47976203 0,503 -0,037582804 1 1
TRUE
A34 T6 A34T6 22 17054291 51207180 0,5 -0,060909815 1 1
TRUE
A44 M A44M 1 1563789 248814052 0,5 -0,042972375 1 1
TRUE
A44 M A44M 2 675831 242814463 0,5 -0,037889733 1 1
TRUE
A44 M A44M 3 239347 197765432 0,5 -0,023676495 1 1
TRUE
A44 M A44M 4 47658 190395259 0,505 -0,040397262 1 1 TRUE
A44 M A44M 5 140532 180661256 0,505 -0,04074769 1 1
TRUE
A44 M A44M 6 203722 29856347 0,503 -0,007091312 1 1
TRUE
A44 M A44M 6 29856427 33053728 0,505 -0,074702756 1 1
TRUE
A44 M A44M 6 33053737 33053971 0,6815 -0,197056003 1 0
FALSE
A44 M A44M 6 33054046 170632383 0,506 -0,046474494 1 1
TRUE
A44 M A44M 7 228930 158827401 0,5 -0,01340634 1 1
TRUE
A44 M A44M 8 195347 146056279 0,5 -0,035272335 1 1
TRUE
A44 M A44M 9 154933 141069927 0,5 -0,037830353 1 1
TRUE
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A44 M A44M 10 285200 51582686 0,5 -0,035550394 1 1
TRUE
A44 M A44M 10 51620231 51620499 0,875 -0,917013216 1 0
TRUE
A44 M A44M 10 51623190 135271764 0,5 -0,027999311 1 1
TRUE
A44 M A44M 11 193865 134251777 0,5 -0,025083784 1 1
TRUE
A44 M A44M 12 247900 32945769 0,5095 -0,066413605 1 1
TRUE
A44 M A44M 12 39997598 133324600 0,5 -0,004704174 1 1
TRUE
A44 M A44M 13 19042463 115091399 0,506 -0,044486774 1 1
TRUE
A44 M A44M 14 19400419 107283156 0,5 -0,045203035 1 1
TRUE
A44 M A44M 15 20170449 102312835 0,5035 -0,058403309 1 1
TRUE
A44 M A44M 16 115041 90050880 0,5 0,012496504 1 1
TRUE
A44 M A44M 17 177359 81052423 0,5 -0,01040917 1 1
TRUE
A44 M A44M 18 196829 77659561 0,5 -0,073871413 1 1
TRUE
A44 M A44M 19 373897 59082368 0,5 0,041411961 1 1
TRUE
A44 M A44M 20 207889 62903830 0,5 -0,038581426 1 1
TRUE
A44 M A44M 21 10624139 48078611 0,5 -0,029270366 1 1
TRUE
A44 M A44M 22 16157883 51171497 0,5 -0,024235809 1 1
TRUE
A44 S A44S 1 1563789 248814052 0,5 -0,022171402 1 1
TRUE
A44 S A44S 2 675831 242814463 0,504 -0,014591875 1 1
TRUE
A44 S A44S 3 239347 197765432 0,504 -0,008848574 1 1
TRUE
A44 S A44S 4 47658 190395259 0,5 -0,028159589 1 1 TRUE
A44 S A44S 5 140532 180661256 0,5 -0,038101924 1 1
TRUE
A44 S A44S 6 203722 170632383 0,5 -0,036655762 1 1
TRUE
A44 S A44S 7 228930 158827401 0,5005 0,013719948 1 1
TRUE
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A44 S A44S 8 195347 146056279 0,5 -0,026262773 1 1
TRUE
A44 S A44S 9 154933 141069927 0,5 -0,014261308 1 1
TRUE
A44 S A44S 10 285200 135271764 0,503 -0,033236595 1 1
TRUE
A44 S A44S 11 193865 134251777 0,502 -0,014374646 1 1
TRUE
A44 S A44S 12 247900 32945769 0,5065 -0,038506502 1 1
TRUE
A44 S A44S 12 39997598 133324600 0,5 -0,00776582 1 1
TRUE
A44 S A44S 13 19042463 115091399 0,5 -0,033005009 1 1
TRUE
A44 S A44S 14 19400419 107283156 0,5 -0,029034563 1 1
TRUE
A44 S A44S 15 20170449 102312835 0,5 -0,038944566 1 1
TRUE
A44 S A44S 16 115041 90050880 0,504 0,027651501 1 1
TRUE
A44 S A44S 17 177359 81052423 0,5 0,015644454 1 1
TRUE
A44 S A44S 18 196829 77659561 0,5 -0,071504234 1 1
TRUE
A44 S A44S 19 373897 59082368 0,5 0,074398827 1 1
TRUE
A44 S A44S 20 207889 62903830 0,5 -0,006862614 1 1
TRUE
A44 S A44S 21 10624139 48078611 0,5 -0,032461374 1 1
TRUE
A44 S A44S 22 16157883 17076273 0,68 0,010437511 2 1
TRUE
A44 S A44S 22 17131416 51171497 0,5 -0,014503327 1 1
TRUE
A44 T1 A44T1 1 1563789 4772053 0,5 0,097250296 1 1
TRUE
A44 T1 A44T1 1 4847594 6947717 0,71 -0,570922027 1 0
TRUE
A44 T1 A44T1 1 7723588 248814052 0,5 -0,060005948 1 1
TRUE
A44 T1 A44T1 2 675831 242814463 0,5 -0,047703884 1 1
TRUE
A44 T1 A44T1 3 239347 197765432 0,5 -0,038070247 1 1
TRUE
A44 T1 A44T1 4 47658 980464 0,678 -0,41739074 1 0
FALSE
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A44 T1 A44T1 4 982852 190395259 0,5 -0,049389226 1 1
TRUE
A44 T1 A44T1 5 140532 180661256 0,5 -0,054228292 1 1
TRUE
A44 T1 A44T1 6 203722 31324025 0,5 -0,038081726 1 1
TRUE
A44 T1 A44T1 6 31324200 31324830 0,7325 -0,228835162 1 0
TRUE
A44 T1 A44T1 6 31324847 32487038 0,5 0,065660473 1 1
TRUE
A44 T1 A44T1 6 32487054 32487123 0,757 0,279186848 2 0
TRUE
A44 T1 A44T1 6 32487294 33053092 0,504 -0,103830462 1 1
TRUE
A44 T1 A44T1 6 33053477 33054074 0,7 -0,202471029 1 0
TRUE
A44 T1 A44T1 6 33071591 160241440 0,504 -0,050464647 1 1
TRUE
A44 T1 A44T1 6 160445793 160969738 0,702 -0,495918278 1 0
TRUE
A44 T1 A44T1 6 161132146 170632383 0,5 -0,017476142 1 1
TRUE
A44 T1 A44T1 7 228930 158827401 0,611 0,344716034 2 1
TRUE
A44 T1 A44T1 8 195347 146056279 0,5 -0,035709488 1 1
TRUE
A44 T1 A44T1 9 154933 33750748 0,689 -0,570678181 1 0
FALSE
A44 T1 A44T1 9 34089395 141069927 0,505 -0,013175857 1 1
TRUE
A44 T1 A44T1 10 285200 45672429 0,697 -0,525623455 1 0
FALSE
A44 T1 A44T1 10 45689237 47000239 0,506 -0,645952359 0 0
TRUE
A44 T1 A44T1 10 47605468 135271764 0,7 -0,500175202 1 0
FALSE
A44 T1 A44T1 11 193865 134251777 0,508 -0,015473558 1 1
TRUE
A44 T1 A44T1 12 247900 3768705 0,787 -0,03729967 2 0
FALSE
A44 T1 A44T1 12 3948718 133324600 0,506 -0,028153981 1 1
TRUE
A44 T1 A44T1 13 19042463 115091399 0,504 -0,123786429 1 1
TRUE
A44 T1 A44T1 14 19400419 74441684 0,5 -0,047303644 1 1
TRUE
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A44 T1 A44T1 14 74500585 74512698 0,571 -0,315549901 1 1
TRUE
A44 T1 A44T1 14 74514674 107283156 0,5 -0,041285763 1 1
TRUE
A44 T1 A44T1 15 20170449 22016259 0,522 -0,117075689 1 1
TRUE
A44 T1 A44T1 15 22319166 102312835 0,5 -0,050861772 1 1
TRUE
A44 T1 A44T1 16 115041 90050880 0,5 0,027149966 1 1
TRUE
A44 T1 A44T1 17 177359 14673411 0,5 0,033993948 1 1
TRUE
A44 T1 A44T1 17 15134175 21117589 0,688 -0,466517511 1 0
FALSE
A44 T1 A44T1 17 21312542 22214959 0,5 -0,464161883 1 1
TRUE
A44 T1 A44T1 17 25308787 39551763 0,695 -0,55314438 1 0
FALSE
A44 T1 A44T1 17 39578810 81052423 0,5 0,021948007 1 1
TRUE
A44 T1 A44T1 18 196829 77659561 0,5 -0,102171153 1 1
TRUE
A44 T1 A44T1 19 373897 59082368 0,611 0,433086281 2 1
TRUE
A44 T1 A44T1 20 207889 62903830 0,612 0,321061314 2 1
TRUE
A44 T1 A44T1 21 10624139 48078611 0,5 -0,0172864 1 1
TRUE
A44 T1 A44T1 22 16157883 17131416 0,538 -0,261026308 1 1
TRUE
A44 T1 A44T1 22 17156061 51171497 0,701 -0,455930835 1 0
FALSE
A44 T2 A44T2 1 1563789 248814052 0,5 -0,040635608 1 1
TRUE
A44 T2 A44T2 2 675831 242814463 0,506 -0,038558484 1 1
TRUE
A44 T2 A44T2 3 239347 197765432 0,5 -0,026882812 1 1
TRUE
A44 T2 A44T2 4 47658 190395259 0,5 -0,021711812 1 1 TRUE
A44 T2 A44T2 5 140532 180661256 0,5 -0,037080382 1 1
TRUE
A44 T2 A44T2 6 203722 31324516 0,503 0,024088893 1 1
TRUE
A44 T2 A44T2 6 31324547 31324604 0,725821876 0,250445866 3
0 TRUE
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A44 T2 A44T2 6 31324666 32487038 0,5 0,032518399 1 1
TRUE
A44 T2 A44T2 6 32487054 32489672 0,654054728 -0,084984491 2
0 FALSE
A44 T2 A44T2 6 32489744 33053740 0,538 -0,040438763 1 1
FALSE
A44 T2 A44T2 6 33053780 33054074 0,647044474 -0,113927074 2
0 TRUE
A44 T2 A44T2 6 33071591 170632383 0,506 -0,036090908 1 1
TRUE
A44 T2 A44T2 7 228930 158827401 0,57 0,207538862 2 1
TRUE
A44 T2 A44T2 8 195347 146056279 0,5 -0,006575762 1 1
TRUE
A44 T2 A44T2 9 154933 34093274 0,596 -0,301226997 1 0
TRUE
A44 T2 A44T2 9 34096873 141069927 0,5 -0,02753593 1 1
TRUE
A44 T2 A44T2 10 285200 133107496 0,593 -0,275853437 1 0
TRUE
A44 T2 A44T2 10 133608210 133608292 0,670952936 -0,012734618 2
0 TRUE
A44 T2 A44T2 10 133748121 135271764 0,6055 -0,275134018 1 0
TRUE
A44 T2 A44T2 11 193865 134251777 0,5 -0,021109213 1 1
TRUE
A44 T2 A44T2 12 247900 3768705 0,660203926 -0,059109851 2
0 TRUE
A44 T2 A44T2 12 3948718 133324600 0,5 -0,021291253 1 1
TRUE
A44 T2 A44T2 13 19042463 115091399 0,5 -0,033441724 1 1
TRUE
A44 T2 A44T2 14 19400419 107283156 0,505 -0,031637082 1 1
TRUE
A44 T2 A44T2 15 20170449 102312835 0,5 -0,069709097 1 1
TRUE
A44 T2 A44T2 16 115041 90050880 0,5 0,016355088 1 1
TRUE
A44 T2 A44T2 17 177359 15154966 0,5 0,025694464 1 1
TRUE
A44 T2 A44T2 17 15406197 39620399 0,586 -0,289435262 1 0
FALSE
A44 T2 A44T2 17 39622068 81052423 0,508 0,011546491 1 1
TRUE
A44 T2 A44T2 18 196829 77659561 0,5 -0,074465604 1 1
TRUE
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A44 T2 A44T2 19 373897 59082368 0,57 0,255230231 2 1
TRUE
A44 T2 A44T2 20 207889 62903830 0,57 0,171762897 2 1
TRUE
A44 T2 A44T2 21 10624139 48078611 0,5 -0,01325936 1 1
TRUE
A44 T2 A44T2 22 16157883 51171497 0,599 -0,286167962 1 0
TRUE
A44 T3 A44T3 1 1563789 248814052 0,506 -0,048353641 1 1
TRUE
A44 T3 A44T3 2 675831 242814463 0,504 -0,060454428 1 1
TRUE
A44 T3 A44T3 3 239347 197765432 0,5 -0,04962555 1 1
TRUE
A44 T3 A44T3 4 47658 190395259 0,504 -0,080965881 1 1 TRUE
A44 T3 A44T3 5 140532 180661256 0,5 -0,069395358 1 1
TRUE
A44 T3 A44T3 6 203722 29893293 0,509 -0,055845808 1 1
TRUE
A44 T3 A44T3 6 29893461 29911154 0,582570504 -0,161304821 1
0 FALSE
A44 T3 A44T3 6 29911190 170632383 0,507 -0,050901636 1 1
TRUE
A44 T3 A44T3 7 228930 158827401 0,5075 0,147779188 2 2
TRUE
A44 T3 A44T3 8 195347 146056279 0,5 -0,032746241 1 1
TRUE
A44 T3 A44T3 9 154933 33613986 0,53 -0,294687626 0 0
FALSE
A44 T3 A44T3 9 33625082 141069927 0,5 -0,014496935 1 1
TRUE
A44 T3 A44T3 10 285200 135271764 0,517 -0,230080508 0 0
FALSE
A44 T3 A44T3 11 193865 134251777 0,5 -0,01999059 1 1
TRUE
A44 T3 A44T3 12 247900 3768705 0,599852979 -0,100302442 2
0 TRUE
A44 T3 A44T3 12 3948718 133324600 0,5 -0,053123931 1 1
TRUE
A44 T3 A44T3 13 19042463 19727724 0,560044843 -0,237128757 1
0 TRUE
A44 T3 A44T3 13 19748344 115091399 0,5 -0,232176743 0 0
TRUE
A44 T3 A44T3 14 19400419 107283156 0,5 -0,036967283 1 1
TRUE
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A44 T3 A44T3 15 20170449 102312835 0,504 -0,045251949 1 1
TRUE
A44 T3 A44T3 16 115041 90050880 0,5 0,040213363 1 1
TRUE
A44 T3 A44T3 17 177359 14095566 0,5 0,040986932 1 1
TRUE
A44 T3 A44T3 17 14673411 38348616 0,562 -0,188300009 1 0
TRUE
A44 T3 A44T3 17 38609187 81052423 0,5 0,02296327 1 1
TRUE
A44 T3 A44T3 18 196829 77659561 0,5 -0,109983256 1 1
TRUE
A44 T3 A44T3 19 373897 59082368 0,5 0,244806079 2 2
TRUE
A44 T3 A44T3 20 207889 62903830 0,511 0,158580275 2 2
FALSE
A44 T3 A44T3 21 10624139 48078611 0,5 -0,021948935 1 1
TRUE
A44 T3 A44T3 22 16157883 51171497 0,5685 -0,14823684 1 0
TRUE
A44 T5 A44T5 1 1563789 248814052 0,5 -0,027843144 1 1
TRUE
A44 T5 A44T5 2 675831 242814463 0,5 -0,022770425 1 1
TRUE
A44 T5 A44T5 3 239347 197765432 0,5 -0,011982435 1 1
TRUE
A44 T5 A44T5 4 47658 190395259 0,5 -0,013790654 1 1 TRUE
A44 T5 A44T5 5 140532 180661256 0,5 -0,017690111 1 1
TRUE
A44 T5 A44T5 6 203722 32339647 0,505 -0,003534448 1 1
TRUE
A44 T5 A44T5 6 32369488 32489963 0,641 -0,112156475 1 1
FALSE
A44 T5 A44T5 6 32497943 170632383 0,507 -0,036231521 1 1
TRUE
A44 T5 A44T5 7 228930 158827401 0,5 0,075720605 1 1
TRUE
A44 T5 A44T5 8 195347 146056279 0,5 -0,016798216 1 1
TRUE
A44 T5 A44T5 9 154933 141069927 0,5 -0,036736946 1 1
TRUE
A44 T5 A44T5 10 285200 135271764 0,5 -0,096225187 1 1
TRUE
A44 T5 A44T5 11 193865 134251777 0,5 -0,015959239 1 1
TRUE
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A44 T5 A44T5 12 247900 32945769 0,508 -0,057275986 1 1
TRUE
A44 T5 A44T5 12 39997598 133324600 0,5 0,001960039 1 1
TRUE
A44 T5 A44T5 13 19042463 115091399 0,5 -0,005903223 1 1
TRUE
A44 T5 A44T5 14 19400419 107283156 0,5075 -0,026086475 1 1
TRUE
A44 T5 A44T5 15 20170449 102312835 0,5 -0,033725601 1 1
TRUE
A44 T5 A44T5 16 115041 32626855 0,5 0,031845353 1 1
TRUE
A44 T5 A44T5 16 33413927 33413957 0,773 -0,16700353 1 0
TRUE
A44 T5 A44T5 16 34257013 90050880 0,5 0,010623059 1 1
TRUE
A44 T5 A44T5 17 177359 81052423 0,5 -0,006810207 1 1
TRUE
A44 T5 A44T5 18 196829 77659561 0,5 -0,053159782 1 1
TRUE
A44 T5 A44T5 19 373897 59082368 0,5 0,130639089 1 1
TRUE
A44 T5 A44T5 20 207889 62903830 0,5 0,056552389 1 1
TRUE
A44 T5 A44T5 21 10624139 48078611 0,505 -0,019021417 1 1
TRUE
A44 T5 A44T5 22 16157883 51171497 0,5 -0,073379663 1 1
TRUE
SP28 recurrent_M SP28_recurrent_M 1 808928 248813901 0,5 -
0,013669518 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 2 173150 242814463 0,505
0,012613663 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 3 361508 197581147 0,5 -
0,0052783 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 4 60303 190905235 0,5 0,006529089
1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 5 163266 180670470 0,5
0,012421498 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 6 335424 31237727 0,5
0,003224272 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 6 31237767 31238147 0,706
0,021485957 2 1 FALSE
SP28 recurrent_M SP28_recurrent_M 6 31238297 32546703 0,5 -
0,019043974 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 6 32546743 32549331 0,7
0,466609672 2 1 FALSE
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SP28 recurrent_M SP28_recurrent_M 6 32549340 33048348 0,569 -
0,005636757 1 1 FALSE
SP28 recurrent_M SP28_recurrent_M 6 33048599 33052958 0,688
0,216896792 2 1 TRUE
SP28 recurrent_M SP28_recurrent_M 6 33052986 170892848 0,5
0,006754585 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 7 296739 159024799 0,5 -
0,013769875 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 8 182949 146222122 0,5
0,016106563 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 9 154795 141070950 0,5 -
0,00712782 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 10 1052950 135279979 0,5 -
0,001562733 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 11 193112 134856661 0,5 -
0,016602508 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 12 310901 133808129 0,5 -
0,012454859 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 13 19042581 114323997 0,5035
0,018493788 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 14 19411738 107283160 0,5
0,005759296 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 15 20169854 102313869 0,5 -
0,013132091 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 16 97610 90142087 0,5 -0,063592576
1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 17 6115 81052423 0,502 -0,071550762
1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 18 196829 77896242 0,5
0,015525484 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 19 367089 59010819 0,5 -
0,108533768 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 20 76962 62959184 0,5 -0,018716718
1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 21 9650104 11186346 0,582
0,077231359 1 1 FALSE
SP28 recurrent_M SP28_recurrent_M 21 14433284 48083526 0,506
0,005204273 1 1 TRUE
SP28 recurrent_M SP28_recurrent_M 22 16255826 51065831 0,5 -
0,069367822 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 1 808928 147287992 0,507
0,030584765 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 1 148342446 149648627 0,678 -
0,114242534 1 0 TRUE
SP28 recurrent_S SP28_recurrent_S 1 149648696 248813901 0,509
0,050686339 1 1 TRUE
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SP28 recurrent_S SP28_recurrent_S 2 173150 209358027 0,505 -
0,137038733 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 2 210010065 210010136 0,562242793
-0,822774491 0 0 TRUE
SP28 recurrent_S SP28_recurrent_S 2 210043728 242814463 0,5 -
0,148281545 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 3 361508 197581147 0,5
0,050277215 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 4 60303 190905235 0,504 -0,066921899
1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 5 163266 180670470 0,573 -
0,048281024 1 1 FALSE
SP28 recurrent_S SP28_recurrent_S 6 335424 31237727 0,505
0,046922204 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 6 31237767 31238297 0,692 -
0,013108958 1 0 TRUE
SP28 recurrent_S SP28_recurrent_S 6 31238308 32525928 0,5
0,012453931 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 6 32546696 32546935 0,7255
0,442552417 3 1 FALSE
SP28 recurrent_S SP28_recurrent_S 6 32546940 33095615 0,5845
0,066086829 2 1 FALSE
SP28 recurrent_S SP28_recurrent_S 6 33095636 170892848 0,5
0,044326112 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 7 296739 159024799 0,594
0,059972885 2 1 FALSE
SP28 recurrent_S SP28_recurrent_S 8 182949 146222122 0,5
0,105843425 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 9 154795 141070950 0,5
0,037150834 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 10 1052950 51124153 0,711 -
0,186541301 1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 10 51532621 51633027 0,538 -
0,339614192 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 10 51785728 135279979 0,716433627
-0,196330024 1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 11 193112 59830198 0,5
0,275346088 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 11 59860178 63072310 0,691849345
-0,316279419 1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 11 63129782 64950970 0,508 -
0,044585421 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 11 64972354 134856661 0,683 -
0,2890111 1 0 TRUE
SP28 recurrent_S SP28_recurrent_S 12 310901 11244941 0,57 -
0,137024199 1 1 FALSE
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SP28 recurrent_S SP28_recurrent_S 12 11338539 34175508 0,5
0,026353136 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 12 37969194 133808129 0,564 -
0,11422155 1 1 FALSE
SP28 recurrent_S SP28_recurrent_S 13 19042581 42876290 0,505
0,165064311 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 13 43180503 95230412 0,684 -
0,28561787 1 0 TRUE
SP28 recurrent_S SP28_recurrent_S 13 95275576 114323997 0,507
0,114027247 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 14 19411738 107283160 0,5
0,049949032 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 15 20169854 22692271 0,607 -
0,290927489 1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 15 22788922 102313869 0,681 -
0,310055758 1 0 TRUE
SP28 recurrent_S SP28_recurrent_S 16 97610 90142087 0,5 -0,169052845
1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 17 6115 2930339 0,76 0,123790436
2 0 TRUE
SP28 recurrent_S SP28_recurrent_S 17 2965929 2966308 0,51 -
0,032287907 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 17 3144286 20945887 0,767891883
0,092559463 2 0 TRUE
SP28 recurrent_S SP28_recurrent_S 17 21194769 81052423 0,5
0,114558818 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 18 196829 77896242 0,5
0,056464775 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 19 367089 53612720 0,667
0,174135445 2 1 FALSE
SP28 recurrent_S SP28_recurrent_S 19 53612989 59010819 0,649
0,151102047 2 1 FALSE
SP28 recurrent_S SP28_recurrent_S 20 76962 62959184 0,591 -0,17425896
1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 21 9650104 11186346 0,591
0,030737625 1 0 FALSE
SP28 recurrent_S SP28_recurrent_S 21 14433284 48083526 0,506
0,157852634 1 1 TRUE
SP28 recurrent_S SP28_recurrent_S 22 16255826 51065831 0,5
0,020542274 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 1 808928 248813901 0,5
0,025667906 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 2 173150 242814463 0,512 -
0,124968801 1 1 FALSE
SP28 recurrent_T SP28_recurrent_T 3 361508 197581147 0,5
0,046522095 1 1 TRUE
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SP28 recurrent_T SP28_recurrent_T 4 60303 190905235 0,5045 -0,009753476
1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 5 163266 180670470 0,566 -
0,083908871 1 1 FALSE
SP28 recurrent_T SP28_recurrent_T 6 335424 29855401 0,505
0,055625939 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 6 29855849 29855864 0,715469089
-0,126510968 2 0 TRUE
SP28 recurrent_T SP28_recurrent_T 6 29855940 31237723 0,5 -
0,041758471 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 6 31237727 31238322 0,667 -
0,036985894 1 0 TRUE
SP28 recurrent_T SP28_recurrent_T 6 31238372 32522490 0,5 -
0,006887214 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 6 32522501 32546953 0,7245
0,287816002 2 0 TRUE
SP28 recurrent_T SP28_recurrent_T 6 32548122 32629889 0,505 -
0,081587758 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 6 32629904 32634505 0,667 -
0,071775704 1 0 TRUE
SP28 recurrent_T SP28_recurrent_T 6 32713487 114279783 0,503
0,038842098 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 6 116774259 116774616 0,790665671
0,316265501 3 0 TRUE
SP28 recurrent_T SP28_recurrent_T 6 116782478 170892848 0,5
0,055408842 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 7 296739 6063283 0,639
0,084837461 2 1 FALSE
SP28 recurrent_T SP28_recurrent_T 7 6063674 159024799 0,609
0,142740038 2 1 FALSE
SP28 recurrent_T SP28_recurrent_T 8 182949 146222122 0,5
0,036719939 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 9 154795 141070950 0,5
0,012158994 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 10 1052950 135279979 0,684 -
0,289579377 1 0 FALSE
SP28 recurrent_T SP28_recurrent_T 11 193112 59830198 0,565
0,244386614 2 1 FALSE
SP28 recurrent_T SP28_recurrent_T 11 59860178 63072310 0,6765 -
0,309253086 1 0 TRUE
SP28 recurrent_T SP28_recurrent_T 11 63129782 64972354 0,5 -
0,080177249 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 11 64977424 67795353 0,650293642
-0,424069601 1 0 FALSE
SP28 recurrent_T SP28_recurrent_T 11 67798381 134856661 0,66 -
0,311974643 1 0 TRUE
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SP28 recurrent_T SP28_recurrent_T 12 310901 133808129 0,5 -
0,066337641 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 13 19042581 19950468 0,627 -
0,347074778 1 0 FALSE
SP28 recurrent_T SP28_recurrent_T 13 19956653 43358176 0,5
0,137390191 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 13 43597977 95034749 0,659 -
0,281590604 1 0 TRUE
SP28 recurrent_T SP28_recurrent_T 13 95097956 114323997 0,51
0,062777388 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 14 19411738 107283160 0,5
0,044204929 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 15 20169854 22140512 0,531 -
0,340429388 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 15 22145552 102313869 0,667 -
0,329773731 1 0 TRUE
SP28 recurrent_T SP28_recurrent_T 16 97610 90142087 0,5 -0,14275515
1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 17 6115 2930339 0,735 0,003335445
2 0 TRUE
SP28 recurrent_T SP28_recurrent_T 17 2965929 3144286 0,533 -
0,127536746 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 17 3379815 8167600 0,749067021
0,054772336 2 0 TRUE
SP28 recurrent_T SP28_recurrent_T 17 8168224 20945887 0,735 -
0,034250828 2 0 FALSE
SP28 recurrent_T SP28_recurrent_T 17 21194769 81052423 0,5
0,0262627 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 18 196829 77896242 0,5
0,036864229 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 19 367089 59010819 0,625
0,18577287 2 1 FALSE
SP28 recurrent_T SP28_recurrent_T 20 76962 62959184 0,51 -0,150311291
1 1 FALSE
SP28 recurrent_T SP28_recurrent_T 21 9650104 48083526 0,5
0,075104503 1 1 TRUE
SP28 recurrent_T SP28_recurrent_T 22 16255826 51065831 0,5 -
0,048904429 1 1 TRUE
A23 primary_M A23_primary_M 1 13273 72740634 0,5 0,048955309
2 2 TRUE
A23 primary_M A23_primary_M 1 74664149 104076537 0,582984881
-0,232324553 2 0 TRUE
A23 primary_M A23_primary_M 1 104084226 248814126 0,5
0,027449327 2 2 TRUE
A23 primary_M A23_primary_M 2 45843 243037004 0,5 0,016097206
2 2 TRUE
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A23 primary_M A23_primary_M 3 403288 168269756 0,5
0,012332662 2 2 TRUE
A23 primary_M A23_primary_M 3 168804431 180703663 0,621
0,377447201 6 2 TRUE
A23 primary_M A23_primary_M 3 182681740 184588420 0,894
2,325426212 53 2 TRUE
A23 primary_M A23_primary_M 3 184616504 197837967 0,5
0,050384134 2 2 TRUE
A23 primary_M A23_primary_M 4 195436 190903950 0,5
0,018172373 2 2 TRUE
A23 primary_M A23_primary_M 5 163205 180583043 0,5
0,025661524 2 2 TRUE
A23 primary_M A23_primary_M 6 203722 33048663 0,508 -
0,138563225 1 1 TRUE
A23 primary_M A23_primary_M 6 33048686 33053812 0,61344137
-0,12291211 3 0 FALSE
A23 primary_M A23_primary_M 6 33060064 170892848 0,5 -
0,092643346 1 1 TRUE
A23 primary_M A23_primary_M 7 295970 53255471 0,5775
0,204574056 4 2 FALSE
A23 primary_M A23_primary_M 7 53930720 56022544 0,954
3,414444989 127 2 TRUE
A23 primary_M A23_primary_M 7 56047572 159053596 0,5635
0,229197543 4 2 TRUE
A23 primary_M A23_primary_M 8 182934 146228622 0,5 -
0,001298881 2 2 TRUE
A23 primary_M A23_primary_M 9 214864 141071475 0,505
0,005807276 2 2 TRUE
A23 primary_M A23_primary_M 10 132135 38737254 0,589349848
-0,210134696 2 0 TRUE
A23 primary_M A23_primary_M 10 43315692 93771192 0,5685 -
0,195723889 2 0 FALSE
A23 primary_M A23_primary_M 10 93786557 135381592 0,580049312
-0,242444794 2 0 TRUE
A23 primary_M A23_primary_M 11 192997 134252121 0,5 -
0,106982619 1 1 TRUE
A23 primary_M A23_primary_M 12 248202 133795960 0,5
0,034110554 2 2 TRUE
A23 primary_M A23_primary_M 13 19059494 115030714 0,5
0,03841216 2 2 TRUE
A23 primary_M A23_primary_M 14 19401146 107178965 0,5
0,018011793 2 2 TRUE
A23 primary_M A23_primary_M 15 20173245 102304498 0,5
0,021913198 2 2 TRUE
A23 primary_M A23_primary_M 16 97610 90133064 0,5 -0,07425844
2 2 TRUE
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A23 primary_M A23_primary_M 17 6177 81006629 0,5 0,030321604
2 2 TRUE
A23 primary_M A23_primary_M 18 204780 77926862 0,5 -
0,015922866 2 2 TRUE
A23 primary_M A23_primary_M 19 312164 59082605 0,5
0,027127279 2 2 TRUE
A23 primary_M A23_primary_M 20 76962 62903550 0,5 0,036528896
2 2 TRUE
A23 primary_M A23_primary_M 21 9891930 9907416 0,618959177
-0,102170433 3 0 TRUE
A23 primary_M A23_primary_M 21 10862853 48078611 0,5
0,010416835 2 2 TRUE
A23 primary_M A23_primary_M 22 16393311 51219006 0,5
0,027614631 2 2 TRUE
A23 primary_S A23_primary_S 1 13273 72740634 0,5 0,054752312
2 2 TRUE
A23 primary_S A23_primary_S 1 74664149 99753631 0,746771865
-0,564869274 2 0 TRUE
A23 primary_S A23_primary_S 1 100715454 248814126 0,5
0,024026661 2 2 TRUE
A23 primary_S A23_primary_S 2 45843 243037004 0,5 0,014672632
2 2 TRUE
A23 primary_S A23_primary_S 3 403288 171510238 0,505
0,021472492 2 2 TRUE
A23 primary_S A23_primary_S 3 171844787 172099011 0,955
3,436308841 60 2 TRUE
A23 primary_S A23_primary_S 3 172144718 180703663 0,522 -
0,127043818 2 2 FALSE
A23 primary_S A23_primary_S 3 182681740 184299167 0,9655
3,718768161 74 2 TRUE
A23 primary_S A23_primary_S 3 184550501 186276393 0,627
0,337928421 4 2 TRUE
A23 primary_S A23_primary_S 3 186314734 197837967 0,5 -
0,001275892 2 2 TRUE
A23 primary_S A23_primary_S 4 195436 190903950 0,5
0,009662857 2 2 TRUE
A23 primary_S A23_primary_S 5 163205 180583043 0,5
0,021080752 2 2 TRUE
A23 primary_S A23_primary_S 6 203722 29897259 0,5 -
0,029476351 2 2 TRUE
A23 primary_S A23_primary_S 6 29897301 29911240 0,686 -
0,347200886 2 0 FALSE
A23 primary_S A23_primary_S 6 29911260 170892848 0,5
0,001551187 2 2 TRUE
A23 primary_S A23_primary_S 7 295970 53255471 0,625
0,428829697 4 2 TRUE
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A23 primary_S A23_primary_S 7 53930720 55780845 0,941
3,23911179 51 2 TRUE
A23 primary_S A23_primary_S 7 55991292 57642490 0,792
1,382649292 11 2 TRUE
A23 primary_S A23_primary_S 7 63040467 76112060 0,621
0,496106644 4 2 TRUE
A23 primary_S A23_primary_S 7 76131645 76131695 0,78909766
-0,301006668 3 0 FALSE
A23 primary_S A23_primary_S 7 76132898 159053596 0,625
0,437269181 4 2 TRUE
A23 primary_S A23_primary_S 8 182934 146228622 0,506
0,010848146 2 2 TRUE
A23 primary_S A23_primary_S 9 214864 24545513 0,5 -
0,139766383 2 2 TRUE
A23 primary_S A23_primary_S 9 25677933 27567145 0,742720344
-0,587768949 2 0 TRUE
A23 primary_S A23_primary_S 9 28863459 44175535 0,5 -
0,005445438 2 2 TRUE
A23 primary_S A23_primary_S 9 65973404 68433462 0,663 -
0,107066003 3 1 TRUE
A23 primary_S A23_primary_S 9 69002200 141071475 0,506
0,012421476 2 2 TRUE
A23 primary_S A23_primary_S 10 132135 25701341 0,75166698
-0,536707674 2 0 TRUE
A23 primary_S A23_primary_S 10 26310403 26994150 0,627 -
0,232122264 2 1 FALSE
A23 primary_S A23_primary_S 10 27326999 38737254 0,741792705
-0,592961328 2 0 TRUE
A23 primary_S A23_primary_S 10 43315692 63964653 0,591 -
0,299398166 2 1 TRUE
A23 primary_S A23_primary_S 10 64239709 73970451 0,75 -
0,502007625 2 0 TRUE
A23 primary_S A23_primary_S 10 75556404 77807092 0,514
0,261298103 3 3 TRUE
A23 primary_S A23_primary_S 10 79779150 82249108 0,731528639
-0,649199765 2 0 TRUE
A23 primary_S A23_primary_S 10 85902394 90034899 0,656 -
0,899547427 1 0 TRUE
A23 primary_S A23_primary_S 10 90354589 135381592 0,75 -
0,541094995 2 0 TRUE
A23 primary_S A23_primary_S 11 192997 134252121 0,604 -
0,25193671 2 1 TRUE
A23 primary_S A23_primary_S 12 248202 133795960 0,5
0,019962785 2 2 TRUE
A23 primary_S A23_primary_S 13 19059494 115030714 0,503
0,036953339 2 2 TRUE
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A23 primary_S A23_primary_S 14 19401146 107178965 0,507
0,014225361 2 2 TRUE
A23 primary_S A23_primary_S 15 20173245 102304498 0,5
0,035246944 2 2 TRUE
A23 primary_S A23_primary_S 16 97610 90133064 0,589 -0,211368732
2 1 FALSE
A23 primary_S A23_primary_S 17 6177 81006629 0,5 0,03951862
2 2 TRUE
A23 primary_S A23_primary_S 18 204780 77926862 0,505
0,00492966 2 2 TRUE
A23 primary_S A23_primary_S 19 312164 59082605 0,6 -
0,210281083 2 1 TRUE
A23 primary_S A23_primary_S 20 76962 62903550 0,502 0,024923894
2 2 TRUE
A23 primary_S A23_primary_S 21 9891930 48078611 0,5 -
0,002972587 2 2 TRUE
A23 primary_S A23_primary_S 22 16393311 51219006 0,5
0,053387456 2 2 TRUE
A23 primary_T A23_primary_T 1 13273 72740634 0,5 0,032504932
2 2 TRUE
A23 primary_T A23_primary_T 1 74664149 99753631 0,753 -
0,594331048 2 0 TRUE
A23 primary_T A23_primary_T 1 100715454 248814126 0,5
0,00554177 2 2 TRUE
A23 primary_T A23_primary_T 2 45843 243037004 0,505 -0,010445404
2 2 TRUE
A23 primary_T A23_primary_T 3 403288 168269756 0,5
0,003635093 2 2 TRUE
A23 primary_T A23_primary_T 3 168804431 170425956 0,8655
1,807140231 17 2 TRUE
A23 primary_T A23_primary_T 3 170797252 178917005 0,611
0,215366557 3 2 FALSE
A23 primary_T A23_primary_T 3 178922274 180703663 0,757
0,915563062 8 2 TRUE
A23 primary_T A23_primary_T 3 182681740 184766392 0,899
2,211003361 24 2 TRUE
A23 primary_T A23_primary_T 3 185635685 197837967 0,5 -
0,028464965 2 2 TRUE
A23 primary_T A23_primary_T 4 195436 190903950 0,5 -
0,012765349 2 2 TRUE
A23 primary_T A23_primary_T 5 163205 180583043 0,5
0,006545532 2 2 TRUE
A23 primary_T A23_primary_T 6 203722 170892848 0,5 -
0,027424967 2 2 TRUE
A23 primary_T A23_primary_T 7 295970 53255471 0,6305
0,427207212 4 2 TRUE
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A23 primary_T A23_primary_T 7 53930720 56022544 0,962
3,672188406 71 2 TRUE
A23 primary_T A23_primary_T 7 56047572 159053596 0,6275
0,427597441 4 2 TRUE
A23 primary_T A23_primary_T 8 182934 146228622 0,5 -
0,006066039 2 2 TRUE
A23 primary_T A23_primary_T 9 214864 24545513 0,5 -
0,140046673 2 2 TRUE
A23 primary_T A23_primary_T 9 25677933 27567145 0,719 -
0,741132557 1 0 FALSE
A23 primary_T A23_primary_T 9 28863459 44175535 0,5 -
0,01660197 2 2 TRUE
A23 primary_T A23_primary_T 9 65973404 66455647 0,6325 -
0,195350092 2 1 TRUE
A23 primary_T A23_primary_T 9 66457475 141071475 0,5
0,004263455 2 2 TRUE
A23 primary_T A23_primary_T 10 132135 25701341 0,7615 -
0,552544414 2 0 TRUE
A23 primary_T A23_primary_T 10 26310403 26534937 0,62 -
0,24210603 2 1 FALSE
A23 primary_T A23_primary_T 10 26559571 38737254 0,75 -
0,57268752 2 0 TRUE
A23 primary_T A23_primary_T 10 43315692 63700245 0,588 -
0,30436576 2 1 FALSE
A23 primary_T A23_primary_T 10 63964653 75556404 0,749 -
0,606564925 2 0 FALSE
A23 primary_T A23_primary_T 10 75671875 77807092 0,51
0,17757269 2 2 TRUE
A23 primary_T A23_primary_T 10 79779150 82249108 0,740172548
-0,703045639 2 0 TRUE
A23 primary_T A23_primary_T 10 85902394 88428335 0,508 -
0,589807045 1 1 TRUE
A23 primary_T A23_primary_T 10 88635779 92912588 0,734328559
-0,735134922 2 0 FALSE
A23 primary_T A23_primary_T 10 92912773 135381592 0,762 -
0,573993845 2 0 TRUE
A23 primary_T A23_primary_T 11 192997 134252121 0,597 -
0,28790233 2 1 TRUE
A23 primary_T A23_primary_T 12 248202 133795960 0,5
0,007573605 2 2 TRUE
A23 primary_T A23_primary_T 13 19059494 115030714 0,507 -
0,115762542 2 2 TRUE
A23 primary_T A23_primary_T 14 19401146 107178965 0,5
0,010978763 2 2 TRUE
A23 primary_T A23_primary_T 15 20173245 102304498 0,5
0,012436059 2 2 TRUE
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A23 primary_T A23_primary_T 16 97610 90133064 0,5065 -0,202505391
2 2 TRUE
A23 primary_T A23_primary_T 17 6177 81006629 0,5 0,01657154
2 2 TRUE
A23 primary_T A23_primary_T 18 204780 77926862 0,504 -
0,012410016 2 2 TRUE
A23 primary_T A23_primary_T 19 312164 59082605 0,5
0,04771544 2 2 TRUE
A23 primary_T A23_primary_T 20 76962 62903550 0,5 0,017515004
2 2 TRUE
A23 primary_T A23_primary_T 21 9891930 48078611 0,502 -
0,009818456 2 2 TRUE
A23 primary_T A23_primary_T 22 16393311 51219006 0,506 -
0,074019911 2 2 TRUE
SP28 primary_M SP28_primary_M 1 808928 248813901 0,5 -
0,000371537 1 1 TRUE
SP28 primary_M SP28_primary_M 2 173150 242814463 0,502
0,017289829 1 1 TRUE
SP28 primary_M SP28_primary_M 3 361508 197581147 0,5
0,012809525 1 1 TRUE
SP28 primary_M SP28_primary_M 4 60303 190905235 0,5 0,035888252
1 1 TRUE
SP28 primary_M SP28_primary_M 5 163266 180670470 0,5
0,016919492 1 1 TRUE
SP28 primary_M SP28_primary_M 6 335424 31237833 0,5
0,003376966 1 1 TRUE
SP28 primary_M SP28_primary_M 6 31237862 31239766 0,632
0,116876804 2 1 FALSE
SP28 primary_M SP28_primary_M 6 31239802 31924327 0,5 -
0,035378104 1 1 TRUE
SP28 primary_M SP28_primary_M 6 31926600 32714516 0,5755
0,027650416 1 1 FALSE
SP28 primary_M SP28_primary_M 6 32714592 170892848 0,5
0,02399774 1 1 TRUE
SP28 primary_M SP28_primary_M 7 296739 159024799 0,5
0,007514868 1 1 TRUE
SP28 primary_M SP28_primary_M 8 182949 146222122 0,5
0,025616635 1 1 TRUE
SP28 primary_M SP28_primary_M 9 154795 141070950 0,506 -
0,003593571 1 1 TRUE
SP28 primary_M SP28_primary_M 10 1052950 135279979 0,5045 -
0,01157027 1 1 TRUE
SP28 primary_M SP28_primary_M 11 193112 134856661 0,5 -
0,009454102 1 1 TRUE
SP28 primary_M SP28_primary_M 12 310901 8203273 0,503 -
0,070715019 1 1 TRUE
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SP28 primary_M SP28_primary_M 12 8492799 8509576 0,744 -
0,31777576 1 1 TRUE
SP28 primary_M SP28_primary_M 12 8509668 133808129 0,5
0,004120847 1 1 TRUE
SP28 primary_M SP28_primary_M 13 19042581 114323997 0,5015
0,030213101 1 1 TRUE
SP28 primary_M SP28_primary_M 14 19411738 107283160 0,5 -
0,004108061 1 1 TRUE
SP28 primary_M SP28_primary_M 15 20169854 102313869 0,5 -
0,007211947 1 1 TRUE
SP28 primary_M SP28_primary_M 16 97610 90142087 0,5 -0,050338588
1 1 TRUE
SP28 primary_M SP28_primary_M 17 6115 81052423 0,5 -0,062575304
1 1 TRUE
SP28 primary_M SP28_primary_M 18 196829 77896242 0,5015
0,023080347 1 1 TRUE
SP28 primary_M SP28_primary_M 19 367089 7743159 0,5 -
0,128676849 1 1 TRUE
SP28 primary_M SP28_primary_M 19 7754942 7755056 0,769 -
0,126731082 1 0 FALSE
SP28 primary_M SP28_primary_M 19 7755159 59010819 0,503 -
0,065501578 1 1 TRUE
SP28 primary_M SP28_primary_M 20 76962 62959184 0,5 -0,038576729
1 1 TRUE
SP28 primary_M SP28_primary_M 21 9650104 48083526 0,5
0,010527718 1 1 TRUE
SP28 primary_M SP28_primary_M 22 16255826 51065831 0,5 -
0,068285282 1 1 TRUE
SP28 primary_S SP28_primary_S 1 808928 147287992 0,505 -
0,029224509 1 1 TRUE
SP28 primary_S SP28_primary_S 1 148342446 148902833 0,717 -
0,023598749 1 0 FALSE
SP28 primary_S SP28_primary_S 1 149648627 248813901 0,5
0,026114229 1 1 TRUE
SP28 primary_S SP28_primary_S 2 173150 242814463 0,5
0,022086935 1 1 TRUE
SP28 primary_S SP28_primary_S 3 361508 197581147 0,5
0,012702413 1 1 TRUE
SP28 primary_S SP28_primary_S 4 60303 190905235 0,503 0,034478274
1 1 TRUE
SP28 primary_S SP28_primary_S 5 163266 180670470 0,5
0,015191908 1 1 TRUE
SP28 primary_S SP28_primary_S 6 335424 31237727 0,504
0,004132437 1 1 TRUE
SP28 primary_S SP28_primary_S 6 31237767 31238308 0,6765
0,027601497 2 1 TRUE
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SP28 primary_S SP28_primary_S 6 31238318 32489642 0,507 -
0,000865771 1 1 TRUE
SP28 primary_S SP28_primary_S 6 32489707 32628001 0,628 -
0,036818021 1 1 FALSE
SP28 primary_S SP28_primary_S 6 32628030 33036630 0,513
0,001732368 1 1 FALSE
SP28 primary_S SP28_primary_S 6 33036717 33037768 0,6495
0,264528516 2 1 TRUE
SP28 primary_S SP28_primary_S 6 33043930 170892848 0,5
0,018152218 1 1 TRUE
SP28 primary_S SP28_primary_S 7 296739 159024799 0,5 -
0,004728198 1 1 TRUE
SP28 primary_S SP28_primary_S 8 182949 146222122 0,505
0,017022579 1 1 TRUE
SP28 primary_S SP28_primary_S 9 154795 45372293 0,506
0,023631267 1 1 TRUE
SP28 primary_S SP28_primary_S 9 65595104 141070950 0,5
0,001708899 1 1 TRUE
SP28 primary_S SP28_primary_S 10 1052950 135279979 0,5
0,003575793 1 1 TRUE
SP28 primary_S SP28_primary_S 11 193112 134856661 0,5 -
0,007932024 1 1 TRUE
SP28 primary_S SP28_primary_S 12 310901 133808129 0,5 -
2,73E-05 1 1 TRUE
SP28 primary_S SP28_primary_S 13 19042581 114323997 0,504
0,026764251 1 1 TRUE
SP28 primary_S SP28_primary_S 14 19411738 107283160 0,5
0,005921423 1 1 TRUE
SP28 primary_S SP28_primary_S 15 20169854 102313869 0,5 -
0,004197176 1 1 TRUE
SP28 primary_S SP28_primary_S 16 97610 90142087 0,5 -0,065855136
1 1 TRUE
SP28 primary_S SP28_primary_S 17 6115 81052423 0,5 -0,073291896
1 1 TRUE
SP28 primary_S SP28_primary_S 18 196829 77896242 0,5
0,034432231 1 1 TRUE
SP28 primary_S SP28_primary_S 19 367089 59010819 0,5 -
0,122919503 1 1 TRUE
SP28 primary_S SP28_primary_S 20 76962 62959184 0,5 -0,035923271
1 1 TRUE
SP28 primary_S SP28_primary_S 21 9650104 48083526 0,5 -
0,008482657 1 1 TRUE
SP28 primary_S SP28_primary_S 22 16255826 51065831 0,5 -
0,070960888 1 1 TRUE
SP28 primary_T SP28_primary_T 1 808928 248813901 0,508
0,05366553 1 1 TRUE
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SP28 primary_T SP28_primary_T 2 173150 242814463 0,582 -
0,260783298 1 1 FALSE
SP28 primary_T SP28_primary_T 3 361508 197581147 0,536
0,029285458 1 1 FALSE
SP28 primary_T SP28_primary_T 4 60303 190905235 0,5 -0,15215363
1 1 TRUE
SP28 primary_T SP28_primary_T 5 163266 180670470 0,612 -
0,12905774 1 1 FALSE
SP28 primary_T SP28_primary_T 6 335424 29855401 0,507
0,039995648 1 1 TRUE
SP28 primary_T SP28_primary_T 6 29855849 29855945 0,801 -
0,584705214 1 0 FALSE
SP28 primary_T SP28_primary_T 6 29856330 29913483 0,514
0,005139506 1 1 TRUE
SP28 primary_T SP28_primary_T 6 29925456 29943067 0,722
0,07229471 2 1 TRUE
SP28 primary_T SP28_primary_T 6 29976789 31237727 0,505
0,014574939 1 1 TRUE
SP28 primary_T SP28_primary_T 6 31237767 31238372 0,73
0,06539921 2 1 FALSE
SP28 primary_T SP28_primary_T 6 31238490 32546696 0,557 -
0,022170317 1 1 FALSE
SP28 primary_T SP28_primary_T 6 32546703 32546953 0,712
0,74820002 3 1 TRUE
SP28 primary_T SP28_primary_T 6 32548122 33085033 0,6 -
0,015948396 1 1 FALSE
SP28 primary_T SP28_primary_T 6 33086249 170892848 0,5
0,021008012 1 1 TRUE
SP28 primary_T SP28_primary_T 7 296739 159024799 0,643
0,143697893 2 1 FALSE
SP28 primary_T SP28_primary_T 8 182949 146222122 0,506
0,099393536 1 1 TRUE
SP28 primary_T SP28_primary_T 9 154795 141070950 0,5
0,030283926 1 1 TRUE
SP28 primary_T SP28_primary_T 10 1052950 46143958 0,85 -
0,405592404 1 0 FALSE
SP28 primary_T SP28_primary_T 10 46965018 47000146 0,605 -
0,241240536 1 1 TRUE
SP28 primary_T SP28_primary_T 10 47605468 51549496 0,84 -
0,338100277 1 0 FALSE
SP28 primary_T SP28_primary_T 10 51623061 51633027 0,538 -
0,695305454 1 1 TRUE
SP28 primary_T SP28_primary_T 10 51785728 135279979 0,847 -
0,398638533 1 0 FALSE
SP28 primary_T SP28_primary_T 11 193112 59860178 0,578
0,403108628 1 1 FALSE
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SP28 primary_T SP28_primary_T 11 59940599 63072310 0,818 -
0,541147973 1 0 FALSE
SP28 primary_T SP28_primary_T 11 63129782 64950970 0,5
0,060385147 1 1 TRUE
SP28 primary_T SP28_primary_T 11 64972354 70829858 0,81 -
0,520963713 1 0 FALSE
SP28 primary_T SP28_primary_T 11 71260047 72316148 0,544
0,07686167 1 1 TRUE
SP28 primary_T SP28_primary_T 11 72407770 134856661 0,812 -
0,549594238 1 0 FALSE
SP28 primary_T SP28_primary_T 12 310901 133808129 0,508 -
0,134747941 1 1 TRUE
SP28 primary_T SP28_primary_T 13 19042581 42876290 0,5
0,143779013 1 1 TRUE
SP28 primary_T SP28_primary_T 13 43180503 95230412 0,836 -
0,558197583 1 0 FALSE
SP28 primary_T SP28_primary_T 13 95275576 114323997 0,507
0,119452914 1 1 TRUE
SP28 primary_T SP28_primary_T 14 19411738 107283160 0,5
0,051310742 1 1 TRUE
SP28 primary_T SP28_primary_T 15 20169854 22788922 0,653 -
0,557483034 1 0 FALSE
SP28 primary_T SP28_primary_T 15 22846965 102313869 0,81 -
0,533854034 1 0 FALSE
SP28 primary_T SP28_primary_T 16 97610 90142087 0,5 -0,167248098
1 1 TRUE
SP28 primary_T SP28_primary_T 17 6115 2930339 0,891 0,235422346
2 0 FALSE
SP28 primary_T SP28_primary_T 17 2965929 2966308 0,529 -
0,016470545 1 1 TRUE
SP28 primary_T SP28_primary_T 17 3144286 18252010 0,892
0,170198769 2 0 FALSE
SP28 primary_T SP28_primary_T 17 18314964 18380154 0,519 -
0,459669711 1 1 TRUE
SP28 primary_T SP28_primary_T 17 18417838 21194785 0,876
0,221151974 2 0 FALSE
SP28 primary_T SP28_primary_T 17 21312542 81052423 0,5
0,186782701 1 1 TRUE
SP28 primary_T SP28_primary_T 18 196829 77896242 0,5
0,012921272 1 1 TRUE
SP28 primary_T SP28_primary_T 19 367089 7755285 0,719
0,422261851 2 1 FALSE
SP28 primary_T SP28_primary_T 19 7755482 7761667 0,948759057
0,246842257 2 0 TRUE
SP28 primary_T SP28_primary_T 19 7794609 59010819 0,709
0,412590001 2 1 FALSE
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SP28 primary_T SP28_primary_T 20 76962 58645262 0,625 -0,270698237
1 1 FALSE
SP28 primary_T SP28_primary_T 20 59829847 62959184 0,5 -
0,068914521 1 1 TRUE
SP28 primary_T SP28_primary_T 21 9650104 11186346 0,5635
0,068148661 1 1 FALSE
SP28 primary_T SP28_primary_T 21 14433284 48083526 0,507
0,212492584 1 1 TRUE
SP28 primary_T SP28_primary_T 22 16255826 24622648 0,583 -
0,040471716 1 1 FALSE
SP28 primary_T SP28_primary_T 22 24717518 51065831 0,5
0,173599111 1 1 TRUE
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Training model. Expected read counts harbouring a variant allele, for a clonal SNV (adjusted for Copy Number)
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20
Test data. Deep Sequencing reveals clonal SNVs in the primary tumour that are missing in the margin samples. Phylogenetic analysis. The tree supports 
margin samples being ancestral to primary 
tumour regions.
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Deep-resolution clonal SNVs (~3000x)
NV < k in M; tested with read coverage from tumour (NR).
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